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QUILL ON SCALPEL
*
K
This section provides a medium through which Canadian surgeons can declare themselves, briefly 
and informally, on the day-to-day affairs of surgery.
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In this issue (page 71), Gagic draws 
attention to a rare type of internal 
herniation, the right paraduodenal 
hernia. In the two cases he describes, 
the diagnosis was made preoperative- 
ly because of a high index of suspi­
cion. The most useful investigation 
was radiologic study of the small in­
testine with barium contrast medium. 
Gagic emphasizes the important ana­
tomical relations that must be kept in 
mind at the time of repair.
Although the term “paraduodenal 
hernia” is firmly established in the 
literature, it should not be forgotten 
that Moynihan1 recognized two forms 
of “right paraduodenal hernia”. He 
also described other fossae in the vi­
cinity of the duodenum into which the 
small intestine could herniate. With 
this knowledge, it should be obvious 
that two left-sided and three right­
sided internal hernias are possible in 
the periduodenal area (Fig. 1).
The ability of the surgeon to rec­
ognize these fossae after reducing the 
hernia and to be aware of the ana­
tomical differences needs to be 
stressed.
Left-Sided Hernias
On the left side, intestine may her­
niate into either the paraduodenal 
fossa or the fossa mesocolica.
Paraduodenal Fossa (Fig. 1A)
The paraduodenal fossa is situated 
to the left of the ascending limb of 
the duodenum. It is bounded inferior- 
ly by the inferior mesenteric artery or 
its left colic branch. The inferior mes­
enteric vein runs along its free mar­
gin. The superior end of the fossa is 
posterior to the duodenojejunal junc­
tion. The fundus of the fossa extends 
to the left, posterior to the descending 
mesocolon.
the left side of the abdomen, is di­
rected upwards. Its fundus is cephalad 
and blends with the posterior and 
dorsal surfaces of the omental bursa. 
At the free margin of the aditus are 
the middle colic artery medially and 
the marginal artery of Drummond an­
teriorly. Two minor variations may be 
noted. In one, the aditus blends with 
the parietal peritoneum along the in­
ferior border of the pancreas. In the 
other, part of the fossa extends behind 
the descending mesocolon and medial­
ly to the horizontal limb of the duo­
denum. In such cases the left colic 
artery is found along the inferior mar­
gin of the aditus but the inferior mes­
enteric vein and pancreas are covered 
by the peritoneum forming the pos­
terior wall of the fossa.
Right-Sided Hernias
On the right side, intestine may 
herniate into the posterior duodenal 
fossa, the mesentericoparietal fossa or 
the parajejunal fossa.
Posterior Duodenal Fossa (Fig. 1A)
This fossa always arises from the 
superior end of the paraduodenal 
fossa. However, a patient with a para­
duodenal fossa does not necessarily
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Fossa Mesocolica (Fig. IB) FIG. 1—Periduodenal fossae. Five recesses into which small intestine can
. herniate as seen when facing subject in supine position: (A) left-sided paraduodenal
The entrance to this fossa, situated fossa and right-sided posterior duodenal fossa, (B) fossa mesocolica, (C) mesenterico-
within the transverse mesocolon on parietal fossa, (D) parajejunal fossa.
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have a posterior duodenal fossa. The 
aditus is situated behind the duodeno­
jejunal junction to the right of the 
inferior mesenteric vein. The neck of 
the fossa extends to the right, the 
middle colic artery, within the trans­
verse mesocolon, lying anteriorly and 
the pancreas and superior mesenteric 
vessels posteriorly. The fundus is 
downwards, to the right of the middle 
colic artery and behind the ascending 
mesocolon.
Mesentericoparietal Fossa (Fig. 1C)
The orifice of this fossa is directed 
downwards and to the left. The trans­
verse limb of the duodenum forms the 
superior border. The superior mesen­
teric artery passes along its free an­
Surgeons’ assistants have been widely 
employed in the United States in car­
diovascular and thoracic surgical serv­
ices,1,2 in community hospitals as em­
ployees of individual surgeons or of 
hospitals and in university services, 
usually under the aegis of the depart­
ment of surgery. They are allied 
health professionals who have com­
pleted a 2-year educational program 
in medical sciences that includes clin­
ical experience. In the US there are 
many such programs that train both 
physicians’ and surgeons’ assistants.
In 1977 a proposal to use surgeons’ 
assistants in the division of thoracic 
and cardiovascular surgery at the Uni­
versity of Alberta Hospital was made 
to the department of surgery and to 
the hospital board. The thrust of this 
proposal was that there were increas­
ing manpower requirements on the 
busy cardiovascular and thoracic sur­
gical service and yet, because of re­
striction in practice opportunities, 
there was no justification for the 
training of more housestaff. In view 
of the American experience with sur­
geons’ assistants, the possibility of hir­
ing such individuals in Canada was 
entertained.
Both the department of surgery and 
the hospital board endorsed the prop­
osition and, at that time, the College 
of Physicians and Surgeons of Alberta 
was prepared to license such para­
medical personnel. The funding was 
obtained through the Heritage Trust 
Fund’s expansion program in cardio­
vascular surgery.
Contact was made with the Cana­
dian Medical Protective Association; 
it had no experience in medicolegal 
matters relating to surgeons’ assistants,
terior border, formed by the meso- 
jejunum that failed to adhere to the 
posterior parietal peritoneum. Its 
fundus is directed downwards and to 
the right behind the ascending meso­
colon.
Parajejunal Fossa (Fig. 1 D)
This fossa is situated at the root 
of the infolded jejunal mesentery, 
which has adhered along the medial 
border to the posterior parietal peri­
toneum covering the great vessels. Its 
orifice is directed downwards and to 
the left. The fundus is cephalad, to 
the right of the second part or de­
scending limb of the duodenum.
It should be remembered that the 
first few inches of the jejunum are
so arrangements were made to cover 
them under the insurance umbrella of 
the hospital.
A decision was made that such per­
sonnel would be hired by the univer­
sity hospital and would report directly 
to the director of the division of tho­
racic and cardiovascular surgery.
In mid-1979 advertising in Canada 
began; however, after 3 months, no 
replies were forthcoming, so the posi­
tion was advertised in the US. There 
were about 30 applicants, 2 of whom 
were brought to Edmonton for inter­
views and 1 was selected.
This man’s credentials were then 
submitted to the College of Physicians 
and Surgeons, which licensed him to 
function as a surgeon’s assistant with­
in the confines of the University of 
Alberta Hospital. He began his em­
ploy at the University of Alberta Hos­
pital in January 1980. His day-to-day 
functions were determined by the 
chief resident in cardiovascular sur­
gery. His function was carefully de­
fined in his job description. This in­
cluded initial history-taking and phy­
sical examination, consultation with 
the surgeons regarding patient orders, 
instituting necessary recognized emer­
gency procedures required in life- 
threatening situations, recording ap­
propriate information on the patient’s 
record and participating in the pre­
operative and postoperative teaching 
program for patients and families. In 
the operating room he assisted the 
surgeon, either as a first or second 
assistant in the performance of cardio­
vascular and thoracic surgical opera­
tions.
He functioned extremely well and 
his interactions with nurses and res­
incorporated into the wall of the sac 
in all these hernias except that into 
the mesentericoparietal fossa. Only in 
this hernia are the afferent and ef­
ferent limbs of the small intestine seen 
entering and leaving the hernial sac. 
Otherwise, only the efferent small in­
testine is seen emerging from the 
orifice at the time of recognition. 
R o b e r t o  L. E s t r a d a , m d , f r c s [c ],
FACS
Associate professor of surgery,
McGill University;
Senior surgeon.
The Montreal General Hospital. 
Montreal, PQ
Reference
1. M o y n ih a n  BG A: On Retroperitoneal Her­
nia, Bailliere, Tindall & Cox, London, 1899
Canada
idents in the operating room, in the 
cardiac surgical intensive care unit 
and on the ward were without in­
cident. He functioned essentially as a 
junior resident on the service in an 
extremely, capable manner.
After 9 months of satisfactory serv­
ice, he left Canada to return to Flo­
rida for personal reasons. Subsequent­
ly, a Canadian physician’s assistant, 
trained in the US, was hired.
The licensing of paramedical per­
sonnel has been removed from the 
hands of the College of Physicians 
and Surgeons of Alberta by the pro­
vincial government and a Health Oc­
cupations Act (Bill 80) has been 
passed by the legislature. This effec­
tively puts the responsibility for the 
licensing of all paramedical personnel 
into the hands of a bureaucratic agen­
cy. Unfortunately the mechanism for 
licensing has not yet been fully estab­
lished but will be soon.
It is apparent that surgeons’ assist­
ants are going to become an indis­
pensable part of our service. I anti­
cipate that they will be more widely 
employed in other surgical fields in 
the future.
E l l i o t  T. G e l f a n d , m d , f r c s [c ]
Division of thoracic and cardiovascular 
surgery,
Department of surgery.
University of Alberta,
Edmonton, Alta.
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REVIEW ARTICLE
Primary Hyperparathyroidism in Children
R o b ert  M. G irard , m d , f r c s [c ],* A n d r e  B elanger , m d T and  B ern ard  H a zel , m d |
Primary hyperparathyroidism is rare 
in children. This report describes a 
15-year-old boy who had an intrathymic 
chief cell adenoma. The literature 
related to this condition in neonates 
and children is reviewed. Neonatal 
hyperparathyroidism differs from 
hyperparathyroidism in children. The 
severity of symptoms and osseous 
lesions, genetic inheritance in many, 
pathological changes in the parathyroid 
glands and the need for more 
extensive treatment in neonates and 
infants indicate that primary 
hyperparathyroidism in these patients 
should be considered as a different 
entity from that occurring in older 
children.
L’hyperparathyroi'die primaire est 
une maladie rare chez I'enfant. Les 
auteurs rapportent un patient de 
15 ans chez qui un adenome constitue 
de cellules principales a ete trouve 
dans le thymus. La revue de la 
litterature indique que I'hyperpara- 
thyroidie survenant chez le nouveau-ne 
et le jeune enfant est une maladie 
differente de I’hyperparathyroidie 
survenant chez I'enfant plus age.
La severite des symptomes et 
des lesions osseuses, le mode de 
transmission hereditaire chez plusieurs, 
les differences pathologiques dans 
les glandes parathyroides et la 
necessity d'un traitement chirurgical 
plus precoce et plus etendu chez 
le nouveau-ne et le jeune enfant 
indiquent que I'hyperparathyroidie 
primaire chez ces patients doit etre 
consideree comme une entite 
differente de I'hyperparathyroidie 
primaire survenant chez I'enfant plus 
age.
From the department of surgery* and section of endocrinology, t  Hopital Maisonneuve-Rosemont, Universite de Montreal, Montreal, PQ 
Accepted for publication Oct. 5, 1981 
Reprint requests to: Dr. Robert M. 
Girard, 5415, boul. de I’Assomption, Montreal, PQ H IT  2M4
Primary hyperparathyroidism seldom 
occurs in infants and children. Even 
though the diagnosis has been facil­
itated by the use of automated bio­chemical determinations of serum cal­
cium and phosphorus and by the increasing availability of parathor­mone radioimmunoassay, there are 
few reports of this condition in chil­dren under 16 years of age. Until 
1980, only 85 cases had been de­scribed in the literature.1'16 We report the case of a 15-year-old boy with primary hyperparathyroidism caused 
by an intrathymic chief cell adenoma. When diagnosed early, the disease can 
be cured by surgical treatment. Be­cause the disease is rare and its mani­festations differ somewhat from the 
adult form, a review of its clinical presentation, pathologic features and 
treatment is worthwhile.The first review of primary hyper­
parathyroidism in children was pub­
lished in 1960 by Nolan and asso­ciates17 who reported 23 cases. Bjernulf and colleagues6 reviewed the 
literature in 1970 and found an addi­
tional 20 patients. To these 43 cases, we must add 2 reported by Hillman and colleagues,1 2 by Miihlethaler and 
associates2 and 3 others reported by 
Corbeel and associates,3 Farriaux’s group4 and Verger and colleagues.5 In 
1970, reports of 50 cases had been published. Mannix7 summarized 14 
cases reported from 1971 to 1973 and described 3 of his own. Since then, we have found 18 other cases plus the case reported here bringing the total 
to 86.
Case Report
A 15-year-old black boy was admitted 
to the Hopital Maisonneuve-Rosemont 
in March 1977 for treatment of anemia 
and retarded growth. He had not com­plained of gastrointestinal, urinary, car­
diac, pulmonary or neurologic symptoms. 
Born in Haiti, he had emigrated to Can­
ada in 1976. He was the youngest of
three children and had been delivered 
normally after a normal pregnancy. His 
mother and father died shortly after his 
birth. His parents, his 30-year-old sister 
and his 28-year-old brother were ap­
parently also of short stature. There was 
no family history of primary hyperpara­
thyroidism.The boy appeared intelligent. He was 
127 cm tall (50th percentile of an 8- 
year-old boy) and weighed 22 kg (50th 
percentile of a 7-year-old boy). There 
was slight truncal obesity without ap­
parent muscle atrophy. Blood pressure 
was 110/60 mm Hg. No hair growth 
was noted over the pubic region or in 
the axillae, and the penis and testes 
seemed rather small for his age. Physical 
findings were otherwise normal.
The following laboratory determina­
tions gave normal results: falciform
hemoglobin S, electrophoresis of hemo­
globin and protein, total serum choles­
terol and triglycerides, blood urea nitro­
gen, glucose tolerance curve, D-xylose 
test and urinary electrophoresis of amino 
acids.Basal pituitary thyroid and adrenal 
functions were normal. An adequate 
pituitary response to luteinizing hormone­
releasing and thyrotropin-releasing hor­
mones, insulin injection and arginine in­
fusion was demonstrated. The initial pro­
lactin value (8.0 ng/ml) increased to 
28 ng/ml after administration of thyro­
tropin-releasing hormone.
The hemoglobin value was 10.2 g/dl, 
hematocrit 32.9%, leukocyte count 
5 X 10V1, erythrocyte sedimentation rate 
9 mm/h and reticulocyte count 3.3% 
red cells. Mean corpuscular volume was 
53 fl (normal 90 ±  9 fl), mean corpus­
cular hemoglobin 19 pg (normal 29 ±  
2 pg), mean corpuscular hemoglobin 
concentration 31 g/dl (normal 34.5 ±  
2 g/dl), serum iron value 40 p.g/dl 
(7.2 p.mol/1) and total iron binding capa­
city 495 g/dl (88.6 p.mol/1).Blood sodium and potassium levels 
were normal while chloride was slightly 
elevated (111 mmol/1). Blood pH was 
7.35 with a carbon dioxide content of 
20 mmol/1.Serum calcium was elevated on many 
occasions (11.3 to 11.8 mg/dl [2.8 to 
2.9 (j.mol/1]) and serum phosphorus was 
always low (2.2 to 2.8 mg/dl [0.7 to
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0.9 mmol/1]). Calculated ionized calcium 
was 5.2 mg/dl (1.3 g.moi/1). Urinary cal­
cium and phosphorus were normal on 
many occasions, values ranging from 78 
to 236 mg/d (1.95 to 5.9 mmol/d) and 
260 to 492 mg/d (8.4 to 15.9 mmol/d) 
respectively. Alkaline phosphatase was 
elevated to 1130 Bodansky units (nor­
mal for this age, up to 200 Bodansky 
units). Two radioimmunoassays for para­
thormone gave values of 587 pg/ml and 
719 pg/ml (normal 163 to 347 pg/ml).
Skull and chest roentgenograms, intra­
venous pyelogram and upper and lower 
gastrointestinal films were normal. Roent­
genograms of the hands and long bones 
showed diffuse demineralization with a 
retarded bone age corresponding to that 
of an 8-year-old child.
Anemia was easily corrected by oral 
iron therapy. Because of several increases 
in the serum calcium values and in para­
thyroid hormone and serum chloride 
levels, and the decrease in serum phos­
phorus and carbon dioxide content, pri­
mary hyperparathyroidism was diagnosed.
The parathyroid glands were explored 
in May 1977. An adenoma 1.5 cm in dia­
meter was found in the right lobe of the 
thymus after transcervical thymectomy. 
Another atrophic parathyroid gland was 
embedded in thymic tissue and removed 
inadvertently. Two other glands were 
found to be atrophic. Histologic exam­
ination showed thymic tissue containing 
an adenoma made up mainly of chief 
cells. After the operation, the patient 
had symptoms of hypocalcemia and re­
quired calcium intravenously for 8 days 
and oral supplements of calcium for 2 
months. Three months after operation, 
the serum calcium level was 8.6 mg/dl 
(2.1 (Amol/1), phosphorus was 5.3 mg/dl 
(1.7 mmol/1), alkaline phosphatase was 
465 Bodansky units, serum chloride 104 
mmol/1 and carbon dioxide content 24 
mmol/1. When the patient was seen 2Vi 
years after operation, his weight was 
50 kg (50th percentile of a 15 '/i -year-old 
boy) and his height 157 cm (50th per­
centile of a 14-year-old boy). Serum cal­
cium, phosphorus, chloride and alkaline 
phosphatase values were normal.
D iscussion
Among the 86 patients reported, 17 
were neonates and all had parathyroid 
hyperplasia.1-4,9,10,14,18-23 Of the remain­
ing 69 patients, 1 was a 12-year-old 
boy with familial primary hyperpara­
thyroidism without anv evidence of 
associated endocrine disturbance.16 In 
this condition, hyperplasia of the four 
parathyroid glands is usually found, 
but this child and his mother had a 
single adenoma, which is the usual 
finding in children. The 68 other cases 
did not have known genetic inherit­
ance and the parathyroid condition 
was adenoma in 54, hyperplasia in 3 
and unknown in 11 patients (Table I).
In neonatal primary hyperpara­
thyroidism there is no sex predomin­
ance (8 boys and 9 girls have been 
described in the literature) while in 
children, 40 boys and 29 girls have 
been reported. Among adults, pri­
mary hyperparathyroidism occurs two 
to three times more frequently in 
women than in men.24
Symptoms and Signs
Neonates and infants with primary 
hyperparathyroidism have symptoms 
such as lethargy, hypotonia, poor 
feeding ability, failure to thrive, de­
hydration, diarrhea or constipation 
and respiratory distress. These symp­
toms may appear as early as a few 
days or weeks after birth. The pa­
tients are frequently very ill and this 
diagnosis is usually not considered. 
Serum calcium levels are always ex­
tremely high. Most infants have serum 
calcium levels greater than 15 mg/dl 
(3.7 jtimol/1), and even above 20 
m g/dl (5.0 /zmol/1). One infant’s se­
rum calcium level was 30.5 mg/dl (7.6 
yumol/1).10 The finding of hypercalce­
mia, obviously, helps establish the 
diagnosis. A single determination, how­
ever, is not sufficient as in several 
patients the serum calcium levels ini­
tially were normal and then rose ra­
pidly over several days. Since neo­
natal primary hyperparathyroidism 
may occur in the setting of familial 
hyperparathyroidism1'22 with auto­
somal dominant inheritance,14,25 neo­
nates and infants with such symptoms, 
and affected family members, should 
be tested early in life and periodically 
thereafter.
During childhood, the clinical pic­
ture of the condition is often non­
specific and inconspicuous. Trivial 
signs and symptoms such as fatigue,
nausea, vomiting, constipation, weak­
ness, anorexia, dizziness, weight loss, 
failure to thrive and personality 
changes are common. They are due 
to the hypercalcemia which is often 
higher than in adults with primary 
hyperparathyroidism. It is obvious 
that this diagnosis may not even be 
considered in many and it is suggested 
that serum calcium determinations be 
made in children with such symptoms.
Infants and children with primary 
hyperparathyroidism have a high fre­
quency of detectable bone diseases.14,26 
Twenty-five of 43 pediatric patients 
reported by Bjernulf and colleagues6 
had skeletal changes demonstrated 
radiologically while overt skeletal 
changes are identified in only approxi­
mately 10% of the adults with pri­
mary hyperparathyroidism.24,27 The 
basic radiologic bone changes are si­
milar to those in adults: demineraliza­
tion, subperiosteal bone resorption and 
pathologic fracture. However, there 
are substantial differences in neonates 
and infants: all those reported in the 
literature had significant diffuse de­
mineralization with severe bone re­
sorption; subperiosteal bone resorption 
involves the long bones rather than 
the phalanges and pathologic fracture 
of the extremities or ribs is common.28
Renal lesions have not been de­
scribed in neonates and infants and 
seem to be less common in children 
than in adults, probably because of 
the shorter duration of the disease. 
Only 25% of the cases reviewed by 
Bjernulf and associates6 had renal 
calculi compared with 30% to 70% 
of adult patients treated surgically for 
this disease. Nevertheless in some 
series, urologic complications are fre­
quent; 78% of the patients with prov-
Table I—Primary Hyperparathyroidism in Children
Sex Pathological findings
Authors cases M F Adenoma Hyperplasia Unknown
Hillman and associates, 1964' 2 2 0 0 2 o
Miihlethaler and associates, 19672 2 0 2 0 2 o
Corbeel and associates, 19681 1 0 1 0 1 o
Farriaux and associates, 1968 * 1 0 1 0 1 o
Verger and associates, 1970s 1 1 0 1 0 o
Bjernulf and associates, 1970® 43 25 18 35 7 1
Ahuja and Rao, 1973s 1 1 0 1 0 o
Garcia-Bunuel and associates, 1974" 1 0 1 0 1 o
Mannix, 19757 17 8 9 14 3 o
Rhone, 197510 1 0 1 o 1 o
IVIalek and Kelalis, 1976“ 9 4 5 0 o 9
Gluckman and associates, 19771 - 1 1 0 1 o o
Behera and associates, 197813 1 1 0 0 o 1
Thompson and associates, 197814 2 2 0 0 2 o
Mejlhede, 197916 1 1 0 1 0 0
Sandler and Moncrieff, 198019 1 1 0 1 o o
Present report 1 1 0 1 0 0
Total 86 48 38 55 20 11
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en primary hyperparathyroidism re­
ported by Malek and Kelalis11 had 
such complications.
Pathological Features
All the reported neonates with 
primary hyperparathyroidism had pa­
rathyroid hyperplasia. Most pathol­
ogists and surgeons do not have ex­
perience with gross and microscopic 
evaluation of infantile parathyroid 
glands, which may be difficult to in­
terpret. The size, weight and micro­
scopic appearance differ considerably 
from those in the adult.29 Their size 
ranges from 1 to 3 mm diameter and 
their average weight is 2.9 mg (range 
from 0.9 to 4.8 mg) in infants 5 to 7 
months of age.30 Rhone10 found the 
average total weight of infantile para­
thyroid glands to be 8.8 mg. A normal 
parathyroid gland (diameter 0.5 to 
0.8 cm) in an adult weighs 30 mg, 
more than 10 times that of an infant’s 
gland. The histology of neonatal para­
thyroid glands must be interpreted 
with caution. After studying the mor­
phology and development of the para­
thyroid glands during the first 30 days 
of life, Kaplan29 found enlarged glands 
with hyperplastic changes in infants 3 
to 10 days old. Garcia-Bunuel and 
colleagues9 found that, except for a 
greater content of cytoplasmic glyco­
gen and a less conspicuous Golgi ap­
paratus, abnormal cells from neo­
nates with hyperparathyroidism close­
ly resembled the adult light chief cells.
Most of the children with primary 
hyperparathyroidism had parathyroid 
adenoma. Among 69 such patients, 55 
had adenomas, 3 had hyperplastic 
glands and in 11 the pathological find­
ings were unknown. So far, no para­
thyroid cancer has been described in 
infants or children.
Treatment
Neonatal primary hyperparathyroid­
ism is a surgical emergency requiring 
immediate parathyroidectomy. These 
patients usually present the “failure 
to thrive” syndrome and parathyroid­
ectomy must be done early to be 
effective.1,22,23 Moreover, parathyroid­
ectomy may be unsuccessful if it is 
delayed until irreversible metastatic 
calcifications develop in the lungs, 
heart or kidney.3'10'14 Eight of 17 in­
fants died before they could be 
operated on.1'*'4'18-20-23 Six infants who 
underwent parathyroidectomy sur- 
vived1'9'14'21,22 and three others died 
postoperatively.3'10'14 Five of the six 
survivors required re-exploration after 
initial subtotal parathyroidectomy 
failed to correct hypercalcemia. Only 
one infant remained well after re-
VOLUME 25, NO. I, JANUARY 1982
moval of 3 Vi glands.1 In spite of 
early diagnosis and recognition of the 
urgent need to operate, failure results 
if insufficient parathyroid tissue is 
removed. The minimal operation for 
neonatal hyperparathyroidism is ex­
cision of 3‘/2 glands but total para­
thyroidectomy is the treatment of 
choice to control the disease. Imme­
diate autotransplantation of parathy­
roid tissue in an accessible area of 
the neck or forearm or freezing of 
parathyroid tissue for future auto­
transplantation in an aparathyroid pa­
tient should be considered after total 
parathyroidectomy.
In children, surgical removal of a 
parathyroid adenoma or hyperplastic 
glands is adequate treatment and the 
majority were cured by removing only 
the enlarged adenomatous gland. Sub­
total parathyroidectomy cured the 
three patients with hyperplasia. Tran­
sitory hypocalcemia often follows the 
successful removal of an adenomatous 
gland as it is known that functional 
adenoma leads to atrophy of the re­
maining glands. After a few days or 
weeks, residual parathyroid glands re­
gain normal function and calcium 
therapy can be stopped.
Parathyroid adenoma can be found 
in supernumerary or ectopic glands 
including those in the mediastinal thy­
mus.31 In children only three cases 
(including ours) of ectopic adenoma 
have been described.8’32 All were 
found in the anterosuperior medias­
tinum and two of them were in the 
thymus.
Although this report emphasizes 
that primary hyperparathyroidism is a 
cause of moderate hypercalcemia in 
children, other diagnoses, such as tran­
sient hyperparathyroidism in a neon­
ate secondary to maternal hypopara­
thyroidism, idiopathic hypercalcemia 
and hypercalciuria, hypervitaminosis 
D, sarcoidosis, hyperparathyroidism 
and malignant disease, should be con­
sidered. Determination of serum pa­
rathormone levels in relation to serum 
calcium and phosphorous concentra­
tions permits accurate diagnosis of the 
condition.
Conclusions
Primary hyperparathyroidism in pa­
tients under 16 years of age is rare. 
Among the 86 reported patients, two 
types are recognized, one occurring 
in neonates and infants and the other 
during childhood. Neonatal hyper­
parathyroidism is often genetically- 
transmitted as an autosomal dominant 
trait and is fatal unless recognized 
and treated early. The characteristic
pathological change is chief cell hy­
perplasia of the parathyroid glands. 
Near-total parathyroidectomy is the 
minimal operation required to control 
the disease. The prognosis following 
surgery is good, providing a delay in 
diagnosis has not resulted in irrever­
sible changes. In children the condi­
tion does not have known genetic in­
heritance and may be an early onset 
of adult acquired primary hyperpara­
thyroidism. It is more frequent in 
boys than in girls and osseous lesions 
are more common than in adults. 
Prognosis is good if appropriate sur­
gery is performed. Excision of the 
adenomatous gland or subtotal para­
thyroidectomy for those with hyper­
plastic parathyroid glands is indicated.
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To reduce the risk 
of stroke
Now, ENTROPHEN* is 
indicated for reducing the risk 
of recurrent transient ischemic 
attacks or stroke in men who 
have had transient ischemia 
of the brain due to fibrin 
platelet emboli. At present 
there is no evidence that 
ASA is effective in reducing 
transient ischemic attacks 
in women, or is of 
benefit in the treatment 
of completed strokes 
in men or women.
Inhibition of platelet 1 
cyclooxygenase activity 
by a single dose of 
ENTROPHEN*-10 
was comparable to JM
that of plain ASA, w ■ 
although the effect was f 11 
delayed, reflecting the 
delayed appearance of 
ASA in the plasma.1
with reduced risk 
of stomach upset
When you prescribe 
ASA for long-term use, 
it is important not to create 
additional problems for 
your patients.
While they may benefit 
from the therapeutic 
effect of ASA, there is 
still a potential for 
gastric irritation and 
upset, particularly 
when the regimen calls 
for continuous daily 
dosage.
Clinical experience 
has shown that 
ENTROPHEN*, coated 
with POLYMER 37* 
reduces gastric distress 
in long-term treatment 
with high doses of ASA.
?• To reduce 
the risk of stroke 
with reduced risk 
of stomach upset3hcmt
1. Ali. M. et al.: Plasma acetylsalicylate and salicylate and platelet cyclooxygenase activity following plain and enteric-coated aspirin. 
Stroke 77777:9-13, Jan/Feb 1980. * 'Trademark
TABLETS
entrophen
(acetylsalicylic acid tablets, USP) 
Enteric-coated with POLYMER 37* 
Anti-inflammatory— Analgesic Agent 
Platelet Aggregation Inhibitor 
DESCRIPTION
ENTROPHEN* is an enteric-coated tablet contain­
ing acetylsalicylic acid coated with POLYMER 37*. 
a partially esterified polyvinyl alcohol,
ACTION
Acetylsalicylic acid (ASA) has analgesic, anti­
pyretic and anti-inflammatory properties.
In rheumatic diseases, although the analgesic and 
antipyretic effects are useful, the major purpose 
for which ASA is used is to reduce the intensity of 
the inflammatory process. Inhibition of prosta­
glandin synthesis may be involved in the anti­
inflammatory action of ASA.
ASA also alters platelet aggregation and release 
reaction by inhibiting prostaglandin synthesis 
Thromboxane A, is an essential step in platelet 
aggregation. ASA prevents Thromboxane A2 for­
mation by acetylation of platelet cyclooxygenase. 
This inhibition of prostaglandin synthesis is 
irreversible and affects platelet function for the 
life of the platelet.
The POLYMER 37* coating substantially resists 
disintegration in aqueous fluids having a pH lower 
than 3.5 for a period of at least 2 hours and is 
capable of disintegrating in aqueous fluids having 
a pH of at least 5.5 in from 10 to 30 minutes. Thus, 
POLYMER 37* coating effectively inhibits the 
release of ASA in the stomach, whilst allowing the 
tablet to dissolve in the upper portion of the small 
intestine for absorption from the duodenal area 
Clinical experience has shown that POLYMER 37* 
coated acetylsalicylic acid diminishes or eliminates 
gastric distress during long-term treatment with 
high doses of ASA.
INDICATIONS
ENTROPHEN* is indicated whenever gastric 
intolerance to ASA is of concern.
ENTROPHEN* is indicated for the relief of signs 
and symptoms of the following:
Osteoarthritis 
Rheumatoid arthritis 
Spondylitis 
Bursitis
and other forms of rheumatism
Musculoskeletal disorders
Rheumatic fever, however, penicillin and other
appropriate therapy should be administered
concomitantly.
ASA is generally considered to be the primary 
therapy for most forms of arthritis.
ENTROPHEN* is also indicated for reducing the 
risk of recurrent transient ischemic attacks or 
stroke in men who have had transient ischemia of 
the brain due to fibrin platelet emboli. At present 
there is no evidence that ASA is effective in 
reducing transient ischemic attacks in women, or 
is of benefit in the treatment of completed strokes 
in men or women.
CONTRAINDICATIONS
Sensitivity to the ingredients 
Active peptic ulcer
Patients who had a bronchospastic reaction to 
ASA or non-steroidal anti-inflammatory drugs.
WARNINGS
ASA is one of the most frequent causes of 
accidental poisoning in toddlers and infants. 
ENTROPHEN* should, therefore, be kept well out 
of the reach of all children.
PRECAUTIONS
Salicylates should be administered with caution 
to patients with asthma and other allergic condi­
tions. with a history of gastrointestinal ulcerations, 
with bleeding tendencies, with significant anemia 
or with hypoprothrombinemia.
Salicylates can produce changes in thyroid 
function tests.
Acute hepatitis has been reported rarely in 
patients with systemic lupus erythematosus and 
juvenile rheumatoid arthritis with plasma sali­
cylate concentrations above 25 mg/100 mL.
Patients have recovered upon cessation of 
therapy.
Use in Pregnancy
ASA does not appear to have any teratogenic 
effects. ASA has been found to delay parturition 
in rats This effect has also been described with 
non-steroidal anti-inflammatory agents which 
inhibit prostaglandin synthesis.
High doses (3 g daily) of ASA during pregnancy 
may lengthen the gestation and parturition time. 
Because of possible adverse effects on the 
neonate and the potential for increased maternal 
blood loss, ASA should be avoided during the last 
three months of pregnancy.
Drug Interactions
Caution is necessary when ENTROPHEN* 
and anticoagulants are prescribed concurrently, as 
ASA may potentiate the action of anticoagulants. 
Salicylates may potentiate sulfonylurea hypo­
glycemic agents Large doses of salicylates may 
have a hypoglycemic action, and thus, affect the 
insulin requirements of diabetics.
Although salicylates in large doses are uricosuric 
agents, smaller amounts may depress uric acid 
clearance and thus decrease the uricosuric 
effects of probenecid, sulfinpyrazone and 
phenylbutazone.
Sodium excretion produced by spironolactone 
may be decreased in the presence of salicylates. 
Salicylates also retard the renal elimination of 
methotrexate.
ADVERSE REACTIONS
Gastrointestinal reactions: nausea, vomiting, 
diarrhea, gastrointestinal bleeding and/or ulcera­
tion. Ear reactions: tinnitus, vertigo, hearing loss. 
Hematologic reactions: leukopenia, thrombo­
cytopenia, purpura. Dermatologic and Hypersen­
sitivity reactions: urticaria, angioedema, pruritus, 
various skin eruptions, asthma and anaphylaxis. 
Miscellaneous reactions: acute reversible hepato- 
toxicity, mental confusion, drowsiness, sweating 
and thirst.
SYMPTOMS AND TREATMENT 
OF OVERDOSAGE 
Symptoms
In mild overdosage these may include rapid and 
deep breathing, nausea, vomiting (leading to 
alkalosis), hyperpnea, vertigo, tinnitus, flushing, 
sweating, thirst and tachycardia. (High blood 
levels of ASA lead to acidosis.) Severe cases may 
show fever, hemorrhage, excitement, confusion, 
convulsions or coma, and respiratory failure. 
Treatment
Treatment is essentially symptomatic and sup­
portive. Administer water, universal antidote and 
remove by gastric lavage or emesis. Force fluids 
(e.g., salty broth) to replace sodium loss. If the 
patient is unable to retain fluids orally, the alkalosis 
can be treated by hypertonic saline intravenously. 
If salicylism acidosis is present, sodium bicar­
bonate intravenously is preferred because it 
increases the renal excretion of salicylates. 
Vitamin K is indicated if there is evidence of 
hemorrhage. Hemodialysis has been used with 
success.
Respiratory depression may require artificial 
ventilation with oxygen. Convulsions may best be 
treated by the administration of succinylcholine 
and artificial ventilation with oxygen. Central 
nervous system depressant agents should not 
be used.
Hyperthermia and dehydration are immediate 
threats to life and initial therapy must be directed 
to their correction and to the maintenance of 
adequate renal function. External cooling with 
cool water or alcohol should be provided quickly 
to any child who has a rectal temperature over 
104°F.
DOSAGE AND ADMINISTRATION 
Analgesic; antipyretic
Up to 2.925 g daily as necessary. 
Anti-inflammatory
Because the suppression of inflammation in­
creases with the dose of salicylate even beyond 
the point of toxicity, the therapeutic objective is 
to employ as large a dose as possible short of 
toxicity. Most patients will tolerate blood salicylate 
levels in the range of 20 to 25 mg per cent. The 
most common reason for failing to obtain a 
therapeutic response to ASA is the administration 
of inadequate doses.
The generally accepted way to achieve effective 
anti-inflammatory' salicylate blood levels ot 20 to 
25 mg per cent is to titrate the dosage by starting 
with 2.6 to 3.9 g daily, according to the size, age 
and sex of the patient. If necessary, the dosage is 
then gradually adjusted by daily increments of 
0.65 g until symptoms of salicylism e.g., auditory 
symptoms, occur. Then, the dosage is decreased 
by 0.65 g daily until these symptoms disappear 
and maintained at that level as long as necessary. 
In adults the median dose at which tinnitus 
develops is 4.5 g per day, but the range extends 
from 2.6 to 6.0 g per day
Intermittent administration is ineffective. Patients 
should be advised not to vary the dose from day 
to day depending on the level of pain because 
that often fluctuates independently of the intensity 
of the inflammation. A continuous regimen of 
0.65 g four times daily is considered to be 
minimum therapy for adults. ENTROPHEN* 
should be administered four times daily. For night­
time and early morning benefits, the last dose 
should be given at bedtime.
Once m aintenance dose is established, 
ENTROPHENM5 may be useful to encourage 
patient compliance.
Optimally, salicylate therapy should be monitored 
by periodic blood salicylate level determinations.
If this is not practical, the appearance of auditory 
symptoms in the form of tinnitus or deafness are 
acceptable as an indication of the maximum 
tolerated salicylate dose.
There is an inverse relation between blood 
salicylate levels at which auditory symptoms 
appear and the age of the patient. In the young 
adult, this is usually in the range of 20 to 30 mg 
per cent. In children, however, the level may be 
much higher, or the effect apparently absent. 
Because salicylate toxicity may appear without 
such warning in children, the usual practice is to 
give ASA in a daily dose of 50 to 100 mg per 
kilogram of body weight and to follow blood levels 
aiming for a concentration of about 30 mg per cent. 
Rheumatic Fever
A total daily dosage of 100 mg per kilogram of 
body weight administered in divided doses to 
allay the pain, swelling and fever.
Cerebral ischemic attacks (men)
The recommended dosage is 1,300 mg per day 
(650 mg twice a day or 325 mg four times a day).
AVAILABILITY
No. 472— ENTROPHEN*-15 tablets containing 
975 mg of acetylsalicylic acid USP, coated with 
POLYMER 37*. Oval, pale yellow, film-coated 
tablets with the FROSST name engraved on one 
face and 472 on the other and supplied in bottles 
of 100 and 500.
No. 470— ENTROPHEN*-10 tablets containing 
650 mg of acetylsalicylic acid USP, coated with 
POLYMER 37*. Oval, orange, film-coated tablets, 
with the FROSST name engraved on one face 
and 470 on the other and supplied in bottles of 
100, 500 and 1,000.
No. 438— ENTROPHEN*-5 tablets containing 
325 mg of acetylsalicylic acid USP, coated with 
POLYMER 37*. Round, brown, film-coated tablets, 
with the FROSST name engraved on one face 
and 438 on the other and supplied in bottles of 
100, 500 and 1,000.
FULL PRODUCT MONOGRAPH AVAILABLE 
ON REQUEST.
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Effect of Surface Roughness on Platelet Adhesion 
under Static and under Flow Conditions
W. Z lN GG, MD, FRCS[C ],  A.W. N E U M A N N , PH D, A.B. STRONG, PH D,
O.S. H u m , m  s c  a n d  D.R. A b s o l o m , p h  d
Normal blood clots when exposed to 
surfaces other than endothelial. 
Various unsuccessful attempts have 
been made to find a synthetic material 
that is compatible with blood. Both 
platelets and clotting factors are 
involved in thrombosis at foreign 
surfaces. The authors are concerned 
with platelet adhesion as a first 
step in thrombus formation. The 
determination of the number of 
platelets adhering per unit area, 
therefore, appears to be a useful 
criterion for the choice of appropriate 
biomaterials contacting blood. However, 
laboratory tests are often carried out 
with specially prepared, well-defined 
biomaterials with a smooth surface, 
whereas biomaterials in clinical use 
may have a variable degree of 
roughness.
In this paper the authors present 
data on platelet adherence to a 
hydrophilic (glass) and to a hydrophobic 
(silane) material, with smooth and 
rough surfaces. Additional data are 
presented that document the extent
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of platelet adhesion to a wide range 
of smooth polymer materials having 
a large variation in surface hydrophobic 
quality. There was no difference 
in platelet adherence between the 
smooth and rough surfaces when 
tested under static conditions. When 
the surfaces were tested in a laminar 
flow cell, the addition of roughness 
caused a decrease in platelet adhesion 
on the hydrophilic surface and an 
increase in platelet adhesion on the 
hydrophobic surface.
Le sang normal coagule au contact 
des surfaces qui ne sont pas 
endotheliales. Diverses tentatives 
infructueuses ont ete faites dans le 
but de trouver un materiel synthetique 
qui serait compatible avec le sang.
Les plaquettes aussi bien que les 
facteurs de coagulation sont impliques 
dans le processus thrombotique sur 
les surfaces etrangeres. Les auteurs 
s’interessent a I'adhesion plaquettaire 
en tant que premiere etape dans la 
formation du thrombus. On presente 
des donnees additionelles qui 
etablissent I’importance de I’adhesion 
plaquettaire pour une large gamme 
de polymeres lisses possedant de 
grandes variations quant a la qualite 
hydrophobe de leur surface. La 
determination du nombre de plaquettes 
adherentes par unite de surface 
semble etre un critere utile pour 
choisir les bio-materiaux appropries 
devant venir en contact avec le sang. 
Toutefois, les epreuves de laboratoire 
sont souvent conduites avec des 
bio-materiaux bien definis, specialement 
prepares pour offrir une surface lisse, 
alors que les bio-materiaux utilises 
en clinique peuvent avoir divers 
degres de rugosite.
Dans cet article, les auteurs 
decrivent les resultats d'adhesion 
plaquettaires sur des materiaux
hydrophile (le verre) et hydrophobe 
(le silane), possedant des surfaces 
lisses et rugueuses. Dans des 
conditions statiques, aucune difference 
d'adhesion plaquettaire n'a ete 
constatee entre les surfaces lisses 
et les surfaces rugueuses. Quand 
I'epreuve a ete conduite dans une 
enceinte a flux laminaire, la rugosite 
a cause une diminution de I’adhesion 
plaquettaire sur la surface hydrophile 
et une augmentation de I'adhesion 
plaquettaire sur la surface hydrophobe.
Intact endothelium is the only known 
material whose surface does not in­
duce clotting when blood is exposed 
to it. The reasons for this are not 
completely understood and it is un­
likely that a man-made material will 
ever have all the properties of endo­
thelium. The desirable properties of 
implant materials in general have been 
described under the heading of “bio­
compatibility”, those of materials ex­
posed to the blood stream as “non- 
thrombogenicity”. Both terms are not 
entirely adequate because they de­
scribe a situation that probably 
never can be achieved: a synthetic 
material that is completely biocom­
patible and nonthrombogenic. How­
ever, this achievement does not appear 
to be absolutely necessary. The living 
body can tolerate a certain amount 
of irritation, chemical or physical, 
caused by an implant, and it reacts in 
a predictable way, as, for example, by 
the formation of a fibrous capsule 
around an implant. Similarly, com­
plete nonthrombogenicity may not be 
necessary, as an intact fibrinolytic 
system can handle a limited amount 
of clot formation.
The important point, therefore, is 
to seek materials that induce pre­
dictable and limited adhesion of blood 
proteins and platelets as well as negli-
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giblc activation of clotting factors — 
considered to be the first steps in the 
formation of a clot. Initially investiga­
tors tried to solve the problem with 
an empirical approach: identify a ma­
terial with desirable properties, such 
as chemical composition, surface tex­
ture, surface charge or surface tension 
and then carry out in vitro clotting 
tests and animal studies by implanting 
the material into the blood stream. 
This approach has produced many of 
the materials in use today. In spite 
of this success, materials that are 
entirely satisfactory and predictable 
are not yet at hand. Indeed, in describ­
ing the current state of the art a 
recent symposium was entitled “Bio­
materials Research — 20 Years of 
Frustration”.1
Other investigators have attempted 
to apply the scientific method to the 
problems of blood clotting in the pres­
ence of foreign materials, breaking 
down the complex process into small­
er steps, which individually allow 
scientific investigation. This procedure 
is much more time-consuming; there 
are no short cuts as there are in the 
empirical approach. As knowledge 
concerning individual steps gradually 
accumulates, correlations have to be 
sought between them, and finally a 
synthesis has to be attempted that 
eventually may explain the whole. 
With this approach, there is less frus­
tration; in fact, considerable progress 
has been made, although correlations 
are few and a synthesis is still in the 
far future.
The viewpoint has been expressed 
that biomaterials research is not re­
warding because clot formation is de­
pendent on hemodynamic rather than 
surface factors. This opinion appears 
simplistic, but it is true that flow con­
ditions influence clot formation and
therefore have to be considered in the 
design of experiments.
There is confusion about the im­
portance of surface texture — or the 
degree of roughness — in the initia­
tion of a clot at the surface. Historic­
ally, smooth surfaces were preferred 
at first. In fact, the desirability of 
smoothness was accepted to the point 
that research on the effect of rough­
ness was discouraged less than 20 
years ago! Later, very rough, flocked 
surfaces were proposed to be less 
thrombogenic than smooth surfaces: 
blood components would enter the 
rough areas resulting in the formation 
of a smooth pseudointima. Porous 
surfaces have also been used with 
success. The addition of cultured cells 
to form a thin cellular lining over a 
polymer substrate appears to have 
merit.2
Our experimental program is de­
signed to study the first two steps of 
clot formation at a foreign surface 
— the adsorption of plasma proteins 
and the adhesion of platelets — in 
order to identify the forces involved 
in the process. In this paper we report 
results on (a) platelet adhesion to 
smooth surfaces with a wide range of 
surface tensions under static condi­
tions and (b) platelet adhesion to hy­
drophilic (glass) and hydrophobic (si­
lane) surfaces, either smooth or with 
a known surface roughness, under 
static and under flow conditions. 
Thus, there are three variables: sur­
face tension, surface texture and pres­
ence or absence of flow.
Materials and Methods
Platelet Preparation
Anticoagulated pig blood was ob­
tained at the slaughterhouse and, fol­
lowing repeated centrifugation, the
platelets were suspended in Tyrode- 
albumin solution3 at a final concen­
tration of 2 X 105 platelets/mm3.
Preparation of Surfaces
The materials used are presented in 
Table I. Films were prepared and 
mounted on microscopic slides.4 
Rough surfaces were prepared by 
abrading with sandpaper. Silane sur­
faces were prepared by exposing 
smooth or roughened glass slides to 
dichlorodimethylsilane vapour. Con­
tact angles were determined with a 
goniometer telescope using drops of 
normal saline on cleaned surfaces.
Static Platelet Adhesion Test5
Under controlled conditions a drop 
of platelet suspension was placed on 
the test surface for 4 minutes. The 
various test surfaces were rinsed under 
standard shear rates and then stained. 
The number of adhering platelets per 
unit area of test surface was deter­
mined microscopically.
Dynamic Platelet Adhesion Test
A newly designed flow cell was 
used6 that assures laminar flow at the 
test surface together with minimal ex­
posure of platelets to foreign surfaces 
before contact with the test surface. 
For the experiments with platelet sus­
pensions a flow rate of 6 ml/min for 
4 minutes was used, for blood 4 ml/ 
min for 4 minutes; the flow cell was 
connected to the jugular vein of a 
dog and the flow rate was controlled 
by a withdrawal pump.
There were four experiments. In 
each experiment, the glass or silane- 
coated surface was investigated in tri­
plicate; on each individual slide 10 
microscopic fields were evaluated.
T ab le  1— Su b stra te s  Used  in  the  P la te le t  Adhes ion  S tu d ie s
Substra te Source M ode  o f p repa ra t io n
Su rfa ce  te n s io n , 
e rg s /cm 2
Gold _ V acuu m  depo s it io n
Su lfona ted  p o ly s ty ren e  (SPS) C e n tra l R esea rch  Labora to ry , F ilm 66.7
Dow C h em ica l Co ., M id land , M ich .
P o ly e th y le n e  te reph th a la te C e lan e se  Canada Inc., To ron to , Ont. H ea t p ress 47.0
A ce ta l Com m erc ia l P la s t ic s  & Supp ly  Corp., H ea t p ress 44.6
T o ron to , Ont.
Ny lon-6 ,6 Com m erc ia l P la s t ic s  &  Supp ly  Corp. S o lv e n t ca s t in g 41.1
Segm ented p o lyu re th an e /g la ss  "1 T36.4
Segm ented p o ly u re th a n e /a ir E th icon  Inc., S o m e rv ille , NJ P o ly m e r iz a t io n 32.1
Segm ented p o ly u re th an e /s ila n e  J L  20.6
Low -den s ity  p o ly e th y len e Com m erc ia l P la s t ic s  & Supp ly  Corp. H ea t p ress 32.5
P o ly s ty ren e C e n tra l R esea rch  Lab., Dow C h em ica l Co. F iim 25.6
S ila n e /d ic h lo ro d im e th y ls ila n e Eastm an Kodak Co., Rochester, NY V a p o u r d epo s it io n 17.6
S ila s t ic  rubber Dow C o rn in g  Canada Inc., S t re e tsv ille , Ont. U se d  as is 18.1
Te flo n  (F E P )  ( flu o r in a ted Com m erc ia l P la s t ic s  & Supp ly  Corp. H ea t p ress 16.4
e th y len e -p ro p y len e  copo lym er)
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Results
Static Platelet Adhesion Test
In Fig. 1 the relation between the 
contact angle measured at the smooth 
solid surface and the number of plate­
lets adhering to the surface per unit 
area is shown using the static test. 
Platelet adhesion decreased with the 
increasing contact angle of the sub­
strate. The contact angle measured on 
the surface of segmented polyurethane 
(SPU) depends on the surface to which 
the material is exposed during solidifi­
cation: three such surfaces are in­
cluded (glass, air and silane), and the 
results show the same relation be­
tween contact angle and platelet 
adhesion as other materials. Selected 
materials (glass and silane) were ex­
amined when smooth and when rough. 
The contact angle was slightly larger 
on the rough surface, and there was 
difference in platelet adhesion to 
the same smooth or rough materials 
in the static test (Figs. 2 and 3). On 
smooth silane the platelets form long 
thin pseudopods. On both rough sur­
faces there appears to be the same 
preferential adherence in the vicinity 
of the crevices.
Dynamic Platelet Adhesion Test
The flow experiment provided dif­
ferences with both platelet suspensions 
and fresh blood.7 The total number 
of platelets adhering was smaller than
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FIG. 1—Platelet adhesion to various 
smooth solid surfaces under static 
conditions. Platelet concentration =  
200 000/mm3. Number of adhering 
platelets increases with decreasing con­
tact angle of surface. SPU =  segmented 
polyurethane, FEP =  fluorinated ethyl­
ene-propylene.
in the static test. From the platelet 
suspension the adhesion to rough glass 
was diminished (P < 0.01, Student’s 
r-test) and to rough silane it was in­
creased (P < 0.05), compared with 
the adhesion to the smooth surfaces 
under the same flow conditions (Fig. 
4). A similar situation was found with 
blood although the difference in plate­
let adhesion to smooth and rough 
silane was not significant.
D iscussion
The purpose of the static experi­
ments was to study the forces involved 
in the adhesion of platelets to surfaces. 
Platelets can be suspended in liquids 
with varying concentrations of elec­
trolytes, plasma proteins and of the 
other blood cells. Thus, the different 
factors influencing platelet adhesion 
can be studied away from the dynamic 
forces of flowing blood. The results 
presented in Fig. 1 show the linear 
relation between the contact angle, 
which is an expression of the surface 
tension of the solid material, and the
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FIG. 2— Platelet adhesion to glass 
(static test): (a) smooth surface, (b) 
rough surface (reduced by 49% from 
X 1600).
number of platelets adhering per unit 
area.
To differentiate between the phy­
sical surface characteristics and the 
effects of the chemical properties of 
the biomaterial on the blood—material 
interface, experiments have been car­
ried out using the same material with 
different physical surface character-
k , k .
•  *#
*.; "
ft. f
■ w
* «
r ry':\ : *
*
M -i....  '■■' x.
*
1t ; " ■ ■ ::: ; '■ft ,
% # w
Fig. 3a
, s mmmm ^  >■ »‘ , ,
ft
* ft # *
ft * ft
* ft
♦
. 40 ' • ** #
f
• #  ^ ft
W t #
#
Fig. 3b
FIG. 3— Platelet adhesion to silane
(static test): (a) smooth surface (note 
long pseudopods of platelets), (b) rough 
surface (reduced by 60% from X1600).
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FIG. 4— Platelet suspension: adhe­
sion to glass and to silane (smooth and 
rough) in flow cell (±SE ). Platelet con­
centration =  200 000 /m m 1. Addition of 
roughness decreases platelet adhesion 
on glass surface and increases adhesion 
on silane surface.
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istics. Wielogorski and colleagues8 
studied the influence of surface rugo­
sity on hemolysis occurring in an 
extracorporeal circuit using three 
types of polyvinylchloride tubing. They 
found that during the initial period of 
pumping the rate of hemolysis in 
rough tubes was almost four times 
greater than in smooth tubes. They 
warned, however, that this finding 
may be caused not only by mechanical 
effects but also the large surface area, 
which increases the likelihood of plas­
ticizer leaking into the blood. Again 
using polyvinylchloride tubing, Hecker 
and Edwards9 found an association 
between roughness and thrombus for­
mation experimentally when catheters 
with different surface roughness were 
inserted into the blood stream of ani­
mals. This may be due to the degree 
of adhesion of the thrombus rather 
than to differences in thrombogenicity. 
We have shown previously10 that if 
surfaces with different tensions are 
produced with the same material, 
platelet adhesion under static condi­
tions varies with the surface tension. 
This observation was confirmed with 
segmented polyurethane (Fig. 1). The 
three materials were prepared in an 
identical way, but during polymeriza­
tion one batch was exposed to glass, 
one to air and one to silane. Clearly, 
platelet adhesion to the silane form 
was less than to the other two sur­
faces of the same material. Polymer 
chemists are familiar with the fact 
that the casting technique may influ­
ence the surface properties, such as 
surface tension. This should be re­
membered by investigators who pro­
duce devices for exposure to blood.
Under static conditions, a signif­
icant effect of roughness on platelet 
adhesion when compared with the 
same smooth material could not be 
demonstrated. Under flow conditions, 
the results were entirely different: 
fewer platelets adhere to rough than 
to smooth glass, and fewer platelets 
stick to smooth than to rough silane. 
In other words, the effect of rough­
ness for a hydrophilic material (glass) 
is opposite to the effect for a hydro- 
phobic material (silane). With a hy­
drophilic material water adheres to 
the surface and fills crevices of the 
rough material. Thus, the roughness 
may cause a layer of water to form 
at the surface so that blood moving 
along the surface is then in contact 
with this layer of water instead of 
the material surface. Although definite 
proof is still lacking, the available evi­
dence (e.g., from hydrogels that have 
a high water content) suggests that 
the number of platelets adhering to
such surfaces is greatly reduced.11
On a hydrophobic surface the de­
gree of roughness is important. Ac­
cording to Merrill’s definition12 the 
surfaces were not “rough to cells”; 
the crevices were too small to retain 
blood cells. Ward and colleagues13 
have shown that on the rough surface 
of a hydrophobic material exposed to 
a fluid such as blood, gas pockets exist 
that are stable and are not dislodged 
by flowing blood. The platelets stick 
to the gas pockets in the crevices, 
rather than to the crevices them­
selves.13 The addition of roughness to 
a hydrophobic surface therefore may 
be associated with stabilized gas poc­
kets; this in turn explains the in­
crease in platelet adsorption, followed 
by better and more prolonged adhe­
sion, which may be the first step 
in the formation of a thrombus. The 
importance of the extended pseudo­
pods that were found on smooth 
silane only is not known. The ma­
jority of the biomaterials to which 
blood is exposed are hydrophobic, 
such as silicone rubber, polyvinyl­
chloride and polyethylene. The results 
of this investigation suggest that these 
surfaces should be very smooth, prob­
ably smoother than some of the com­
mercially available biomaterials. If hy­
drophilic materials are used, such as 
hydrogels or metals, surface roughness 
may be less important; in fact, a cer­
tain degree of roughness may be bene­
ficial.
In the experiments reported in this 
paper, only the surface tension and 
topography of the biomaterials was 
considered. In reality the situation is 
more complex. Nevertheless, it can be 
concluded that the static test —  a 
valuable research tool -— is limited 
in the practical evaluation of bioma­
terials exposed to blood, as the pres­
ence or absence of surface rugosity 
does not influence platelet adhesion. 
Under flow conditions, roughness of 
the surface is detrimental on a hy­
drophobic surface, whereas it may be 
beneficial on a hydrophilic surface. 
As commercially produced biomate­
rials usually exhibit a degree of sur­
face roughness, these observations 
should be considered in the choice of 
materials in contact with blood for a 
given purpose.
Summary
The first step in the formation of 
a thrombus following the exposure 
of blood to a foreign surface is the 
adhesion of platelets to the surface. 
The determination of the number of 
platelets adhering per unit area there­
fore appears to be a useful criterion
for the choice of appropriate bioma­
terials contacting blood. However, 
laboratory tests are carried out with 
specially prepared, well-defined bio­
materials with a smooth surface, 
whereas a variable degree of rough­
ness may be present on the bioma­
terials in clinical use.
In this paper we studied platelet 
adherence to a hydrophilic material 
(glass) and to a hydrophobic material 
(silane) with a smooth and with a 
rough surface. There was no differ­
ence in platelet adherence between 
the smooth and rough surfaces when 
tested under static conditions. When 
tested in a laminar flow cell, the addi­
tion of roughness caused a decrease 
in platelet adhesion on the hydrophilic 
surface and an increase in platelet 
adhesion on the hydrophobic surface.
A.W. Neumann and D.R. Absolom 
were supported by the Ontario Heart 
Foundation through fellowships.
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Enteral nutrition begins in the 
recovery room ...
v
\
Vivonex Jejunostomy Kit
All you need to perform a 
needle-catheter jejunostomy in one 
complete, economical kit.
Each kit contains:
-  hinged easy access tray
-  90 cm (36”) 5 Fr radiopaque polyurethane catheter
-  100 cm ‘soft tip’, stainless steel, flexible guidewire
-  No. 14 gauge, thin-wall, non-coring needles (2)
-  No. 20 gauge, needle cannula with female adapter hub
-  catheter/adapter sleeve for nonshearing, leak- and 
kink-proof connection
-  specially designed anchoring catheter retainer to 
prevent accidental dislodgement
-  instruction sheet
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Appendicovesical Fistula Caused 
by Ileocecal Actinomycosis
Saul Gonor, md, Michael Allard, md, frcs[c] and G. R ene Boileau, md, frcs, frcs[c]*
An appendicovesical fistula, diagnosed 
at laparotomy in a 19-year-old man, 
was found to be due to actinomycosis. 
Both conditions are uncommon and 
this appears to be the first report 
of their coincident occurrence. Both 
present diagnostic problems because 
of nonspecific symptoms and biopsy 
findings, and a negative urine culture.
A combined approach to therapy was 
required in this patient who was 
treated successfully by partial 
cystectomy and appendectomy with 
resection of the cecum. Penicillin G 
was given intravenously for 7 days 
then tetracycline was prescribed for 
13 months.
Line fistule appendico-vesicale 
diagnostiquee a la laparotomie chez 
un homme de 19 ans, s'est averee 
due a une actinomycose. Ces deux 
affections sont rares et ceci semble 
etre le premier rapport de leur 
existence simultanee. Les deux 
presentent des difficultes diagnostiques 
a cause de la non specificite des 
symptomes et des observations de 
biopsie, ainsi que d'une culture 
d’urine negative. Une approche 
therapeutique combinee a ete 
necessaire chez ce patient qui fut 
traite avec succes par cystectomie 
partielle et par appendicectomie avec 
resection of the cecum. Penicillin G 
G fut administree pendant 7 jours 
suivie d'une prescription de tetracycline 
pendant 13 mois.
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Actinomycosis is an indolent, sup­
purative infection characterized by 
the formation of multiple abscesses 
and draining sinuses, and by granula­
tion and dense fibrous tissue. It is 
caused by gram-positive anaerobic ac- 
tinomycetes, most often Actinom yces 
israelii. The infection is abdominal, 
predominantly in the ileocecal region, 
in about 20% of reported cases;1 
genitourinary involvement is uncom­
mon and bladder involvement is rare.
Appendicovesical fistula constitutes 
less than 5% of all vesicointestinal 
communications;2 we could find no re­
port of such a fistula due to actino­
mycosis as described in this report. 
Our patient presented with features 
of both conditions making diagnosis 
difficult and necessitating a combined 
approach to therapy. The nonspecific 
symptoms and biopsy findings, and 
the negative urine culture, underline 
the difficulty in diagnosing both of 
these entities.
Case Report
A 19-year-old Caucasian man was ad­mitted on Oct. 26, 1980. He had suf­fered from lower abdominal discomfort and severe dysuria for 5 months and had had one episode of gross total hema­turia. A course of co-trimoxazole, in­stituted because urinalysis had demon­strated moderate pyuria, relieved the symptoms only temporarily. There were no gastrointestinal symptoms and the history was otherwise noncontributory.The patient was rather thin, but physi­cal findings were normal apart from lower abdominal tenderness on deep palpation and rectal examination. Results of routine laboratory investigations were normal except for eosinophilia (5%) in the peripheral blood and the finding of innumerable leukocytes and two to five red cells per high-power field in the urine. Culture of the urine yielded no growth.An intravenous pyelogram appeared normal. A cystogram was reported as normal, but on retrospective review showed a filling defect on the right side of the dome of the bladder and an irre­
gularity superiorly in the post-voiding 
film (Fig. 1). Cystoscopy revealed a mass lesion in the dome of the bladder; this resembled a bowel polyp and ini­tially was thought to be a urachal tumour or urachal cyst-abscess, but a transure­thral biopsy specimen showed only non­specific cystitis with patchy chronic in­
flammation.At laparotomy through a lower mid­line abdominal incision an inflammatory mass was seen involving the appendix, cecum and urinary bladder. Partial cys­tectomy and appendectomy were per­formed, the cecum was resected and the mass removed en bloc. Gross examina­tion of the specimen confirmed an ap­pendicovesical fistula (Fig. 2). Micro­scopic examination demonstrated “sulfur granules” characteristic of actinomycosis. The actinomycotic lesions were sur­rounded by exuberant fibrosis and chronic inflammation (Fig. 3).The patient’s postoperative course was uncomplicated. He was given penicillin G intravenously (2 million units q4h for 7 days), followed by tetracycline orally (500 mg qid for 1 month, then 250 mg 
qid for 1 year). At last report (February 1981) he was well and had had no recur­rence of symptoms.
Discusssion
Actinom yces israelii is a normal 
constituent of the anaerobic flora of 
the oral cavity in humans. It is an 
opportunistic pathogen, invading and 
proliferating only under anaerobic 
conditions, such as those produced by
FIG. 1—Post-voiding cystogram show­ing irregular margin of bladder dome.
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FIG. 3— Photomicrograph showing “sulfur granule” of actinomycosis within 
lumen of fistula, lining of granulation tissue, and wall of acute and chronic inflam­
m ation (hematoxylin and eosin, enlarged 1.7 x from XlOO).
appendiceal mass, usually with mul­
tiple draining sinuses that contain the 
pathognomonic sulfur granules. Clin­
ical features other than abdominal 
pain include insidious onset, variable 
low-grade fever, loss of weight, le­
thargy, microcytic anemia and leuko­
cytosis. Lymphadenitis may occur, due 
to secondary infection with Staphylo­
coccus aureus or Escherichia coli. 
Definitive diagnosis depends on his­
tologic demonstration of the charac­
teristic granules or culture of the or­
ganism on an enriched medium under 
anaerobic conditions. Therapy con­
sists of a prolonged course of penicil­
lin or tetracycline, to which the or­
ganism is uniformly sensitive. It is 
generally agreed that surgical drainage 
and excision of the lesion facilitate 
recovery.
Vesicointestinal fistula is most com­
monly associated with colonic carci­
noma or diverticular disease and thus 
is found most frequently in the age 
group 50 to 60 years.5 In younger pa­
tients the condition is usually second­
ary to Crohn’s disease. It occurs pre­
dominantly in males, because the 
uterus acts as a barrier to fistula for­
mation.6
In 1969, Gross and Peng2 were able 
to find only 82 reported cases of ap- 
pendicovesical fistula, but spontaneous 
healing of the fistula in some cases 
led Holmlund5 to surmise that the 
condition probably is less rare than 
reports indicate. Holmlund stressed 
the need for awareness of this condi­
tion by all who treat patients, parti­
cularly young men, for repeated uri­
nary infection — the majority of the 
patients are males, between the ages
the local trauma of dental extraction.3 
Once in the tissues, the bacterium 
gives rise to a subacute chronic in­
flammatory reaction with surrounding 
fibrosis, sinus tracts and fistulas. At 
the centre of the inflammatory reac­
tion is the actinomycotic abscess, 
characterized by the presence of sul­
fur granules (masses of filamentous 
organisms) radiating outward, thus the 
misnomer “actinomyces” from the 
Greek for ray fungus.
The mechanism by which A. israelii 
gains access to the abdominal organs 
is a subject of controversy. The most 
widely held theory is that the organ­
ism is swallowed and that it escapes 
from the intestinal lumen when this 
is damaged by trauma or disease.4 
Thus, an inflamed appendix provides 
a likely portal of entry, in which case 
the infection produces a tender peri-
FIG . 2— Cut surfaces of gross speci­
men showing (A) fistula extending from 
vesical mucosa inferiorly and (B) ap­
pendiceal lumen and greatly thickened 
appendiceal wall superiorly.
of 10 and 40 years. The commonest 
cause of appendicovesical fistula is 
perforation of a pelvic appendix, re­
sulting in the formation of an abscess 
and fistula. The clinical picture is 
variable, and either appendiceal or 
vesical symptoms may predominate; 
chronic lower abdominal pain, dys- 
uria, pyuria and hematuria are com­
mon.
In contrast to other forms of vesico­
intestinal fistula, communication be­
tween the bladder and appendix rarely 
gives rise to fecaluria and pneumatu- 
ria. Cystoscopy reveals localized or 
generalized cystitis, bullous edema or 
a depressed necrotic area, and in a 
few cases the aperture of the fistula 
is seen. Prolapse of appendiceal mu­
cosa into the bladder may simulate a 
neoplasm.7 A cystogram or roentgeno­
gram after barium enema with de­
layed exposures may aid in diagnosis. 
Treatment consists of appendectomy, 
excision of the fistula and a surround­
ing cuff of bladder, drainage of the 
abscess cavity and administration of 
appropriate antibiotics.
Renal involvement in the actinomy­
cotic process is commonest when the 
genitourinary system is affected;8 
about 50 cases have been reported, 
mostly evolving from subclinical in­
fection elsewhere.9 An association 
with intrauterine contraceptive devices 
is said to be common in cases of 
pelvic involvement, and one such case 
of isolated actinomycosis of the blad­
der has been described.10 Five other 
cases of vesical actinomycosis not in­
volving the appendix have been re­
ported.11
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Blunt Renal Trauma: the Value of a Conservative Approach 
to Major Injuries in Clinically Stable Patients
S. G ibson , m d , I.W. Kuzmarov , m d , frcs[c], D.R. M cC lu r e , m d , frcs[c] 
and D.D. Morehouse , m d , facs, fr c s[c]
A 10-year retrospective study of 393 
cases of blunt renal trauma was 
carried out to evaluate the use of a 
conservative approach to therapy in 
clinically stable patients with major 
renal injuries. Injuries were minor 
in 357 patients who were successfully 
treated conservatively. Major injuries 
occurred in 36 patients; 28 were 
treated conservatively. Of the 28,
17 had no complications. Seven 
required total or partial nephrectomy 
to control bleeding and four had 
drainage, one with marsupialization 
of a large renal cyst, 1 year after injury. 
The authors advocate conservative 
treatment of major blunt renal injuries 
in clinically stable patients.
On a mene une etude retrospective 
portant sur une periode de 10 ans, 
de 393 cas de traumatisme renal 
ferme afin d’evaluer I'emploi des 
methodes conservatrices chez les 
malades souffrant de lesions renales 
majeures dont I'etat clinique est 
stable. Les contusions etaient mineures 
chez 357 patients qui furent traites 
de faqon conservatrice avec succes. 
Des lesions majeures sont survenues 
chez 36 malades; 28 ont ete traites 
de fapon conservatrice. Des 28, 17 
n’ont subi aucune complication. Sept 
ont necessity une nephrectomie 
totale ou partielle afin de juguler 
I'hemorragie, quatre ont subi un 
drainage, un avec une marsupialisation 
d'un gros kyste renal 1 an apres le 
traumatisme. Les auteurs preconisent 
le traitement conservateur des 
traumatismes renaux fermes majeurs 
chez les patients dont I'etat clinique 
est stable.
The great controversy in blunt renal 
trauma is the management of major 
renal injury in the patient who is 
clinically stable. Most (80%) blunt 
renal injuries are minor and do well 
with conservative management alone, 
and there is little argument that clin­
From the department of urology, 
McGill University, Montreal, PQ
Accepted for publication May 20, 1981
Reprint requests to: Dr. I.W. Kuzmarov, 
175 Stillview Rd., Ste. 138, Pointe 
Claire, PQ H9R 4S3
ically unstable patients with major in­
juries require immediate operation. 
But in the relatively small group of 
clinically stable patients with major 
renal injuries there is considerable 
disagreement about management. In 
most centres, if this group of patients 
is managed surgically, there is a 50% 
likelihood that nephrectomy will be 
carried out.1 On the other hand, if 
the same group is managed conserva­
tively, nephrectomy will usually be 
performed in only 5% to 20% of 
patients.2’2 To evaluate the effective­
ness of the conservative approach, 
which we use, we reviewed 393 cases 
of blunt renal trauma seen over a 10- 
year period.
Patients and Methods
Between 1968 and 1978, 393 pa­
tients with blunt renal injury were 
admitted to one of five McGill Uni­
versity hospitals, two of which were 
major referral centres, two commu­
nity hospitals and one a major pedia­
tric hospital.
All patients initially underwent in­
travenous pyelography. When this 
study proved inadequate and the pa­
tient was clinically stable, nephro­
tomography, with either a double dose 
of contrast material or an infusion of 
200 ml of Renografin-76, was done. 
Renal scanning was often used after 
intravenous pyelography, especially in 
children, to evaluate deficits in func­
tion of the renal parenchyma. It was 
also used as a follow-up study to 
assess the progress of healing. Arte­
riography was used selectively in cases 
of suspected pedicle injury or when 
operative intervention was contem­
plated.
All cases were classified as minor, 
major or pedicle injuries as advocated 
by Hodges and associates.4 Paren­
chymal lacerations not involving the
T able  1— Age D is trib u tio n  (N =  393)
Age, y r No. ( % )
0 10 69 (18)
11 20 171 (43)
21 40 105 (27)
41 60 40 (10)
> 6 0 8 (2)
/
vasculature or collecting system to an 
appreciable degree (extravasation be­
yond the capsule) were classed as 
minor injuries. Most major injuries in 
our series were associated with func­
tional failure of at least one third of 
the renal parenchyma.
Results
Of all blunt renal injuries, 88% oc­
curred in patients under the age of 
40 years (Table I). Motor vehicle ac­
cidents (in 45%) accounted for most 
of the multiple injuries; 55% of the 
cases were due to other causes and 
were most often isolated events (Table 
II).
Most (357) injuries were minor and 
responded well to conservative man­
agement. There were 36 major in­
juries including 2 pedicle injuries. In 
both these patients immediate ne­
phrectomy was necessary because the 
patient was clinically unstable. Of the 
other 34 patients, 6 required imme­
diate operation for continued acute 
uncontrollable bleeding and 28 were 
treated conservatively. Many patients 
in the latter group manifested an ini­
tial period of clinical instability, but 
were easily stabilized in the emer­
gency department or in the initial pe­
riod after admission.
The temperature, hematocrit and 
renal function (serial intravenous pve- 
lograms) were monitored closely in 
this group of 28 patients. Seventeen 
of them had no clinical problems. At 
the time of discharge half had better 
renal function (as demonstrated on 
the intravenous pyelogram) than they 
had at the time of admission. None 
showed deterioration of function. The 
other 11 patients with major blunt 
renal injuries managed conservatively 
had complications (Table III). Seven 
required either a nephrectomy or a 
partial nephrectomy for the control of
T ab le  II— Etio logy (N = 393)
C ause No. (% )
M otor v e h ic le  acc id en t 177 (45)
Fall 97 (25)
Sport 88 (22)
Blow 31 (8 )
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secondary bleeding. One patient in 
this group was stabilized easily with 
blood transfusion before operation. 
Four secondary drainage procedures 
were necessary. One patient returned 
1 year later with a large renal cyst 
and complaining of persistent pain 
(Table III). One 17-year-old boy had 
hypertension (diastolic blood pressure 
of 90 mm Hg); the pressure returned 
to normal within 2 years.
Of the 28 patients who had major 
injuries managed conservatively, 5.5 
kidneys were subsequently removed, a 
nephrectomy rate of 19.6%.
Discussion
Preservation of functioning renal 
parenchyma was the goal in managing 
blunt renal injuries especially in view 
of the young age of our patients: 60%
of the major injuries occurred in pa­
tients under the age of 20 years.
In the clinically stable patient we 
found the conservative approach satis­
factory. Our 19% nephrectomy rate 
is reasonable and in four patients with 
complications a simple drainage pro­
cedure was all that was needed. The 
patients who were managed conserva­
tively and who had no complications 
showed no deterioration in renal func­
tion; 50% had better function, as 
shown by pyelography, than on ad­
mission.
Intravenous pyelography was ade­
quate in 85% of cases to diagnose 
the extent of the renal injury. When 
greater renal definition was required, 
nephrotomography proved to be a 
simple, cost-effective addition and, 
when coupled with double- or high- 
dose infusion of contrast medium, will
demonstrate 90% of the findings 
achieved by angiography.3 Renal scan­
ning is easy to carry out and is un­
affected by the presence of stool, gas 
or contrast material from previous 
examinations. We found it most use­
ful for following major injuries in 
clinically stable patients, especially 
children, as the radiation dose is lower 
than that of intravenous pyelography. 
Angiography is best reserved for pa­
tients suspected of having a pedicle 
injury and for those with a major 
injury who are in a clinically unstable 
state. In the latter, angiography will 
not only display the extent of the 
renal injury, but will also demonstrate 
associated splenic and hepatic bleed­
ing.
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Table III-- Complications and Treatment (n =  11)
Complication No. Treatment No.
Uncontrolled hemorrhage 7 Nephrectomy 4
Partial nephrectomy 3
Abscess 1 Drainage 1
Urinoma 2 Drainage 2
Unremitting hematuria 1 Marsupialization of 1
renal cyst
Vesicopsoas Hitch: a Versatile Procedure
L o r n e  D. Su l l iv a n , m d , f r c s [c ], J ohn  S.T. M a s ter so n , md  
and  J a m ie  E. W r ig h t , m d , f r c s [c ]
The vesicopsoas hitch is an ideal 
operation for the management of lower 
ureteral injury and disease requiring 
replacement of varying lengths of 
ureter. It is safe and easy to perform, 
complications are minimal and the 
success rate is high. In combination 
with the Boari flap and downward 
mobilization of the kidney, up to 
70% of the ureter may be replaced 
by this technique.
The authors describe their experience 
between 1970 and 1980 with 52 
patients treated by the vesicopsoas 
hitch, with and without the Boari 
flap.
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La cystopexie au muscle psoas est 
I’operation ideale pour le traitement 
des lesions ureteraies basses et 
celui des maladies necessitant le 
remplacement de diverses longueurs 
d’uretere. Elle est sure et simple a 
realiser, les complications sont 
minimes et le taux de reussite est 
eleve. En association avec le lambeau 
de Boari et une mobilisation du rein 
vers le bas, on peut remplacer par 
cette technique jusqu'a 70% de 
I'uretere.
Les auteurs decrivent leur experience 
chez 52 patients qui, entre 1970 et 
1980, ont ete traites par cystopexie 
au muscle psoas, avec ou sans 
le lambeau de Boari.
The vesicopsoas hitch is easily and 
quickly performed and is a reliable 
method of replacing the lower ureter 
in cases of ureteral injury or disease 
of the lower ureter. It was originally
described by Whitsall in 18961 and 
was repopularized by Warwick and 
Worth,1 and Gross and associates.2 
Ehrlich and associates3 and Kishev4 
emphasized the fact that this proce­
dure fixed a portion of the bladder 
wall extending the functional trigone 
and allowing better “backing” of uret­
eral implants with increased length of 
the tunnels to prevent reflux. They 
also pointed out that the fixation of 
the bladder base prevents angulation 
and kinking of the ureter with bladder 
filling and emptying. The combination 
of the psoas hitch and the Boari flap 
with downward mobilization of the 
kidney allows for replacement of up 
to 70% of the lower ureter. The pro­
cedure has the advantage of simplicity 
over transureteral ureterostomy. The 
other ureter is not involved in this 
operation thus avoiding possible com­
promise of the contralateral renal unit.
Between 1970 and 1980 we man-
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aged 52 patients in this manner with 
excellent results in 55 ureters. In 44 
patients the problem was unilateral 
and in 8 it was bilateral. This has be­
come our procedure of choice for 
patients with lower ureteral disease
Table I— Indications
Indication No. of ureters
Iatrogenic injuries 22
Gynecologic 18
Colorectal 3
Urologic (basket) 1
Failed reimplantation 13
Radiation fibrosis 7
Congenital distal obstruction 7
Gross reflux 4
Endometriosis 2
Malacoplakia
Carcinoma of the distal u reter
2
(solitary kidneys) 2
Tuberculosis 1
FIG. 1—Midline bladder incision.
FIG. 2—Fixation of bladder to psoas 
with 3-0 silk sutures.
FIG. 3—Relation of femoral nerve 
to psoas muscle.
requiring excision and replacement of 
varying lengths of ureter (Table I).
Technique
A Pfannenstiel incision is usually 
used. In cases requiring extensive re­
placement of the lower half of the 
ureter, with or without downward mo­
bilization of the kidney, a midline 
incision is preferred. The bladder and 
ureter are approached through an ex- 
traperitoneal route. The extent of 
ureteral disease is assessed by mobil­
izing the ureter from above in the 
usual manner. The injured or diseased 
portion of the ureter is then excised 
(Fig. 1). A midline incision is made 
in the bladder and the peritoneum is 
dissected from the bladder dome to 
allow free mobility of the dome over 
to the psoas area. We do not divide 
the contralateral superior vesical ar­
tery and obliterated umbilical artery, 
as other authors have done, unless 
there is a need to relieve tension. The 
bladder floor is visualized and the op­
posite ureteral orifice identified. The 
site of the new tunnel is selected. An 
attempt is made to bring the ureter 
as close to the trigone as possible, 
just medial to the ipsilateral orifice. A 
tunnel may then be constructed after 
the fashion of Leadbetter-Politano or 
may be constructed following the fix­
ation of the bladder. By evaginating
Mr!
Fig. 4a
Fig. 4b
FIG. 4—Reimplantation of ureter by 
submucosal tunnel.
/
the posterolateral angle of the bladder 
over the little finger (Fig. 2), the 
site of fixation can be selected. We 
use 3-0 silk sutures placed into the 
psoas fascia above the external iliac 
vessels, through the muscle of the 
bladder without penetrating the mu­
cosa. It is important to bear in mind 
that the femoral nerve passes deep 
in the psoas muscle. The sutures 
should therefore not be placed too 
deeply (Fig. 3). The ureter is then 
placed through a submucosal tunnel 
in the usual manner. The submucosal 
tunnel and the bladder hiatus must be 
wide enough to prevent stenosis of 
the ureter (Fig. 4a). The ureter should 
lie in a straight tunnel from the en­
trance of the bladder to its exit as 
close to the trigone as possible. Su­
tures of 4-0 chromic catgut are used 
to anchor the distal ureter (Fig. 4b). 
A Silastic ureteral stent, cystostomy 
catheter and perivesical Penrose drains 
are left in situ. Firm backing for the 
reimplanted ureter is obtained by the 
use of the vesicopsoas hitch maneuver.
This procedure can be used in bi­
lateral ureteral injuries, full mobiliza­
tion of the superior vesical and obli­
terated umbilical arteries being man­
datory. Tension at the lower end of 
the bladder incision may prevent ade­
quate closure but this may be over­
come by a rotation flap as illustrated 
in Figs. 5 and 6.
FIG. 5— Bilateral psoas hitch with 
relaxing incision.
FIG. 6— Closure of bladder using re­
laxing incision and rotation of bladder 
flap.
VOLUME 25, NO. 1, JANUARY 1982 THE CANADIAN JOURNAL OF SURGERY 27
Large dilated ureters may require 
trimming of varying lengths of the 
distal ureter. The elongation of the 
trigone produced by the psoas hitch 
procedure allows placement of the 
entire ureteral suture line in an intra­
vesical position, greatly reducing the 
possibility of ureteral fistulas.
In patients with extensive injury or 
disease of the ureter, the defect may 
be bridged by a combination of psoas 
hitch and Boari flap (Fig. 7). This, 
combined with downward mobiliza­
tion of the kidney, has allowed us to 
replace up to 70% of the ureter in 
two patients. Although it was not nec­
essary in our cases, further downward 
displacement of the right kidney can 
be achieved with translocation of the 
renal vein as described by Gil-Vernet.5 
Penrose drains are placed extravesical- 
ly. The bladder is closed in two layers.
Case Reports
Case 1
A 53-year-old woman, who had under­
gone vaginal hysterectomy for menor­
rhagia, presented with pain in the left 
flank. An intravenous pyelogram dem­
onstrated a nonfunctioning left kidney. 
Retrograde pyelography revealed partial 
ligation of the distal left ureter (Fig. 8). 
Examination under anesthesia revealed a 
large edematous pelvic mass. The pa­
tient was managed with a ureteral cath­
eter for 14 days and was readmitted in 
4 weeks with persistent hydronephrosis. 
At exploration dense periureteral scar 
was found below the pelvic vessels. The 
left ureter was reimplanted using the 
vesicopsoas hitch procedure. Follow-up 
cystography and pyelography (Fig. 9) 
showed satisfactory drainage with no 
evidence of ureteral reflux as shown in 
a voiding cystourethrogram. The urine 
was sterile when the patient was dis­
charged from hospital.
Case 2
After undergoing a difficult abdominal 
hysterectomy, this 57-year-old woman 
was noted to be anuric in the recovery 
room. Intravenous pyelography' demon­
strated bilateral delay in function, and 
gross hydroureteronephrosis was evident 
on delayed films. Immediate retrograde 
pyelography revealed bilateral obstruc­
tion of the lower ureters. The patient was 
returned to the operating room about 8 
hours after her original operation. There 
was extensive injury to both ureters. Bi­
lateral ureteroneocystostomies were car­
ried out using the vesicopsoas hitch 
procedure. There was tension on closure 
of the bladder, which was relieved by 
use of a rotation flap. The patient had 
an uncomplicated postoperative course. 
Within 3 months the findings of intra­
venous pyelography and voiding cysto­
urethrography were normal.
Case 3 Case 4
A 52-year-old woman, who had renal 
failure due to bilateral renal obstruction 
secondary to malacoplakia, was managed 
by bilateral nephrostomy and adminis­
tration of urecholine8 for 18 months. At 
the time of operation her urinary crea­
tinine value was 4.1 mg/kg daily and 
her creatinine clearance was 16 ml/min 
(Fig. 10).
She underwent a right to left trans- 
ureteroureterostomy and a left vesicop­
soas hitch with combined Boari flap and 
left ureteral reimplantation.
Internal stents were left in situ for 4 
months (Fig. 11). Following removal of 
the stents her creatinine value increased 
to 8 mg/kg daily and a left nephrostomy 
was performed. Renal function did not 
improve so she was placed on main­
tenance hemodialysis.
Fig. 7c
FIG. 7— Use of psoas hitch plus 
Boari flap technique.
This 61-year-old man presented with 
right renal tuberculosis and was treated 
with triple-drug therapy for 2 years.
FIG. 8— Case 1. Retrograde pyelo- 
gram showing partial ligation of distal 
left ureter.
FIG. 9— Case 1. Follow-up pyelo­
gram shows good drainage of left ureter.
FIG. 10— Case 3. Pyelogram shows 
renal obstruction bilaterally due to mal­
acoplakia.
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His urine became sterile, but pro­
gressive stricture of a 4-cm segment of 
the lower right ureter developed with 
progressive hydroureteronephrosis. He 
underwent a right vesicopsoas hitch and 
reimplantation of the ureter. Three 
months later the ureteral calibre had 
returned to normal. There was no reflux 
on the voiding cystourethrogram. The pa­
tient continues to do well.
Case 5
Ten years after treatment for carci­
noma of the cervix with radiation and 
radium implants, a 41-year-old woman 
was admitted complaining of pain in the 
right flank. She had progressive hydro­
ureteronephrosis. Her ureter was reim­
planted with a psoas hitch procedure. 
Ten days later a fistula developed. After 
4 weeks of drainage right nephrectomy 
was necessary. At operation the lower 
end of the ureter was found to be ne­
crotic. Three years later she had an ileal 
loop diversion for progressive hydro­
nephrosis of the left unit and a con­
tracted bladder due to radiation fibrosis.
Case 6
A vesicopsoas hitch was used to cor­
rect a stenotic right ureter, reimplanted 
because of gross reflux in a 45-year-old 
woman. Two days after operation she 
was noted to have an incomplete femoral 
nerve palsy. This did not respond to 
conservative therapy. Another operation 
was performed 7 days after the psoas 
hitch procedure and the sutures in the 
psoas area were removed. (It was noted 
at the time that she did not have a well- 
developed psoas tendon and consequent­
ly the sutures were placed somewhat 
deeper than usual into the psoas muscle.) 
She recovered completely over a 3-month 
period. Her intravenous pyelogram and 
voiding cystourethrogram remain normal.
FIG. 11—Case 3. Internal stents in 
position after right to left transuretero­
ureterostomy and left vesicopsoas hitch 
with Boari flap.
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Indications
The indications for vesicopsoas 
hitch are noted in Table I. Iatrogenic 
injury was the most common indica­
tion (in 22 patients) with injury of 
the ureter during gynecologic proce­
dures being the most frequent. Over 
the 10-year period of the study there 
were 14 ligated ureters and 8 uretero- 
vaginal fistulas. These cases were re­
ferred to our hospital. Failed reim­
plantation was the next most common 
indication (13 patients).
On the basis of persistent reflux or 
stenosis 4 ureters (two patients) dem­
onstrating gross ureteral reflux and 
13 reimplanted ureters that had failed 
were reoperated on using this tech­
nique. In 16 of the 17 ureters the 
procedure was successful; 1 ureter 
exhibited minimal nonobstructing re­
flux.
Seven patients had combined ra­
dium implant and external irradiation 
to the pelvis for carcinoma of the 
cervix up to 14 years before the psoas 
hitch procedure was performed. These 
patients were carefully selected for 
the procedure on the basis of progres­
sive hydroureteronephrosis without 
evidence of residual disease and min­
imal evidence of radiation changes in 
the dome of the bladder. Successful 
reconstruction was achieved in six of 
the seven patients. One (case 5) had 
a fistula that led to sacrifice of the 
right kidney. Three years later pro­
gressive radiation changes in the blad­
der and opposite ureter necessitated 
diversion to an ileal loop.
The vesicopsoas hitch was also used 
for seven cases of congenital distal 
obstruction (megaureter), two cases of 
endometriosis, two cases of malacop- 
lakia, two cases of distal carcinoma 
of the ureter in solitary kidneys and 
one case with distal ureteral tuber­
culosis with progressive hydrone­
phrosis.
Results
The results were generally good. 
The stenosis and reflux were corrected 
in 56 of the 60 ureters. One patient 
continued to have mild nonobstructive 
reflux. Another patient had a uretero- 
cutaneous fistula that healed satis­
factorily after placement of a ureteral 
stent for 3 weeks. One of the seven 
patients treated for the effects of 
radiation on the ureter lost her kidney 
as noted earlier. Another patient with 
extensive malacoplakia had renal fail­
ure despite aggressive surgery, place­
ment of a stent and nephrostomy (the 
ureteral anastomoses appeared to be 
intact but the ureters became virtually
adynamic due to progressive malacop­
lakia); she had to be placed on main­
tenance hemodialysis. One patient had 
a transient femoral nerve palsy caused 
by sutures too deeply placed in the 
psoas muscle, which did not have a 
well-developed tendon. We now avoid 
going deeply into the muscle and find 
that even without a well-developed 
psoas tendon, adequate attachment to 
muscle can be obtained with super­
ficial stitches no deeper than 3 mm.
D iscussion
The vesicopsoas hitch is useful 
when replacing the lower ureter in 
patients with a variety of lower uret­
eral problems. By combining it with 
a Boari flap and downward mobiliza­
tion of the kidney, 70% of the ureter 
may be replaced. On the right side, 
by mobilizing the kidney and reposi­
tioning the renal vein caudad on the 
vena cava, most of the ureter may be 
replaced. Larger ureters requiring 
trimming may be brought entirely into 
the bladder following a psoas hitch 
because of elongation of the trigone; 
this virtually prevents the formation 
of ureteral fistulas.
A highly selected group of women 
with ureteral stricture following irradi­
ation for carcinoma of the cervix 
(radium implants and external radia­
tion) were successfully treated, using 
a psoas hitch, by reimplantation into 
tissue from the dome of the bladder, 
avoiding the heavily irradiated tissues 
at the base. Six out of seven patients 
treated in this m anner achieved good 
results; one patient had a nephrec­
tomy because of stenosis of the ureter. 
The vesicopsoas hitch has become our 
procedure of choice for dealing with 
lower ureteral injury or disease re­
quiring lower ureteral resection. The 
procedures of transureteral ureteros­
tomy, ureteral replacement with ileum 
and autotransplantation are rarely 
needed.
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Intravesical Therapy with Adriamycin in 
Urothelial Dysplasia and Early Carcinoma in Situ
R.W. Glashan, frcs(glas), frcs( edin) and A. Riiey , fimls*
The authors studied the effect of 
instilling Adriamycin intravesically in 
21 patients with urothelial dysplasia 
and early carcinoma in situ. The 
effectiveness of the treatment was 
assessed by repeated urine cytology, 
cystoscopy and repeated biopsy of 
the bladder mucosa. No serious side 
effects were noted.
Adriamycin causes the death of 
malignant cells, general improvement 
in the appearance of the bladder 
mucosa at cystoscopy and histologic 
evidence of endothelial damage to 
the bladder mucosa. The cytologic 
changes continue for many months 
after treatment.
Les auteurs ont etudie les effets de 
I’instillation intravesicale d'Adriamycine 
chez 21 patients atteints de dysplasie 
urotheliale et d’un cancer pre-invasif 
precoce. L'efficacite du traitement a 
ete mesuree par cytologies urinaires 
repetees, cystoscopie et biopsies 
repetees de la muqueuse vesicate. 
Aucun effet secondaire serieux n'a ete 
observe.
L’Adriamycine a entraine la mort 
des cellules malignes, une amelioration 
generate de I'apparence de la 
muqueuse vesicale a la cystoscopie 
et des signes histologiques de 
dommages a ('endothelium de la 
muqueuse vesicale. Ces changements 
cytologiques persistent plusieurs mois 
apres ie traitement.
Over the past 20 years much attention 
has been focused on the extent and be­
haviour of precancerous intraepithelial 
lesions such as carcinoma in situ of 
the bladder. This lesion consists of a 
flat area of epithelium with cells that 
have anaplastic features and a disor­
dered pattern of growth.1-8 Acceptance
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of this condition as a precancerous 
state has become more widespread and 
there now seems little doubt that this 
is an early phase in the evolution of 
bladder cancer.
For 12 years we have worked in a 
region where bladder cancer is com­
mon, because many people working in 
the chemical industry were exposed in 
the past to carcinogens during the 
manufacture of a -  and /J-naphthyl- 
amine, magenta, auramine and ben­
zidine. Because there may be a 20- to 
30-year latent period before bladder 
cancer develops, a widespread cyto­
logic screening program has been 
instituted, resulting in the early detec­
tion of atypical cells in the urine. The 
term “urothelial dysplasia” refers to 
the dysplastic changes seen in a biop­
sy specimen of the bladder mucosa in 
the presence of an apparently normal 
bladder, or one showing only minimal 
reddening or slight swelling of the 
mucosa at cystoscopy but with ab­
normal urine cytology, suggesting a 
premalignant or malignant change. 
Primary carcinoma in situ is com­
paratively uncommon and cystoscopie 
examination of patients with bladder 
tumours often reveals other areas of 
slightly abnormal mucosa that show 
signs of carcinoma in situ in biopsy 
specimens; this has been termed sec­
ondary carcinoma in situ.
Patients and Methods
At the Royal Infirmary in Hudders­
field, between February 1980 and 
May 1981, 34 patients with precancer­
ous lesions of the bladder were given 
Adriamycin intravesically; but only 
21, followed up for 9 months or more, 
are presented here. All 21 patients 
were men. They were classified into 
three groups (Table I).
Because of exposure of the study
population to industrial carcinogens, 
specific enquiry was made into each 
patient’s occupational background 
(Table II). In all patients a complete 
blood count was done and serum elec­
trolyte levels were measured. Intra­
venous pyelography, urine culture and 
cytologic examination of the urine 
were carried out. Cystoscopy was then 
performed under general anesthesia 
and multiple biopsies of the bladder 
mucosa were done. Only patients with 
histologic evidence of urothelial dys­
plasia or carcinoma in situ and malig­
nant cells in the urine were entered 
into the study. All urine specimens 
were graded cytologically using the 
Papanicolaou technique.
Informed consent was obtained from 
all patients. They were treated on 
an out-patient basis. The bladder was 
emptied by a small urethral catheter 
and 50 mg of Adriamycin dissolved in 
50 ml of sterile saline was introduced 
into the bladder and the catheter with­
drawn. The patient was placed in a 
different position (e.g., left lateral, 
head down, prone) every 20 minutes 
and after 2 hours was allowed to emp­
ty the bladder. The patients were not
Table II— Occupation of the 21 Patients
Occupation No. of patients
Chemical workers* 9
Furnace workers* 3
Woodworkers 2
Rubber processor* 1
Dyehouse foreman 1
Asphalt worker* 1
Electrician 1
Hairdresser 1
Coal miner 1
Textile worker* 1
‘Probable exposure to industrial carcino 
gens.
Table 1— Patient Groups
Group Description
No. of 
patients
1
Primary tumour 
Dysplasia/carcinoma in situ 6
2
Secondary tumour
Previous Ti tumour-)- carcinoma in situ 7
3 Papillary T, tumour-f carcinoma in situ 8
Total 21
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dehydrated but were asked not to 
drink excessively for several hours 
before treatment. The procedure was 
repeated at weekly intervals for 6 
weeks, so that a total of 300 mg of 
Adriamycin was given to each patient. 
The first 12 patients had the blad­
der filled with normal saline to assess 
the size of the bladder and to note 
any changes in the cytologic findings 
caused by the introduction of saline; 
none were found.
Assessment of Adriamycin Therapy
The effectiveness of Adriamycin 
therapy was assessed in three ways: 
(a) Early morning urine specimens 
were examined cytologically before 
treatment, after three and after six 
instillations of Adriamycin, after 1, 
2 and 3 months, and thereafter at 
3-month intervals, (b) Cystoscopic ex­
aminations were made every 3 
months, (c) Serial biopsy specimens 
of the bladder mucosa were examined.
Cytologic Assessment
There is ample evidence that intra- 
vesically administered Adriamycin 
damages and kills malignant cells. Cy­
tologic examination of the urine shows 
many grossly enlarged cells with dis­
ruption of the nuclear membrane and 
fragmentation of the nucleus. The cy­
toplasm becomes ragged and vacu­
olated; phagocytosis is often seen and 
large pink inclusions are a consistent 
finding; eventually the cells become 
anucleate. After two instillations of 
Adriamycin and for many months 
after treatment has ended large num­
bers of degenerated cells can be seen 
in the urine, suggesting that the 
changes caused by Adriamycin ther­
apy are progressive.
Attempts were made to quantify 
the number of cells being exfoliated 
but this number is variable and the 
procedure was not practical. In the 
first few weeks, large degenerate
malignant cells were predominant in 
the urine but eventually the cells be­
came smaller and it became apparent 
that these were basal cells from the 
deeper layers of the mucosa.
Results
Cytologic Response
The initial assessment of the course 
of treatment was made 1 month after 
the last Adriamycin treatment (Table 
III). In 17 of 21 patients the tumour 
had regressed at 1 month, and in 12 
of them the cells became benign; in 
the other 4, although damaged malig­
nant cells were found, the cytologic 
grading did not appreciably alter and 
these patients were classified as show­
ing no change. At 3 months, 15 con­
tinued to improve but in 2 patients the 
lesion became more malignant and 
carcinoma in situ was shown to have 
progressed to invasive carcinoma. In 
retrospect, on reviewing the original 
biopsy, one of these patients should 
not have been included in the trial, 
since the lamina propia had already 
been invaded by malignant cells be­
fore he received any treatment. In 
three other men, at 6 months, the 
cytologic pattern, which had initially 
improved in two and was unchanged 
in one, showed signs of deterioration 
and, in each case, this was associated 
with the development of a papillary 
tumour.
The overall cytologic response was 
that of marked damage to malignant 
cells in 20 of 21 patients. In 12 the 
cells reverted to a benign form; in 
the other 8, marked cellular damage 
was shown, which, in some cases, con­
tinued for many months. In these pa­
tients the Adriamycin therapy should 
have been continued because the dose 
of Adriamycin was probably not large 
enough to kill all the malignant cells. 
Further treatment has been instituted 
in these patients.
Cystoscopic Response
In three patients, bladders that ap­
peared normal before treatment con­
tinued to have a normal appearance. 
The bladders of 17 others were great­
ly improved as shown by the marked 
reduction in the reddened areas of 
mucosa noted before treatment. In 
only one man did the carcinoma in 
situ become worse cystoscopically; this 
was the patient who probably had an 
invasive carcinoma before he received 
any treatment. New tumours devel­
oped in six patients; five tumours were 
small, superficial transitional cell car­
cinomas, which gave the bladder an 
unhealthy friable appearance, and one 
was a squamous cell carcinoma.
Histologic Changes
Repeated mucosal biopsy specimens 
showed marked surface damage to 
the bladder epithelium following the 
instillation of Adriamycin. The degree 
of this damage is probably related to 
the total dose of drug used.
Adriamycin causes localized necro­
sis and mucosal ulceration of the su­
perficial layers of the bladder mucosa 
and this is associated with obvious 
cystoscopic improvement and marked 
alteration in the exfoliative cytology. 
We have noticed that some patients 
who had histologic changes of carci­
noma in situ in the Brunn’s nests and 
crypts of the bladder mucosa re­
quired a longer course of Adriamycin 
before any cytologic changes were ob­
served.
Side-Effects
Repeated complete blood counts 
and serum electrolyte determinations 
confirmed the earlier observations of 
Edsmyr and colleagues,9 that intra­
vesical instillation of Adriamycin does 
not cause any important systemic up­
sets. In 136 catheterizations for the 
instillation of Adriamycin, only three 
urinary infections were noted; in two, 
the patient had a long history of uri­
nary infection. One patient had dy- 
suria without evidence of infection 
and three had minimal hematuria 
which cleared up within 24 hours. 
Only 1 patient had the signs and 
symptoms of irritative cystitis, but in 
12 other patients not reported in this 
series, 3 had evidence of quite severe 
spasm brought on by the introduction 
of Adriamycin into the bladder; in 2 
of these the treatment had to be 
stopped after four instillations.
Discussion and Conclusions
Repeated cystoscopic examination 
in the follow-up of patients with blad­
der cancer may reveal no evidence of
T a b le  I I I —C y to lo g ic  A s s es s m e n t
G roup , n o . o f p a tie n ts
C y to lo g ic  f in d in g s
1
(n  =  6 )
2
(n  =  7 )
3
(n  =  8 ) T o ta l
A t  1 mo
R e g ress io n 4 6 7 17
N o ch a n g e 2 1 1 4
P ro g re s s io n 0 0 0 0
A t 3 mo
R e g re s s io n 4 4 7 15
N o c h an g e 1 3 0 4
P ro g ress io n 1 0 1 2
A t  6 mo
R e g ress io n 5 5 6 16
No c h an g e 0 2 0 2
P ro g ress io n I 0 2 3
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active tumour but may reveal mu­
cosal abnormalities that, histologically, 
are precancerous. In such cases it is 
reasonable to assume that these ab­
normal areas are new tumours in the 
early stages of development. The im­
portance of these findings has been 
emphasized by Weinstein and asso­
ciates10 and by Farrow and associates,11 
who stated that in patients with ex­
tensive carcinoma in situ but with no 
previous history of a bladder tumour, 
the probability of finding a focus of 
microinvasive carcinoma at cystec­
tomy is approximately 20%. Accord­
ing to Daly,12 in a patient with a 
previously resected bladder carcinoma 
and the finding of a carcinoma in situ, 
the likelihood of an invasive tumour 
developing is 42% and when the in- 
situ changes are in close proximity to 
a low-grade carcinoma the likelihood 
is 83% .13 The clinical progression of 
bladder carcinoma from its premalig- 
nant state is variable and it is difficult 
to know how best to treat this condi­
tion. We have found that the response 
to radiotherapy varies. In the opinion 
of De Voogt'1 the prognosis of car­
cinoma in situ is so poor that patients 
with this condition should be treated 
by total cystectomy. This is a radical 
form of therapy for a disease that 
may take years to develop; there­
fore, it is reasonable to treat carci­
noma in situ, particularly if an early 
diagnosis is made, by intravesical 
chemotherapy.
As a result of treating 21 patients, 
who had either malignant urothelial 
dysplasia or carcinoma in situ, with 
Adriamycin instilled intravesically we 
found that (a) Adriamycin caused the 
death of malignant cells, (b) reddened 
areas of bladder mucosa disappeared 
in 17 of 18 bladders, (c) histologic 
evidence of endothelial change was 
shown, (d) cytologic changes occurred 
after two treaments but may occur 
after many months, (e) new tumours 
developed in 6 patients and (f) there 
were minimal side-effects.
There seems little doubt that Adria­
mycin given intravesically is effective 
in treating carcinoma in situ. In pa­
tients treated early in this series the 
improvement has been maintained for 
up to 1 year. This agrees with the 
observations of Edsmyr and col­
leagues9 and Eposti and colleagues,15 
although Jakse and Hofstadter16 found 
a good response in only three of six 
patients. It is reasonable to continue 
this form of treatment and to obtain a 
much longer follow-up before reach­
ing any final conclusions. Previous ex­
perience with other agents adminis­
tered intravesically, such as thiotepa,
cyclophosphamide, Epipodophyllotox- 
in VM 26 and Epodyl, leads us to 
believe that Adriamycin is superior to 
other drugs in treating carcinoma in 
situ. Some patients may require treat­
ment for a longer period than we 
used. This could be explained by the 
histologic changes that occurred in the 
Brunn’s nests and crypts of the blad­
der mucosa. Nevertheless the prelimi­
nary results of this trial suggest that 
many patients show substantial regres­
sion of the premalignant condition at 
cystoscopy and as judged by serial 
urine cytologic examinations and may 
be improved even more by treatment 
for a longer period.
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Vasoepididymostomy: the Role of the Microscope
Martin G. McLoughlin, md, frcs[c]
Reconstructive surgery of the 
epididymis has been facilitated by 
the use of the microscope. The 
author describes his technique for 
end-to-end and end-to-side anastomoses 
and reports the results of 
reconstruction in 23 patients over 
a 10-year period. The pregnancy 
rate following reconstructive 
surgery was 39% overall: 40% after 
vasoepididymostomy (performed in 
10 patients) and 35% after repair of 
primary epididymal obstruction 
(performed in 13 patients). With the aid 
of the microscope end-to-side and 
end-to-end anastomoses between the 
vas deferens and epididymis can be 
performed with greater precision 
because the anatomy can be defined 
precisely and reconstruction planned 
better.
La chirurgie reconstructive de 
I'epididyme a ete facilitee par I'emploi 
du microscope. L'auteur decrit la 
technique qu'il utilise pour les 
anastomoses termino-terminales et 
termino-laterales et il rapporte ses 
resultats de reconstruction chez 33 
patients au cours d'une periode de 
10 ans. Globalement, le taux de 
grossesse consecutif a la chirurgie 
reconstructive a ete de 39%: 40% 
consecutif a la vasoepididymostomie 
(chez 10 sujets) et 35% consecutif 
a la reparation de I’obstruction 
primaire de I'epididyme (chez 13 
sujets). A I'aide du microscope, les 
anastomoses termino-terminales et 
termino-laterales entre le vas deferens 
et I'epididyme peuvent etre pratiquees 
avec une plus grande precision car 
I’anatomie peut etre definie avec 
precision et la reconstruction mieux 
planifiee.
Since Martin first described vasoepi- 
didymostomy in 1902,1 the surgical 
technique has continued to improve 
and, recently, with the introduction of 
microsurgical techniques, has become
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more sophisticated. Reports by Hag- 
ner in 1936,2 Humphreys and Hotch­
kiss in 1939,3 Phadke in 195 64 and 
Dubin and Amelar in 19775 have pop­
ularized the use of the macroscopic 
technique. We report our experience 
with the microscopic technique.
Patients, Method and Results
Between 1977 and 1979, 100 vasec­
tomy reversal operations were per­
formed at the University of British 
Columbia. Ten of the patients re­
quired vasoepididymostomy for recon­
struction. During this time 13 patients 
had primary epididymal blockage. All 
patients underwent vasoepididymos­
tomy with microscopic control.
In the 10 patients who required 
vasoepididymostomy, 8 had a primary 
end-to-end anastomosis and 2 had an 
end-to-side anastomosis. Four preg­
nancies (40%) resulted in this group. 
Of the 13 patients who had primary 
epididymal obstruction, 11 had end- 
to-end anastomosis and 2 had end-to- 
side anastomosis. Five pregnancies 
(35%) resulted.
Development of Technique
The surgical treatment is divided 
into two categories, the end-to-side 
and the end-to-end techniques. Both 
utilize the microscope since it facil­
itates direct mucosal approximation 
and anatomical reconstruction of the 
tubule. Exploration of the scrotum is 
similar in both techniques, which 
differ only in the type of anastomosis 
used.
Under general anesthesia, we ex­
plore the scrotum to define the ab­
normality and decide on the recon­
structive technique to be used. The 
incision is generous enough that the 
testes may be delivered into the wound 
to define the epididymal abnormality. 
The vas deferens is identified and 
traced to its junction with the epidi­
dymis. A tense and turgid epididymis 
with tortuous tubules visible under the 
epididymal serosa is suggestive of 
obstruction to epididymal outflow. 
Blue zones or white sclerotic tissue 
found in the epididymis indicates se­
vere, long-standing obstruction, which 
is often seen in primary epididymal 
obstruction; in this type, inspissated 
material is often found in the tubules.
The inspissated material does not al­
low teasing out of the tubules and 
therefore end-to-side anastomosis is 
preferable. Identification and pres­
ervation of the vessels to the vas def­
erens and epididymis are important as 
injury will result in a scarred and com­
promised anastomosis. The vas def­
erens is then mobilized to provide a 
tension-free vasoepididymal anastom­
osis. A 1-cm longitudinal incision is 
made as distal as possible in the epidi­
dymis but proximal to any obvious 
site of obstruction (Fig. 1). The epi­
didymal ducts are then squeezed and 
opened to look for milky fluid that 
may extrude from the lumen. If the 
material is inspissated or if sclerotic 
areas are seen, an end-to-side anas­
tomosis is performed. If the fluid 
from the tubules is liquid and the tu­
bules can be separated, then a primary 
end-to-end anastomosis is carried out. 
The material from the cut end of the 
epididymis is placed on a glass slide 
and examined for live motile sperm. 
If none are found, a more proximal 
incision is made in the epididymis to 
search for live sperm. We make the ini­
tial incision in the epididymis as distal 
as possible because this will allow a 
longer transit time for the sperm and 
thus may provide better sperm matura­
tion and fertility. A suitable site in the
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vas is then selected and the patency 
checked by injecting saline proximally. 
We then join either an end of the vas 
deferens to the side of the epididymis 
or make an end-to-end anastomosis. 
Up to this point, the preparation of 
the epididymis and vas has been per­
formed macroscopically. The micro­
scope is used for the anastomosis.
In the end-to-side anastomosis, the 
distal end of the vas deferens is spatu- 
lated and anastomosed to an elliptical
incision in the epididymis using 6x  
to 10X magnification (Fig. 2). The 
anastomosis is carried out with 8-0 
Dexon. We use a modified suction 
apparatus consisting of a tuberculin 
syringe attached to a no. 20 blunt 
needle and copious irrigation. After 
placement of the two corner sutures, 
the individual sutures are placed full 
thickness. With rotation of the epidi­
dymis, we can then suture the poste­
rior wall.
Usually, when we reverse a pre­
vious vasectomy that requires epidi- 
dymal reconstruction, end-to-end ana­
stomosis is superior. After making the 
incision in the epididymis and check­
ing the fluid for sperm, we use the 
microscope to identify the epididymal 
ductule that leads proximally. With 
16 X to 25 X magnification, we can 
tease out the cut ends of the epidi­
dymis and finally the epididymal duc­
tule and dilate the lumen with no. 5 
jewellers’ forceps. The lumen of the 
vas deferens is also dilated. We can 
then place four sutures between the 
dilated ductule and the mucosa above 
the vas deferens (Fig. 3), using 8-0 
Dexon or 9-0 monofilament nylon. 
These sutures are mucosa to mucosa, 
but in the vas deferens they incor­
porate some submucosa. After com­
pletion of the mucosal sutures, a 
second row of serosal sutures of 8-0 
Dexon is placed approximating the 
muscular wall of the vas deferens to 
the serosal wall of the epididymis.
After these anastomoses have been 
completed the testis is placed back 
in the scrotum and the dartos muscle 
is closed with 2-0 chromic catgut. The 
skin is closed with 4-0 Dexon and a 
pressure dressing is applied for 24 
hours.
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F IG . 3— End-to-end anastomosis between dilated end of epididymal duct and 
lumen of vas deferens.
This condition often lends itself best 
to an end-to-end anastomosis. The 
microscope is invaluable to the sur­
geon who must perform reconstructive 
surgery of the epididymis. It facilitates 
accurate suture placement and allows 
the surgeon to perform the end-to- 
end or the end-to-side anastomosis 
with good mucosa to mucosa apposi­
tion. This will decrease the likelihood 
of anastomotic leaks and scar forma­
tion and stenosis.
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Discussion
Patients with epididymal obstruc­
tion may benefit from vasoepididym- 
ostomy. In patients presenting with 
primary epididymal obstruction, Han­
ley and Hodges6 found a 50% inci­
dence of obstructive congenital an­
omalies in the epididymis on micro­
dissection. Many patients had multiple 
obstructions. The most common an­
omaly seen was macroscopic — the 
normal head of the epididymis faded 
into a poorly developed body or tail. 
With the microscope we can define 
the anatomy and therefore plan re­
constructive surgery with more pre­
cision.
Epididymal obstruction secondary 
to vasectomy is usually not recognized 
until exploration has been carried out 
for reversal of the vasectomy. We 
now perform vasoepididymostomy if, 
on exploration, the cut end of the 
testicular side of the vas does not 
show any dilatation of the lumen, if 
no sperm are found in this lumen 
and if the vasectomy has involved the 
junction of the epididymis and the vas 
deferens, resulting in the possible re­
moval of a segment of the epididymis. 
These patients undergo epididymal ex­
ploration to find a region in the epi­
didymis, most preferably in the tail, 
where the lumen is adequate and there 
are viable motile sperm in the fluid.
The Japanese and Canadian societies 
for biomaterials invite participation 
in a joint conference session to be 
held at the University of British Co­
lumbia, Vancouver, July 28-30, 1982. 
Invited are papers on orthopedic, car­
diovascular and dental materials and 
tissue mechanics. All papers must be 
received by Apr. 2, 1982. Commer­
cial exhibitors and sponsors are wel­
come to take a complimentary role 
in the conference; exhibit space is 
available. Further information can be 
obtained from: Dr. R.H. Roydhouse, 
Conference chairman, Secretariat Bio­
materials ’82, #1704, 1200 Alberni 
St., Vancouver, BC V6E 1A6.
Clinical Application 
of Hyperbaric Oxygen
The 7th Annual Conference on the 
Clinical Application of Hyperbaric 
Oxygen is scheduled for June 9 to 11, 
1982 at the Disneyland Hotel in Ana­
heim, California. Included in the con 
ference will be plenary sessions on the 
use of hyperbaric oxygen in neuro­
logic disorders and anaerobic infec­
tions. Original papers will be pre­
sented and there will be workshops 
and exhibits. For more information, 
write: Baromedical department, Me­
morial Hospital Medical Center, 2801 
Atlantic Ave., Long Beach, CA 90801- 
1428, or call (213) 595-3613.
continued on page 63
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Intermittent Percutaneous Infusion into the Hepatic Artery 
of Cytotoxic Drugs for Hepatic Tumours
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Between June 1, 1976 and Apr. 30, 
1981, 157 patients were treated for 
inoperable cancer of the liver by 
intermittent percutaneous infusion 
of chemotherapeutic agents into 
the hepatic artery. The majority of 
these patients had metastatic 
colorectal cancer. The regimen of 
chemotherapeutic infusion evolved 
during the study and is described. 
The survival of the total group of 
patients is analysed according to type 
of cancer, extent of disease, dosage 
and combination of drugs. This 
therapeutic modality appears to benefit 
patients with metastases from 
colorectal cancer confined to the liver. 
The complication rate for this 
procedure is relatively low. The results 
from this study suggest that 
intermittent percutaneous infusion
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of cytotoxic agents into the hepatic 
artery is worthwhile for selected 
patients and should be studied 
further in combination with other 
forms of therapy.
Entre le 1er juin 1976 et le 30 avril 
1981, 157 malades ont ete traites 
pour un cancer inoperable du foie par 
perfusion percutanee intermittente 
d'agents chimiotherapeutiques dans 
I'artere hepatique. La majorite de 
ces patients souffraient de cancer 
metastatique du colon ou du rectum. 
Le regime chimiotherapeutique qui a 
evolue durant I'etude est decrit. On 
a analyse la survie du groupe de 
malades selon le type de cancer, 
I’etendue de la maladie, la dose et 
('association de medicaments. Ce 
regime therapeutique semble profiter 
aux patients atteints de metastases 
confinees au foie d'un cancer du 
colon ou du rectum. Le taux de 
complications rattache a cette 
procedure est relativement bas. Les 
resultats de cette etude indiquent 
que la perfusion percutanee 
intermittente d'agents cytotoxiques 
dans I'artere hepatique est utile pour 
les cas choisis et que I'etude de ce 
regime therapeutique merite d'etre 
poursuivie en association avec d’autres 
formes de traitement.
The prognosis of neoplastic disease of the liver, primary or metastatic, re­
mains poor.1 Current methods of treatment are unsatisfactory. The use 
of standard systemic chemotherapy with 5-fluorouracil (5-FU) has re­
sulted in a response in 10% to 20% 
of patients, with a median duration 
of 3 to 5 months, but improvement 
in survival has been minimal.2”3
The rationale for infusing cytotoxic 
drugs via the hepatic artery is that it 
will give a much higher concentration 
of drug in the tumour, compared with the surrounding normal hepatic tissue, 
for a longer time.4,5 This route of ad­ministration will allow concentrations 
of drug to be administered that would 
be lethal if given systemically.6 The techniques for regionalized chemother­
apy to the liver include infusion via 
the hepatic artery alone,7,8 in combina­
tion with hepatic artery occlusion9 or 
in combination with radiotherapy.10
Although the success of this ther­
apeutic approach has varied over the 
last 15 years, a number of encouraging 
studies have reported response rates 
of 30% to 60%, with slightly longer 
survival and improved quality of 
life.7-9”11-
Patients
From June 1, 1976 to Apr. 30. 
1981, 157 patients with primary or 
secondary hepatic tumours received 
chemotherapy by intermittent percu­
taneous infusion into the hepatic ar­
tery. Nine patients died within the 
first month of therapy (Table I) and 
were excluded from further analysis. All patients had unresectable tumours. 
There were 94 men and 54 women
Table 1— Cause of Death in First Month
Cause No. of patients
Sepsis
Catheter-related 2
Other 1
Liver failure 1
Disseminated tumour 5
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ranging in age from 20 to 77 years. 
The majority had carcinoma meta­
static to the liver; the site of the pri­
mary tumour was colorectal in 98 
(66%), gastric in 7 (5%), breast in 6 
(4%), pancreatic in 6 (4%) and at 
other sites in 10 (7%). The primary 
hepatic tumours were hepatocellular 
carcinoma in 14 (9%) and cholangio- 
carcinoma in 7 (5%).
M ethods
After initial assessment a percu­
taneous transfemoral catheter was 
placed in the common hepatic artery, 
except in those patients in whom the 
hulk of, the tumour in the right hepa­
tic lobe was supplied by a right he­
patic artery arising from the superior 
mesenteric artery. In these patients 
the catheter was placed in the aberrant 
right hepatic artery.
Cytotoxic drugs were infused at a 
constant rate with an IMED pump 
(IMED Canada, Streetsville, Ont.). 
Patients were kept on strict bed rest 
for the duration of the infusion and 
for 12 hours following removal of 
the catheter; then they were dis­
charged.
The choice of cytotoxic drugs and 
regimen used for the patients with 
liver metastases from gastrointestinal 
malignant tumours (colorectal, gastric 
and pancreatic carcinoma) and breast 
cancer evolved during the study. Ini­
tially, 5-FU was infused at l to 2 
g/d for 3 to 7 days. In the last 3 
years, 7.5 to 12 g were infused over 
3 to 5 days. At the conclusion of the 
latter regimen, one group of patients 
received mitomycin C (5 to 10 mg) 
as an intra-arterial bolus over a 10- 
minute period.
The cytotoxic drugs given to the 
patients with hepatoma were 5-FU 
and Adriamycin; patients with mela­
noma received dacarbazine (DTIC) 
and melphalan, and those with sar­
coma received Adriamycin and actin- 
omycin D. Six of the 148 patients 
received cytotoxic drugs other than 
5-FU.
Each patient was readmitted at 4- 
to 8-week intervals for reinfusion if 
the leukocyte and platelet counts al­
lowed. Patients with extrahepatic neo­
plastic disease were treated with drugs 
systemically in addition to hepatic ar­
tery infusion. All patients remained 
on the intermittent infusion regimen 
which was discontinued if the hepatic 
artery became occluded, if the tumour 
enlarged rapidly despite the infusion, 
if the blood counts became too low 
or if the patient could not tolerate 
the 3 to 5 days of bed rest.
Results
The 157 patients in the group were 
infused 338 times. Most received 3 
to 6 infusions (range from 1 to 18). 
The nine patients who died within the 
first month either were severely ca­
chectic or had widespread metastatic 
disease before hepatic artery infusion 
was begun. In most, death was not 
directly attributable to the infusion.
The life-survival curves are shown 
in Fig. 1. The median survival time 
was 11.5 months and the 1- and 2- 
year survival rates were 44% and 
12% respectively.
Of the 157 patients, 148 had meta­
static tumour; 110 had hepatic meta­
stases only and the other 38 also had 
major systemic metastases. The 1- and 
2-year survival rates of the patients 
with hepatic metastases only were 
50% and 19% respectively compared 
with 31 % and 7 % for those with sys­
temic metastases also (Fig. 2). The 98 
patients with colorectal carcinoma 
were similarly analysed. The 1- and 
2-year survival rates of those with 
metastases to the liver only were 60% 
and 17% respectively compared with 
32% and 5% for patients with meta-
FIG. 1— Life-survival curves for total 
patient population (157) (dotted line) and 
for those who survived first month of 
infusion (148) (solid line), calculated 
from date of first infusion.
stases to other sites in addition to 
the liver (Fig. 3).
The results in the 98 patients with 
colorectal carcinoma were analysed to 
determine if mitomycin C therapy had 
any additional effect (Fig. 4). The 1- 
and 2-year survival rates for the 52 
patients receiving 5-FU only were 
52% and 15% respectively compared 
with 52% and 8% for the 46 pa­
tients receiving 5-FU and mitomycin 
C.
Thirty-nine patients received low- 
dose 5-FU (7.5 g total per infusion); 
the 1- and 2-year survival rates were 
38% and 18% respectively. This 
compares with 49% and 11% for 103 
patients receiving more than 7.5 g of 
5-FU per infusion (Fig. 5).
Complications
There were 23 complications during 
the 338 catheter placements and in­
fusions (Table II). Two patients died 
of clostridial infection that developed 
during the infusion. Currently, our 
protocol includes intravenous admin-
FIG. 2— Life-survival curves for pa­
tients with metastases confined to liver 
(dotted line) and for those with addition­
al systemic metastases (solid line).
FIG. 3— Left: life-survival curve for all patients with colorectal carcinoma. 
Right: curves for patients with colorectal carcinoma with metastases confined to liver 
(dotted line) and for those with additional systemic metastases (solid line).
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istration of antibiotics whenever the 
temperature rises above 38°C, after 
blood samples have been cultured, 
and this has avoided repetition of that 
complication.
Injury to the hepatic artery oc­
curred in 13 patients. Occlusion was 
demonstrated subsequently in two pa­
tients by arteriography; recannulation 
in both cases allowed resumption of 
the infusion. The development of a 
hepatic artery aneurysm in one patient 
forced us to stop the infusion.
Dislodgement of the catheter was 
suspected whenever a patient had 
acute nausea, vomiting or upper ab­
dominal pain. When these symptoms 
occurred, the infusion was temporarily 
stopped and the catheter position 
checked by angiography and corrected 
when necessary.
D iscussion
Current therapy and survival fig­
ures for primary and metastatic neo­
plasms involving the liver are unsatis­
factory. The mean survival time
FIG. 4— Life-survival curves for pa­
tients with colorectal carcinoma who re­
ceived hepatic infusion with 5-fluoro- 
uracil (5-FU) alone (dotted line) and for 
patients who received hepatic infusion 
with 5-FU and mitomycin C (solid 
line).
FIG. 5— Life-survival curves compar­
ing low-dose (less than 7.5 g, solid line) 
and high-dose (more than 7.5 g, dotted 
line) 5-FU hepatic artery infusion for 
142 patients.
quoted in the literature for systemic 
therapy or treatment by infusion of 
cytotoxic drugs continues to be 6 to 
9 months depending on the series of 
patients studied.7-8,1112 Moreover, there 
is a substantial number of complica­
tions for the various methods of in- 
fusional treatment and for systemic 
drugs when used alone. The long­
term survival is limited.
The present series is noteworthy for 
several reasons. First, the complica­
tion rate related to intermittent cath­
eter placement is low. In contrast to 
a previously reported series,13 throm­
bosis of the hepatic artery occurred 
in only 10 patients. These patients did 
not survive longer than the others in 
this group, as has been previously 
reported;9 however, the number of 
patients in this series who had throm­
bosis of the hepatic artery may be too 
small to draw such conclusions. Sec­
ond, our median survival rate for the 
entire group of patients is slightly be- 
ter than what is reported in the litera­
ture. Third, the quality of life in the 
survivors was better because the ther­
apy, which is always toxic to a vari­
able extent, is administered intermit­
tently for short periods. Fourth, it is 
apparent that when this form of ther­
apy is used, patients whose disease is 
limited to the liver have an improved 
survival rate. The survival rate is the 
same or slightly better when a larger 
dose of drug is administered over a 
shorter period. Since this is not asso­
ciated with any notable increase in 
side-effects, giving a larger dose of 
5-FU shortens hospital stay and the 
period of bed rest. This period is 
further shortened bv giving a bolus 
infusion of mitomycin C at the end 
of the 5-FU infusion. Thus, patients 
can be treated at 4- to 8-weekly inter­
vals for 72 hours with no intervening 
therapy if their disease is limited to 
the liver.
T a b le  I I — C o m p lic a tio n s  in  338 
P la c e m e n ts  to r  H e p a tic  A r te ry
C a th e te r
In fu s io n
C o m p lic a tio n N o .
S epsis
C lostrid iu m  sp. 2 *
S ep tic  em b o li 1
In fe c t io n  a t  s ite 2
C a th e te r - re la te d
H e p a tic  a r te r y  o cc lus ion 10
O c c lu s io n  and  re c a n n u la t io n 2
H e p a tic  a r te ry  an e u rys m 1
F e m o ra l a r te ry  in ju r y 4
O th e r
M ye lo s u p p re s s io n 1
'R e s u lt in g  in  d e a th .
Patients with advanced, widespread 
tumour and those with severe liver 
dysfunction from tumour invasion are 
not candidates for hepatic artery in­
fusion as shown by the nine deaths 
that occurred in the first month.
Patients with colorectal disease me­
tastatic to the liver alone, survived 
longer than 1 year. It is these patients 
who are of greatest interest relative 
to the present therapeutic regimen. It 
is suggested that because this sub­
group of patients appears to be sur­
viving substantially longer and be­
cause the method is safe, this ap­
proach be continued and perhaps 
combined with regional hyperther­
mia,14 limiting the therapy to those 
patients who have hepatic involve­
ment only. This does not exclude its 
use occasionally for patients with sys­
temic metastases. The extrahepatic 
metastases may respond to appropriate 
systemic cytotoxic therapy while those 
in the liver fail to regress. In such a 
situation the use of infusional therapy 
for the hepatic disease can be worth­
while. We have noted this in a number 
of patients with metastases from car­
cinoma of the breast, but the experi­
ence is limited to these patients. In 
this small group an 80% remission 
rate has been observed. But systemic 
therapy adequate to prevent progres­
sion of the disease in the majority of 
these patients has not yet evolved.
Summ ary
Hepatic metastases due to gastroin­
testinal or breast cancer can be treated 
with intermittent high-dose infusions 
of drugs through a percutaneously 
placed catheter, with relatively low 
morbidity and mortality. A dose of 
5-FU up to 4 g/d can be administered 
safely without substantial side-effects. 
The quality of life that is produced 
by such intermittent therapy is su­
perior to that of patients on weekly 
regimens. The results of this study 
require further evaluation in conjunc­
tion with other regional therapeutic 
modalities and more experience is re­
quired with breast cancer metastatic 
to the liver to evaluate whether this 
treatment is worthwhile in providing 
remission in patients whose disease 
involves a critical organ.
The authors wish to thank Lana 
Bryant for the preparation of the manu­
script.
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Structure and Function of Small Bowel Allografts 
in the Dog: Immunosuppression with Cyclosporin A
R.K. R e zn ic k , m d , G.N. C raddock, m d , frcs, frcs [c ], B. L a n g e r , m d , frcs [c ], facs, T. G ila s , m d
and  J.B. C u l l e n , m d , frcp [c ]
Pairs of mongrel dogs received 
orthotopic total small bowel 
allografts. Half were treated with 
the immunosuppressive agent 
cyclosporin A and the other half 
were not.
Ten untreated dogs survived a 
mean of 12.5 days (range from 7 to 
25 days). They lost up to 30% of 
their initial body weight and rejection 
with hemorrhagic necrosis was 
usually the cause of graft failure.
The mean survival of 11 dogs treated 
with cyclosporin A was 90.6 days 
(range 9 to 287 days) with early 
deaths being due to pneumonia or 
volvulus. Intestinal mucosa appeared 
normal, but there was some smooth 
muscle hypertrophy. Reconnection of 
lymph vessels was complete in all 
dogs examined more than 21 days 
after allografting. Two dogs survived 
for 203 and 221 days, respectively, 
and one dog remains alive and well 
287 days after operation. The long-term 
survivors remained healthy, with 
steady body weights, formed stools, 
normal plasma protein values and 
xylose absorption curves that did not 
differ from those of autografted 
dogs. Roentgenography after a barium
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meal and follow-through study showed 
normal mucosa. The transit time was 
around 60 minutes (normal 150 
minutes). Late, acute episodes of 
rejection occurred in two dogs, when 
blood levels of cyclosporin A were 
low (less than 400 ng/m l). Bowel 
mucosa showed ulceration and villous 
atrophy, with lymphoid infiltration, 
leading to malabsorption as a terminal 
event.
Cyclosporin A is effective in 
increasing the duration of survival 
in dogs with small bowel allografts 
while maintaining essentially normal 
bowel structure and good function.
Des paires de chiens batards ont regu 
des allogreffes orthotopiques totales 
d'intestin grele. La moitie a regu un 
traitement a la cyclosporine A,
I'autre moitie restant intraitee.
Dix chiens non traites ont survecu 
durant 12.5 jours en moyenne (ecart 
de 7 a 25 jours). Ils perdirent jusqu’a 
30% de leur poids initial et le rejet 
accompagne de necrose hemorragique 
furent habituellement la cause de la 
defaillance du greffon. La survie 
moyenne des 11 chiens traites a la 
cyclosporine A fut de 90.6 jours 
(entre 9 et 287 jours), les deces 
precoces etant dus a la pneumonie 
ou a un volvulus. La muqueuse 
intestinale paraissait normale bien 
qu’il y ait eu un peu d’hypertrophie 
de la musculature lisse. La revascu­
larisation lymphatique etait complete 
chez tous les chiens qui ont ete 
examines plus de 21 jours apres la 
greffe. Deux chiens ont survecu 
pendant 203 et 221 jours respectivement, 
et un chien est toujours vivant et 
en bon etat, 287 jours apres I'operation. 
Les chiens qui ont eu une survie
prolongee sont demeures en sante, 
conservant un poids corporel constant, 
des selles normalement moulees des 
proteines plasmatiques normales et 
des courbes d'absorption du xylose 
qui ne differaient pas de celles des 
chiens qui recoivent une autogreffe.
Le temps du transit intestinal etait 
d’environ 60 minutes (la normale est 
de 150 minutes). Des crises tardives 
de rejet sont survenus chez deux 
chiens alors que leurs taux sanguins 
de cyclosporine A etaient bas 
(moins de 400 ng/ml). La muqueuse 
intestinale montrait de I'ulceration 
et de I’atrophie villositaire avec 
infiltration lymphoi'de, entrainant une 
malabsorption comme evenement 
terminal.
La cyclosporine A est efficace pour 
prolonger la survie chez le chien qui 
a regu une allogreffe d'intestin grele 
tout en maintenant une structure 
intestinale essentiellement normale 
et une bonne fonction.
Allotransplantation of the small bowel 
has been reported in seven patients.1,2 
The longest survival was 76 days, but 
no useful intestinal function was ob­
tained from this or any o f the other 
small bowel transplants. Many at­
tempts at small bowel allografting 
have been made in animals, mainly in 
dogs, but results have been discour­
aging. Lillehei and colleagues3 showed 
that short segments o f small bowel 
are rejected following allotransplanta­
tion; dogs survived an average o f 9 
days. Animals not treated with immu­
nosuppressive agents who had long 
segments o f bowel transplanted all 
died within 10 days, of what was 
thought to be graft-versus-host dis­
ease.4 The addition of azathioprine,
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prednisone and antilymphocyte globu­
lin to the therapeutic regimen in­
creased average survival to 20 days. 
Cohen and colleagues5 confirmed Lil- 
lehei’s findings in the case of un­
treated total small bowel orthotopic 
aliotransplants and showed that graft 
survival could be increased to a mean 
of 28 days by pretreating the donor 
bowel with 50 rad of x-radiation. 
One such animal lived for 58 days 
after transplantation — the longest 
survivor yet reported.
A new immunosuppressive agent 
cyclosporin A has been shown to be 
the most effective single agent in 
preventing rejection of kidney, liver, 
pancreas and heart transplanted in 
laboratory animals and man.6 It is 
also effective in preventing and treat­
ing graft-versus-host disease in patients 
with bone-marrow transplants.7 Cy­
closporin A is a unique immunosup­
pressant in that it almost specifically 
inhibits the early stages of T-cell 
transformation,8 without having a 
marked effect on other lymphocytes or 
polymorphs. Thus, it was considered 
ideal for use with small bowel trans­
plantation where the three main ob­
stacles to success have been rejection, 
graft-versus-host disease and sepsis. 
This experiment was undertaken to 
test the efficacy of cyclosporin A in 
prolonging survival of animals after 
total small bowel transplantation.
M aterial and M ethods
Pairs of adult mongrel dogs of 
approximately equal size and weight 
were randomized into either control 
or treated groups. Preoperatively all 
dogs had bowel preparation, which 
included orally administered neomycin 
(500 mg) and a fluid diet. They also 
received 1 g cephalothin intramuscu­
larly. Dogs assigned to the treatment 
group received 25 mg/kg of cyclo­
sporin A dissolved in mygliol, intra­
muscularly, the day before the oper­
ation.
The animals were anesthetized with 
thiopentone and anesthesia was main­
tained with nitrous oxide, oxygen and 
halothane. A long, midline, abdom­
inal incision was made. The complete 
small bowel was removed from both 
donor and recipient. The donor bowel, 
from the duodenojejunal flexure to 
the ileocecal valve, was mobilized in 
the manner described by Lillehei and 
colleagues.9 This was harvested along 
with its mesentery and vascular pe­
dicle, consisting of superior mesenteric 
artery and vein just distal to the duo­
denal and middle colic vessels. The 
intestine to be transplanted was per­
fused through the superior mesenteric 
artery with 1 litre of cold Ringer’s 
lactate solution containing 2000 units 
of heparin (Fig. 1). This allowed at 
least 2 hours of safe ischemic time.10 
The average time required to re-estab­
lish circulation was 45 minutes. In the 
recipient, the vascular anastomoses 
were performed between the superior 
mesenteric artery and vein and the 
abdominal aorta and inferior vena 
cava respectively, as described by 
Monchik and Russell11 (Fig. 2). To 
reduce the chance of twisting the 
anastomotic pedicle, the vein was 
placed just below the origin of the 
renal veins and the artery about 4 cm 
distal to that point. Intestinal anas­
tomoses were performed end-to-end 
using a two-layer technique so that 
the transplanted intestine was ortho­
topic. The intestine was placed in an 
appropriate position in the abdomen 
and totally covered with recipient 
omentum.
Postoperatively all dogs were main­
tained on intravenous fluid infusions 
until they were able to drink normally, 
about 48 hours. Three doses of ce­
phalothin were administered intra­
venously (1 g q8h)
ITG. 1— Donor bowel being perfused 
with cold heparinized Ringer’s lactate 
through superior mesenteric artery.
aorta and inferior vena cava respec­
tively.
The first 30 animals were fed a 
standard diet of beef chow (Romar 
Pet Supplies Co., Toronto, Ont.). Then 
the diet was changed to intestinal diet 
(Hill’s Ltd., Topeka, Kan.), a rapidly 
absorbed high protein, high calorie 
mixture of eggs, rice and cheese, de­
signed for dogs with chronic diarrhea.
Animals in the treatment group re­
ceived cyclosporin A (25 mg/kg daily) 
intramuscularly, dissolved in mygliol, 
for 30 days, and thereafter orally, dis­
solved in olive oil. Surviving dogs 
were weighed regularly and the he­
moglobin level, leukocyte count and 
serum electrolyte levels were meas­
ured. During the latter part of 
the experiment, when the technique 
of radioimmunoassay for cyclosporin 
A became available, blood levels of 
the drug were measured in several 
animals. All animals that died under­
went complete autopsy. In four of the 
long-term survivors, immediately after 
death, a lymphatic channel of the 
transplanted intestinal mesentery was 
cannulated and methylene blue in­
jected to ascertain if lymphatic recon­
nection had occurred.
Xylose tolerance tests were per­
formed on healthy (nontransplanted) 
dogs, dogs receiving autografts but not 
cyclosporin A and two of the long­
term survivors from the treated group.
Results
All animals that died within 6 days 
of operation were excluded from the 
study and were considered technical 
failures (Table I). Thirty dogs were 
thereby excluded; most deaths were 
due to vascular problems, mainly 
thrombosis of either artery or vein. Of 
the dogs receiving small bowel allo­
grafts 21 survived beyond 6 days, 10 
in the control group (not given cyclo­
sporin A) and 11 receiving cyclosporin 
A as their only form of immunosup­
pression.
Survival
The 10 control animals survived a 
mean of 12.5 days (range from 7 to 
25 days) (Table II). During this time 
the animals initially appeared well and
Table 1—Technical Failures
Reason No. of dogs
Venous infarction 12
Arterial thrombosis 7
Hemorrhage 4
Intestinal perforation 3
Sepsis 2
Unknown 2
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Table II— Survival after Transplantation
Controls (n =  10)
Survival, d Cause of death
25 Rejection
23 Rejection
13 Rejection
9 Rejection
12 Rejection
8 Rejection
7 Rejection
12 Rejection
8 Rejection
8 Rejection
‘Still alive.
Cyclosporin A (n =  11)
Survival, d Cause of death
54 Pneumonia
60 Pneumonia
221 Rejection
10 Peritonitis
9 Dehydration
37 Pneumonia
203 Rejection
40 Pneumonia
36 Internal hernia
40 Pneumonia
287*
tolerated their diet but soon became 
anorectic, had severe diarrhea and 
lost up to 30% of their initial weight.
Eleven treated animals survived a 
mean of 90.6 days (range from 9 to 
287 days). Their clinical course was 
different from the untreated animals. 
Many of the deaths were unrelated to 
primary intestinal problems. They 
maintained a good appetite and de­
spite an initial weight loss often re­
gained all the lost weight. Of the 11 
treated dogs, 1 was sacrificed at 9
FIG. 3— Blood levels of cyclosporin 
A in two long-term survivors.
days because it would not eat or 
drink. A second dog died at 10 days 
of peritonitis. Another died at 36 days 
of herniation of small bowel through 
the defect in the transplanted me­
sentery. Five others died at 37, 40, 
40, 54 and 60 days respectively, all 
of pneumonia. Two animals survived 
203 and 221 days respectively. Both 
were clinically well until 3 weeks be­
fore death when they became ano­
rectic, had diarrhea and died quickly. 
Both had blood levels of cyclosporin 
A during the last 3 weeks of life 
below 400 ng/ml (therapeutic range 
greater than 400 ng/ml) suggesting 
they were absorbing suboptimal doses 
of the drug (Fig. 3). One animal re­
mains alive and well at 287 days.
Autopsy Findings
Control animals.—Dogs that re­
ceived total small bowel allografts and 
no immunosuppression all died of in­
testine-related complications. In some 
the degree of postmortem autolysis of 
the transplanted small bowel was 
such that a specific pathologic diag­
FIG. 4—Whole mount of bowel anastomotic region in control animal. Host 
bowel (right) shows preservation of mucosal architecture. Transplanted bowel 
(left) shows diffuse hemorrhagic necrosis (hematoxylin and eosin, original magnif­
ication x5).
nosis was precluded. However, major 
changes were present in the trans­
planted bowel in all these dogs. The 
most common finding was a patchy 
hemorrhagic necrosis of the small 
bowel, often with perforations through 
the necrotic segments. The resultant 
sepsis was probably the immediate 
cause of death. Grossly, the large 
blood vessels in these transplanted 
bowels appeared normal as did all 
other organs studied.
The histologic findings in the trans­
planted bowel were nonspecific and 
showed a gross loss of epithelium with 
polymorphonuclear infiltration of the 
whole thickness of the bowel wall. The 
adjacent host small bowel was histo­
logically normal (Fig. 4).
The mesenteric lymph nodes were 
frequently enlarged and occasionally 
contained obvious gas bubbles. Histo­
logically, these nodes showed reactive 
changes and occasional bacteria. Sec­
tions of the transplanted blood ves­
sels and host kidney, liver, spleen and 
lymph nodes were all normal. No 
convincing evidence of graft-versus- 
host disease was found and the final 
diagnosis in all control animals was 
acute rejection of the transplanted 
bowel.
Treated animals.—The findings on 
gross and microscopic examinations 
of the intestines of the animals that 
died 9 days after operation were en­
tirely normal. The animal that died at 
10 days had gross peritonitis and a 
presumed intestinal perforation. His­
tologic examination of the trans­
planted bowel was normal. The ani­
mal that died at 36 days with an 
internal hernia demonstrated normal 
intestinal architecture. Five dogs died 
between 37 and 60 days after oper­
ation. They had pneumonia with or 
without empyema. In each case the 
transplanted intestine appeared nor­
mal except for a thickened bowel wall. 
This thickening was due to hyper­
trophy of the smooth muscle layer 
(Fig. 5). In all these cases the mucosal 
architecture was normal. Spleen and 
lymph nodes (both donor and host) 
were noted to be smaller than normal 
and there was a central depletion of 
lymphoid elements (Fig. 6).
Two animals survived 203 and 
221 days respectively. The findings 
were similar. The transplanted bowel 
showed smooth muscle hypertrophy 
as the only gross abnormality. Mi­
croscopically, however, abnormalities 
were seen in the entire transplanted 
segment. These changes were most 
severe at the caudal end of the graft 
and least extensive cephalad. Near the 
cephalic intestinal anastomosis the
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mucosal architecture was almost nor­
mal. There was evidence of epithelial 
regeneration as manifest by hyper- 
chromasia and an increased number 
of mitoses. There was round cell in­
filtration in the lamina propria and 
patches of round cell infiltration in 
the muscle. At the other end the mu­
cosal damage was extensive. There 
was complete circumferential ulcera­
tion. There were transmural round 
cell and polymorphonuclear cell in­
filtrations, which were limited to the 
mucosal surface. The middle zones of 
the transplanted segment showed 
changes intermediate between the 
other two with rapidly regenerating 
areas in ulcerated portions. These 
changes were compatible with rejec­
tion as the cause of death in these 
two animals (Fig. 7). The spleen and 
lymph nodes were small and showed 
central depletion of lymphoid ele­
ments.
Side-Effects
The long-term survivors all showed 
gingival hypertrophy, a recognized ef­
fect of cyclosporin A.12 This hyper-
FIG. 5—Whole mount of trans­
planted intestine showing marked 
smooth muscle hypertrophy (hematoxy­
lin and eosin, original magnification 
X 5 ).
FIG. 6—Whole mount of host lymph 
node showing central depletion of lym­
phoid elements (hematoxylin and eosin, 
original magnification X 5).
trophy receded about 1 month before 
death in both dogs surviving over 200 
days. One animal had an injection site 
ulcer that healed spontaneously. No 
important abnormalities were found 
in the leukocyte count and levels of 
blood urea nitrogen, serum electro­
lytes, creatine, bilirubin, alkaline phos­
phatase and glutamic oxaloacetic trans­
aminase.
Lymphatic Reconnection
Four animals were studied at 36, 
40, 40 and 203 days respectively after 
transplantation to determine whether 
lymphatic reconnection had occurred. 
In all animals the injection of methyl­
ene blue into transplant lymphatics 
was followed by rapid spread of the 
dye to host lymphatics and nodes, 
confirming lymphatic recannulation.
Xylose Tolerance Test
Carbohydrate absorption was meas­
ured in two long-term survivors treated 
with cyclosporin A and compared to 
that of two healthy nontransplanted 
dogs and two animals receiving auto­
grafts but no cyclosporin A. Absorp­
tion in the transplanted intestine was 
less than that seen in healthy non­
transplanted dogs but equalled that 
seen in dogs receiving autografts (Fig. 
8).
Discussion
Increasing numbers of patients with 
a variety of crippling intestinal con­
ditions are surviving at present be­
cause of total parenteral nutrition 
programs administered at home.13 Al­
though this treatment has achieved 
unparalleled success with those pa­
tients who have a short segment of 
functioning small bowel or malfunc­
tioning small intestine, there have 
been several problems in its applica­
tion. There are patients who are not 
capable of handling the rather sophis­
ticated home equipment, and another 
group of patients, who, after long-term 
total parenteral nutrition at home, 
have had catheter-related problems 
and difficulties with venous access 
sites. Because these patients survive 
longer and live productive lives, re­
newed interest in the potential of 
small bowel transplantation seems jus­
tified.
FIG. 7—Whole mount of transplanted intestine of long-term survivor treated 
with cyclosporin A. There is extensive mucosal ulceration, loss of villi and chronic 
inflammatory infiltrate (hematoxylin and eosin, original magnification X5).
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To date no human small bowel 
allograft has been successful and the 
longest survival of an animal in lab­
oratory experiments has been 58 days. 
Excluding technical failures, the most 
important causes of death in experi­
mental small bowel transplantation 
have been rejection and graft-versus- 
host disease. The major difference be­
tween these two entities is the status 
of the transplanted intestine. In cases 
of rejection this shows extensive mu­
cosal ulceration and round cell infil­
tration. In graft-versus-host disease, 
the transplanted intestine is normal. 
Moreover, the diagnosis can only be 
made if there is histologic evidence 
of an immunocyte infiltration of host 
tissue. This is most reliably seen in 
host intestine and skin.14
In this experiment dogs receiving 
total small bowel orthotopic allografts 
and no immunosuppressive therapy 
all died of intestine-related complica­
tions due to rejection. Several previ­
ous studies have shown what was 
thought to be graft-versus-host disease, 
but evidence for this is circumstantial. 
Like others1’15'18 we found no evidence 
of such disease in our control animals. 
Several variations in technique may 
account for these pathologic differ­
ences. In other studies17 the venous 
drainage of the intestine was into the 
portal system whereas in our experi­
ment the superior mesenteric vein 
drained into the inferior vena cava. 
Bypass of the liver alters the immuno­
logic responses to allografting in some 
systems studied18 and may have al­
tered the balance towards rejection in 
these animals. Transfusion of donor 
blood may delay the rejection reac­
tion. A third factor is that of splenec­
tomy, which Cohen and associates18 
performed in all their experiments 
with small bowel transplantation. In 
our experiments the spleens were not 
removed and this might also promote 
rejection rather than development of 
graft-versus-host disease.
The mean survival of animals 
treated with cyclosporin A shows 
clearly that this drug is effective in 
prolonging graft and animal survival. 
Moreover, we have seen useful bowel 
function in 9 of 11 treated dogs as 
manifest by weight gain, near-normal 
xylose tolerance tests and normal-ap­
pearing, formed stools. Only two an­
imals died of gut-related causes and 
these survived over 200 days. Both 
had changes in the transplanted small 
bowel segment compatible with acute 
rejection. The cyclosporin A absorp­
tion curves in these animals clearly 
showed that they were achieving sub- 
optimal levels of the drug during the
month before they died. This is further 
corroborated by the recession of gin­
gival hypertrophy in both animals dur­
ing the same period.
The reason for falling levels of the 
drug despite a constant maintenance 
regimen may be malabsorption. This 
may be secondary to smooth mus­
cle hypertrophy or chronic rejection 
resulting in a cycle leading to malab­
sorption and decreased levels of cyclo­
sporin A and further rejection. What 
may have initiated this cycle is un­
certain; we suspect our treatment regi­
men was suboptimal. We have recently 
obtained cyclosporin A absorption 
curves in small bowel transplanted 
dogs and have found that the peak 
level after an oral dose of the drug 
occurs 2 hours after administration. 
This may mean that the animal re­
mains unprotected for long periods 
during each day when a single daily 
dose is given.
There was a gradation of changes 
in the transplanted intestine of long­
term surviving dogs that died of re­
jection. The cephalic portion of the 
transplanted bowel was minimally af­
fected whereas the changes in the 
caudal portion were severe. The rea­
son for this remains uncertain; how­
ever, it leads to speculation that cy­
closporin A has a local protective 
effect in the more cephalic areas of 
the bowel.
The large numbers of cyclosporin 
A-treated dogs that died of pneumonia 
suggests that these dogs were more 
subject to infection although there 
was no important change in peripheral 
total blood or differential counts. Im­
munologic studies were not done.
Conclusions
Increased survival has been achieved 
with cyclosporin A given to dogs that 
underwent total small intestinal allo­
transplantation. In the model de­
scribed, the control animals died of 
rejection rather than graft-versus-host 
disease.
We believe that these promising re­
sults justify interest in animal and 
human small bowel transplantation. 
Small bowel allografts may in future 
become an alternative in the manage­
ment of patients whose only hope for 
survival at present rests with long­
term total parenteral nutrition.
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Usual Adult Dosage
Type of Infection Daily Dosage Frequency and Route
Uncomplicated forms* 3-4 grams 1 gram every 6-8 hours
of infections such as IV or IM
pneumonia, urinary tract 
infection, soft tissue infection
Moderately severe or 
severe infections
6-8 grams 1 gram every 4 hours
or
2 grams every 6-8 hours IV
Infections commonly 
needing antibiotics in 
higher dosage (e g. 
gas gangrene)
12 grams 2 grams every 4 hours
or
3 grams every 6 hours IV
•Including patients in whom bacteremia is absent or unlikely.
Therapy may be started while awaiting the results of susceptibility 
testing.
Antibiotic therapy for group A beta-hemolytic streptococcal infections 
should be maintained for at least 10 days to guard against the risk of 
rheumatic fever or glomerulonephritis. In staphylococcal and other 
infections involving a collection of pus, surgical drainage should be 
carried out where indicated.
Dosage in Adult Patients with Impaired Renal Function
MEFOXIN* may be used in patients with reduced renal function but 
a reduced dosage should be employed and it is advisable to monitor 
serum levels in patients with severe impairment.
In adults with renal insufficiency, an initial loading dose of 1 g to 2 g 
should be given. After a loading dose, the following recommendations 
for maintenance dosage may be used as a guide:
RENAL
FUNCTION
CREATININE
CLEARANCE DOSE FREQUENCY
Mild impairment
mL/min
50-30 1-2 g every 8-12 hrs
Moderate impairment 29-10 1-2 g every 12-24 hrs
Severe impairment 9-5 0.5-1 g every 12-24 hrs
Essentially no function <5 0.5-1 g every 24-48 hrs
In the patient undergoing hemodialysis, the loading dose of 1-2 g should 
be given after each hemodialysis, and the maintenance dose should be 
given as indicated in the table above.
Infants and Children
The recommended dosage in children three months of age and older 
is 80 to 160 mg/kg of body weight per day divided into four to six equal 
doses. The higher dosages should be used for more severe or serious 
infections. The total daily dosage should not exceed 12 g.
At *his time no recommendation is made for children from birth to three 
months of age (see PRECAUTIONS).
At present there is insufficient data to recommend a specific dosage for 
children with impaired renal function. However, if the administration of 
MEFOXIN* is deemed to be essential the dosage should be modified 
consistent with the recommendations for adults (see Table above).
PROPHYLACTIC USE
For prophylactic use, a three-dose regimen of MEFOXIN* is recom­
mended as follows:
Vaginal hysterectomy and abdominal surgery
2 g administered intramuscularly or intravenously just prior to surgery 
(approximately one-half to one hour before initial incision).
The second and third 2 g doses should be administered at 2-6 hour 
intervals after the initial dose.
Cesarean Section
The first dose of 2 g should be administered intravenously as soon as 
the umbilical cord has been clamped. The second and third 2 g doses 
should be given intravenously or intramuscularly four hours and eight 
hours after the first dose.
DOSAGE FORMS
Sterile MEFOXIN* is a dry white to off-white powder supplied in vials 
containing cefoxitin sodium as follows:
No. 3356—1 g cefoxitin equivalent in boxes of 10 vials 
No. 3357—2 g cefoxitin equivalent in boxes of 10 vials
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Rotator Cuff Tears: the Role of Surgery
Peter Earnshaw, m b , b s , lrcp, mrcs,* Denis Desjardins, md, FRcs[c],f 
Kiriti Sarkar, md, frcp[c]$ and Hans K. Uhthoff, md, frcs[c]§
The indications for operative 
intervention in patients with rotator 
cuff tears and the reasonable 
expectations of such surgery are 
not well defined. This retrospective 
study of 37 such patients treated 
operatively at Ottawa General Hospital 
showed good results in 65% of cases. 
However, efforts to re-establish 
continuity of the cuff did not always 
result in a permanent cuff 
reconstruction. The persisting defect 
did not impede functional recovery 
as long as the edges of the tear were 
debrided along with division of the 
coracoacromial ligament, acromioplasty, 
or excision of osteophytes at the 
greater tuberosity. Impingement plays 
a major role in the disability associated 
with this condition.
Les indications d'une intervention 
chirurgicale chez les patients souffrant 
d’une rupture de la coiffe des 
rotateurs et les esperances 
raisonnables qu’on peut attendre 
d'une telle operation ne sont pas 
bien definies. Cette etude retrospective 
portant sur 37 patients qui ont ete 
operes a I'Hopital General d’Ottawa 
montre de bons resultats dans 65%
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des cas. Toutefois, les tentatives 
pour retablir la continuity de la coiffe 
n’ont pas toujours resulte en une 
reconstruction permanente de la 
coiffe. Le defaut residue! n'a pas 
empeche la recuperation fonctionnelle, 
en autant que les bords de la 
dechirure aient ete debrides avec 
une division du ligament acromio- 
coracoidien ou une acromioplastie.
Un empietement contribue de fapon 
importante a I'invalidite associee a 
cette affection.
The diagnosis and treatment of rotator 
cuff tears may present manifold prob­
lems. The findings of a painful shoul­
der with weak abduction of the arm, 
atrophy of supraspinatus and infra­
spinatus muscles and a palpable defect 
of the cuff with crepitus on movement 
are all highly suggestive but not diag­
nostic of a tear. The accuracy of clin­
ical diagnosis is enhanced by roent­
genography, a decrease in the acrom- 
iohumeral gap and sclerosis of the 
undersurface of the acromion due to 
superior subluxation of the humerus 
being indicators of a cuff tear.1-1
According to De Palma,5 90% of 
patients with rotator cuff tears will 
respond to conservative measures 
including rest, the administration 
of analgesics and anti-inflammatory 
agents, and physiotherapy. Who, then, 
should be considered for operative in­
tervention and what are reasonable 
expectations of such surgery?
Since Codman* introduced surgical 
repair for rotator cuff tears, others 
have recommended many refinements 
in operative technique to re-establish 
continuity between the tendon and its 
humeral insertion, because they pos­
tulated that functional recovery de­
pends upon successful anatomical re­
construction. Several authors7'10 have 
reported a successful outcome in 
about 70% of patients operated on.
The purpose of this retrospective 
study of surgical treatment for rotator 
cuff tears, carried out at the Ottawa 
General Hospital, was to determine
whether reconstruction of the cuff was 
maintained and to correlate these find­
ings with the clinical outcome. Fur­
thermore, we re-examined histologic­
ally the ruptured edges of the tendon 
to determine if there were specific 
morphologic factors that could have 
influenced postoperative recovery.
Patients
From 1970 to 1979, 37 patients (28 
men, 9 women) underwent operation 
for tears of the rotator cuff at the 
Ottawa General Hospital. Their ages 
ranged from 31 to 68 years (mean 55 
years). Twenty (54%) patients were 
manual workers while among the 
other 17 (46%) there were office 
workers and housewives, and 2 were 
physicians. The onset was acute in 
15 (40%) patients. All reported a 
traumatic incident, such as falling on 
an outstretched arm, heavy lifting or 
pulling before the sudden appearance 
of symptoms. The other 22 (60%) 
had an insidious onset generally ex­
tending over several months. Opera­
tion was performed when conserva­
tive management for more than 3 
months failed to ameliorate the symp­
toms.
For this study, 27 of the 37 pa­
tients were available for re-examina­
tion. Four of the 27 patients had bi­
lateral tears, hence 31 shoulders were 
clinically evaluated
Methods
Operation
An anterior approach was used in 
29 shoulders and the posterior ap­
proach described by Debeyre and col­
leagues11 was used for the other 2. 
All the tears were complete or of full 
thickness. The tear was massive (more 
than 2 cm long) in 10 and localized 
(less than 2 cm) in 19. There was a 
peripheral or rim tear in two. A 
simple repair was performed on 18 
shoulders (58%). In nine (29%), a 
trough was cut in the greater tuber-
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osity and the tendon reattached by 
drill holes made in the bone. In only 
one patient was the biceps tendon 
used to close the defect. Simple de­
bridement was performed on three 
shoulders in which repair was not 
possible because of the large size of 
the tear and retraction of the fibres.
Other conditions associated with 
the mtator cuff tear included biceps 
tendinitis in two patients, biceps rup­
ture in two, biceps subluxation in one, 
humeral osteophytes in two and cal­
cium deposits in one patient. The 
operative procedures are summarized 
in Table I.
Postoperatively, immobilization was 
achieved in two ways with an almost 
equal number of patients in each 
group: (a) by a spica cast or splint in 
abduction for an average of 5 to 6 
weeks or (b) by a sling or Velpeau 
bandage for an average of 3 to 4 
weeks. There was only one postoper­
ative complication, a superficial 
wound infection that resolved within 
2 weeks.
T a b le  1 —O p e ra tiv e  P ro c e d u re s
N o . o f
P ro c e d u re shou lders
D e b rid e m e n t and re p a ir 28
S im p le  d e b r id e m e n t and  re p a ir 7
T ro u g h  c u t in g re a te r
tu b e ro s ity 9
C o rac o a c ro m ia l lig a m e n t
d iv id e d 5
B icep s  e x c ised  o r tra n s p la n te d 3
P a r t ia l  a c ro m io n ecto m y 2
D is ta l c la v ic le  resected 1
C a lc iu m  deposits  c u re tte d 1
D e b rid e m e n t o n ly 3
B iceps exc ised  o r tra n s p la n te d 2
S yn o vec to m y 1
T a b le  I I — S co ring  M eth o d
F a c to r S core
P a in
A b s e n t 5
M ild  w ith  v igorous  a c t iv ity 4
M o d e ra te , re s tr ic t in g  som e a c t iv i ty  3
M o d e ra te , re s tr ic t in g  m ost a c t iv i ty  2
S e v e re , c o n s ta n t, d is a b lin g 1
S tre n g th
A b le  to  l i f t  4 kg fo r  2 m in 2
A b le  to  l i f t  2 .5 kg fo r  2 m in 1
A b le  to  overcom e g ra v ity  o n ly 0
A b d u c tio n  a g a in s t res is ta n c e
>  500 m m  Hg 1
<  500 m m  Hg 0
R a n g e  o f m o vem en t, %  o f n o rm a l
> 7 5 2
75 to  50 1
< 5 0 0
M a x im u m  s co re  possib le 10
Assessment
At follow-up examination of 31 
shoulders, performed 3 months to 10 
years after operation, we assessed the 
degree of pain, strength and range of 
movement. Points were given for each 
(Table II). We considered pain to be 
by far the most important factor and 
therefore allocated half the points 
available (5 points). Pam was graded 
according to its severity and effect on 
the patient’s daily life. Strength was 
graded according to the ability to 
carry out sustained weight lifting; it 
was further quantitated by using a 
sphygmomanometer, the cuff of which 
was rolled on itself and inflated to 
20 mm Hg. It acted as a pressure 
transducer to measure the power of 
abduction when held by the examiner 
against the patient’s arm at the mid­
point between olecranon and acro­
mion. This was done with the arm in 
three positions: at 30°, 60° and 90° 
of abduction. The readings obtained 
were added. When the total was 
greater than 500 mm Hg, one point 
was given. Totals in normal subjects 
averaged 800 mm Hg. The active 
range of movement was measured in 
all six directions (flexion, extension, 
abduction, adduction and internal and
external rotation). The result was then 
expressed as a percentage of the range 
of movement in a normal shoulder 
and rated accordingly.
The maximum score possible was 
10. A score of 10 or 9 was rated 
excellent, 8 or 7 good, 6 or 5 fair 
and 4 or less poor. The patients were 
also asked for their own opinion about 
the outcome of the operation. Their 
assessment correlated well with our 
scoring.
Roentgenograms of both shoulders 
were taken in several positions. Ante­
roposterior views with the arm at the 
side and abducted to 40°, however, 
proved to be the most useful for this 
study.
Results
By our scoring method, the results 
in 16 of 23 shoulders in men were 
excellent or good, while 4 of 8 in 
women were in this category (Table 
ill). Patients in the fourth and fifth 
decades of life generally did well ex­
cept for one 42-year-old man whose 
rupture was complicated by villo- 
nodular synovitis. Repair was not pos­
sible and after synovectomy he had a 
stiff, painful shoulder and weak arm.
T a b le  I I I —C lin ic a l R e s u lts
N o . o f 
p a tie n ts
R a tin g , no. ( % )
E xce l le n t /g o o d  F a ir /p o o r
C a te g o ry (N  =  31 ) (n  =  2 0 ) (n  =  1 1 )
Sex
M a le 23 16 (7 0 ) 7 ( 3 0 )
F e m a le 8 4 (5 0 ) 4 (5 0 )
A g e , y r
< 4 0 2 2 (1 0 0 ) 0
41 50 2 2 (1 0 0 ) 0
51 60 17 10 (5 9 ) 7 ( 4 1 )
> 6 0 10 6 (6 0 ) 4 ( 4 0 )
O ccu p a tio n
M a n u a l 17 12 (7 0 ) 5 ( 3 0 )
O th e r 14 8 (5 7 ) 6 ( 4 3 )
O n s e t
Sudden 13 9 (7 0 ) 4 ( 3 0 )
In s id io u s 18 11 (6 1 ) 7 ( 3 9 )
P re v io u s  o p e ra tio n 3 1 (3 3 ) 2 ( 6 6 )
P re v io u s  s te ro id s
Yes 19 11 (5 8 ) 8 ( 4 2 )
No 12 9 (7 5 ) 3 ( 2 5 )
O p e ra t iv e  f in d in g s
M as s iv e  te a r 10 6 (6 0 ) 4 ( 4 0 )
Lo ca l te a r 19 12 (6 0 ) 7 ( 4 0 )
R im  te a r 2 2 ( 1 0 0 ) 0
B ila te ra l te a r 4 1 (? 5 ) 3 ( 7 5 )
R e p a ir
P o s s ib le 28 18 (6 4 ) 10 (3 6 )
Im p o ss ib le 3 2 (6 6 ) 1 ( 3 3 )
S eco n d ary  p ro c e d u re  on  
a cro m io n  o r a c ro m io c la v ic u la r
lig a m e n t 7 6 (8 6 ) 1 ( 1 4 )
P ostop  im m o b iliz a t io n , w k
< 4 15 10 (6 7 ) 5 (3 3 )
> 4 16 11 (6 9 ) 5 ( 3 1 )
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In contrast, only 60% of patients in 
the sixth and seventh decades had 
good results. Of patients in manual 
occupations and those with a sudden 
onset of symptoms, 70% had an ex­
cellent or good result, compared with 
about 60% of patients in other occu­
pations or with insidious onset.
Of the 28 shoulders that were re­
paired, excellent or good results were 
obtained in 18. The same outcome 
was seen in two out of three shoulders 
in which repair was not possible. The 
result of repair of rim tears was uni­
formly good. The success rate de­
creased to 60% for massive and local­
ized tears and to 25% for bilateral 
tears. Secondary procedures involving 
the acromion or coracoacromial liga­
ment, performed on seven shoulders, 
gave excellent or good results in six. 
Whether a spica cast was applied for 
more than 4 weeks or a sling for less 
than 4 weeks, the results were similar.
Radiologic Appearance
The radiologic findings were div­
ided into four groups: group 1— 
nonspecific changes around the af-
Fig. lb
FIG. 1—(a) Preoperative view of ro­
tator cuff tear in 61-year-old man who 
fell from ladder onto his outstretched 
arm. There is subluxation of humerus, 
sclerosis of undersurface of acromion 
and degenerative changes in acromio­
clavicular joint, (b) Follow-up view 5 
years after reconstruction shows marked 
progression and acromiohumeral articu­
lation.
fected shoulder, such as acromioclavi­
cular joint disease, humeral cysts, hu­
meral sclerosis and glenoid changes; 
group 2—changes more specific for a 
rotator cuff tear, namely, superior 
subluxation of the humerus and scle­
rosis of the undersurface of the acro­
mion; group 3—calcific deposits in 
the tendon; group 4—no changes.
Preoperative roentgenograms of 15 
of the 31 shoulders showed group 1 
changes in 6 shoulders, group 2 
changes in 4 and group 3 changes in 
1. Four shoulders showed no changes. 
At follow-up examinations, roentgeno­
grams of 28 of the 31 shoulders 
showed group 1 changes in 24, group 
2 changes in 10 and group 3 changes 
in 4. Three shoulders showed no 
changes (Fig. 1 and Table IV).
Histologic Appearance
The histologic examination revealed 
that in the majority of instances the 
ruptured edges of the tendon were 
close to the bone insertion. Sharpey’s 
fibres were in disarray. Marked frag­
mentation of tendon fascicles in the 
area of rupture was frequently accom­
panied by irregular projections of 
mesenchymal tissue with villous con-
FIG. 2—Calcification in tendon (ar­
rows) (hematoxylin and eosin).
figurations. Vascular channels of vari­
able number were present in these 
villous structures. In some the vessels 
were abundant while in others the 
tissue was completely hyalinized. Mi­
croscopic calcification, which did not 
appear on the roentgenograms, was 
found in three specimens (Fig. 2).
Discussion
Although conservative treatment of 
rotator cuff tears is usually adequate, 
a patient with severe persistent symp­
toms may require operative interven­
tion.
According to Adams,12 the results 
of surgery in older patients are so 
poor that repair should not be per­
formed in patients over 40 years of 
age. Wolfgang9 stated that good re­
sults were less likely with advancing 
age. All our patients under 50 years 
of age did well and 60% of patients 
over 50 had good results. We believe, 
therefore, that, although the chance 
of success is not as good in the older 
patient, surgery should not be re­
fused on the grounds of age alone.
Neither the mode of onset of the 
tear nor the timing of repair have a 
bearing on the outcome. In fact, a 
cuff with a sudden traumatic tear 
repaired early does not function any 
better than a tear of insidious onset 
repaired many months or years later. 
Also the size of the tear has surpris­
ingly little influence on the outcome. 
The repair of a massive tear will give 
a result comparable to that of a small 
tear. Contrary to Nixon and DiSte- 
phano’s13 observations, both our pa­
tients with a tear of the rim did well. 
Patients with bilateral tears did not 
do well. Three of four patients had
T a b le  I V — R a d io lo g ic  A p p ea ra n c e s  
P re o p e ra t iv e ly  (1 5  S h o u ld e rs )  
and P o s to p e ra t iv e ly  (28  S h o u ld e rs )
A t fo llo w -u p  
Score
G roup
B e fo re  o p e ra tio n ,
R a d io lo g ic  fe a tu re s  no. ( % )
s h o u ld ers  E xc e lle n t/g o o d  
( % )  (n  =  19)
F a ir /p o o r  
(n  =  9 )
1 D e g e n e ra t iv e  changes  
H u m e ra l cys ts , s c le ro s is , 
g le n o id  ch an g es  and  
a c ro m io c la v ic u la r  jo in t  
d is e a se 6 ( 4 0 ) 24 (8 6 ) 15 9
2 D e f in it iv e  s igns o f a c u ff 
te a r
S u p e rio r  s u b lu x a tio n  of 
th e  h u m e ru s  and  sclerosis  
o f th e  u n d e rs u rfa c e  o f th e  
acro m io n 4 ( 2 7 ) 10 (3 6 ) 5 5
3 C a lc if ic  d epos its 1 (7 ) 4 (1 4 ) 3 1
4 No c h an g e 4 ( 2 7 ) 3 ( 1 0 ) 3 0
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problems in one or both shoulders 
sufficiently disabling to prevent their 
return to work.
The importance of calcium deposits, 
macroscopic or microscopic, is not 
well understood. Wolfgang9 found 
that 23% of such deposits were 
visible on preoperative roentgeno­
grams. On the other hand, McLaugh­
lin and Asherman14 found calcium de­
posits only twice in several hundred 
cases of rotator cuff tear. We believe 
that localization of the calcium de­
posit is important. Radiologically vi­
sible deposits in the body of the ten­
don away from its insertion into 
bone must be distinguished from the 
microscopically visible deposits at the 
site of Sharpey’s fibres where the ten­
don is anchored to the bone. The 
former deposits, indicating calcifying 
tendinitis and resulting from a pri­
mary metaplasia of tendon, did not 
prevent a good outcome, but micro­
scopic calcium deposits found in three 
patients were all associated with a 
poor result. Here, calcification seems 
to occur in response to previous trau­
ma, inflammation, degeneration and 
the reparative process. In addition to 
the microscopic presence of calcium 
at the tendon insertion, villonodular 
synovitis was associated with a poor 
outcome. Whether villonodular syno­
vitis is the cause of the tear, as 
Neviaser15 has postulated, or is the 
result of a tear, as Cotton and Ride­
out1 believe, is still open to discussion.
The kind of postoperative immo­
bilization used seems to be of little 
importance. We advocate McLaugh­
lin’s method of support in a sling. 
This is simple and permits earlier 
mobilization. Prolonged splinting in 
abduction offers no advantage.
Most shoulders showed progression 
of the radiologic features of the dis­
ease despite surgical repair (Fig. 1). 
Particularly common were the acro­
mioclavicular joint changes and su­
perior subluxation of the humeral 
head. A prime function of the ro­
tator cuff is to hold the humeral head 
against the glenoid when the arm 
abducts. When the cuff is not intact, 
subluxation occurs and leads to arti­
culation with the acromion and scle­
rosis of its undersurface.
The success of surgery has always 
been associated with an intact recon­
struction. Thus, it is not surprising 
that many reconstructive techniques 
have been described using fascia lata,16 
biceps tendon17 and freeze-dried rota­
tor cuff;18 all of them have been 
claimed to give good results. The 
question is whether a good functional 
result is synonymous with a success-
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ful repair. Can one expect normal 
healing of a degenerated and torn 
cuff by approximating the fibres? Our 
follow-up study shows an increase in 
the radiologic signs of cuff tear such 
as a positive arthrogram and superior 
subluxation of the humeral head with 
sclerosis of the undersurface of the 
acromion. If one adds to this the two 
cases in which, despite the impos­
sibility of a repair, a good result was 
obtained one wonders if the joint 
debridement carried out at operation 
is not as important as repair of the 
cuff.
Conclusions
Our study suggests that the ma­
jority of patients treated surgically for 
rotator cuff tear have pain-free, func­
tioning shoulders even though most 
cuffs do not remain intact postoper- 
atively and radiologic evidence of os­
teoarthritis tends to develop. We be­
lieve, therefore, that functional im­
provement depends less on a meti­
culous cuff repair than on careful 
debridement of the ruptured edges 
and removal of the sources of im­
pingement. The impingement can best 
be treated either by dividing the cora- 
coacromial ligament, resecting osteo­
phytes around the greater tuberosity 
or by a limited anterior acromioplasty 
as described by Neer.19 Radical acro- 
mionectomy is undesirable because 
persistent pain and instability of the 
joint may result.20
Operation should not be withheld 
from older persons on the grounds 
that the capacity to repair decreases 
with age. Relief of pain with restora- j 
tion of function, rather than the ana­
tomical reconstitution of the rotator 
cuff, should be the prime objective of 
operation.
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NOTICES
continued from page 43
American Association 
for Hand Surgery
The American Association for Hand 
Surgery will sponsor the second 
Rocky Mountain Hand Symposium 
in Vail, Colorado, Feb. 13-20, 1982. 
For further information please con­
tact; Dr. Ronald Tegtmeier, 9950 
West 80th Ave., Arvada, Colorado 
80005. Telephone: (303) 424-1174.
Medical and Biological Engineering 
Conference
The 9th Canadian Medical and Bio­
logical Engineering Conference and 
Exposition will be held at the Univer­
sity of New Brunswick, Fredericton, 
NB, Aug. 15 to 18, 1982. Invited are 
papers on biomedical engineering top­
ics, particularly; clinical engineering 
with emphasis on cost containment, 
bioethics as related to technology in 
health care, biological signal process­
ing and control, and extracorporeal 
circulation.
Manuscripts must be submitted by 
Mar. 1, 1982. Further information 
and kits for authors can be obtained 
from: The conference secretariat, Bio- 
Engineering Institute, University of 
New Brunswick, PO Box 4400, Fred­
ericton, NB E3B 5A3.
continued on page 78
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Gastrointestinal Complications after Radiotherapy 
for Carcinoma of the Uterine Cervix
H.R. Shibata, md, m sc, facs, frcs[c], C.R. Freeman, mb, bs, frcp[c] 
and T.N. Roman, md, frcs[c]
Radiotherapy for invasive carcinoma 
of the uterine cervix caused 
gastrointestinal complications in 52 
of 441 patients. External beam and 
intracavitary radiation together caused 
greater bowel damage than either 
method alone. Twenty-eight of the 
52 patients required surgical 
intervention. Ileal stenosis in nine 
patients required primary resection 
with anastomosis in seven while the 
stenosis was bypassed in the other 
two. Acute perforation with peritonitis 
would require a diverting ileostomy and 
creation of a mucous fistula. A 
defunctioning colostomy was indicated 
for relief of pain, bleeding and stenosis 
of the rectum in 11 of 15 patients;
2 patients were treated by 
primary resection, 1 underwent 
abdominoperineal resection and 
another a pelvic exenteration. Of 
four patients with ileal and rectal 
involvement, one underwent right 
hemicolectomy and transverse 
colostomy, two had ileal resection 
and sigmoid colostomy and the other 
had hemicolectomy and rectal 
resection. All patients were well 
at follow-up from 3 to 120 months 
after operation. A Hartmann's 
procedure is indicated when it 
appears that primary closure may not 
succeed. Individualized management 
is essential.
La radiotherapie d'un cancer invasif 
du col uterin a ete la cause de 
complications gastro-intestinales chez 
52 patientes sur 441. Un faisceau 
externe et une irradiation intra-cavitaire 
ont cause ensemble plus de dommages 
intestinaux que chacune des methodes 
utilisee seule. Vingt-huit des 52 
malades ont necessity une intervention 
chirurgicale. De neuf patientes, une 
stenose ileale a commande une 
resection primaire suivie d’une
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anastomose chez sept, alors qu’un 
pontage de la stenose etait pratique 
chez les deux autres. Une perforation 
aigue avec peritonite necessiterait 
une ileostomie de derivation et la 
creation d'une fistule muqueuse. Une 
colostomie de mise au repos a ete 
indiquee pour soulager la douleur, le 
saignement et la stenose du rectum 
chez 11 des 15 patientes; 2 malades 
ont ete traitees par resection primaire, 
1 ayant subi une resection abdomino- 
perineale et I'autre une exenteration 
pelvienne. Des quatre patientes qui 
ont souffert d’une atteinte ileale et 
rectale, une a subi une hemicolectomie 
et une colostomie transverse, deux 
ont eu une resection ileale avec 
colostomie sigmoi'dienne et I’autre a 
eu une hemicolectomie avec resection 
du rectum. Toutes les patientes sont en 
bonne sante de 3 a 120 mois apres 
I’operation. Une operation de Hartmann 
est indiquee quand il parait que la 
fermeture primaire ne reussira pas.
Une traitement adapte a chaque 
patiente est essentiel.
Radiotherapy is the treatment of 
choice for the majority o f patients 
with invasive carcinoma of the uterine 
cervix. The overall 5-year survival 
rate, which was about 35% in the 
1940s, is now about 65% ,1,2 and 
much o f this improvement can be at­
tributed to refinements in radiother­
apy equipment and techniques. The 
most common complication o f such 
treatment is damage to the rectum 
and rectosigmoid colon and, to a less­
er extent, the terminal ileum. Injury 
to the genitourinary tract is consider­
ably less frequent.
At the Royal Victoria Hospital in 
Montreal, a large number of patients 
with invasive carcinoma of the uterine 
cervix are seen each year. The overall 
5-year survival rate in our patients 
treated with radiotherapy is 64% .3 
This paper reviews the gastrointestinal 
complications o f such treatment and 
their management.
Patients and Methods
From Jan. 1, 1968 to Dec. 31, 
1978. 441 patients with invasive car­
cinoma o f the uterine cervix were 
selected for radiotherapy. Of these, 
347 (78.7% ) were treated with com­
bined external beam and intracavitary 
radiation; 51 (11.6% ) were treated by 
external beam radiation alone and 43 
(9.8% ) by one or more intracavitary 
applications o f radioactive material 
alone.
Fifty-two patients (11.8%) pre­
sented, from 6 to 24 months (mean 
12 months) following radiotherapy, 
with symptoms indicating gastroin­
testinal complications. Abdominal pain 
was the primary complaint in 71% 
of the patients, diarrhea was present 
in 51% , rectal bleeding in 22% and 
constipation in 15%. Severe anemia 
requiring blood transfusion occurred 
in 5% .
Seventeen of the 52 patients had 
undergone some form o f abdominal 
surgery before radiotherapy. Five pa­
tients had had total abdominal hyste­
rectomy and bilateral salpingo-ooph- 
orectomy, six had undergone subtotal 
hysterectomy, three laparotomy only, 
two appendectomy and one had had 
bilateral salpingo-oophorectomy alone.
Management and Results
Twenty-four (46.2%) o f the 52 pa­
tients had a mild form of radiation 
enterocolitis that was managed suc­
cessfully by conservative means. How­
ever, 28 patients (53.8% ) required 
surgical intervention. The site o f gas­
trointestinal involvement by radiation 
changes in this group o f patients is 
shown in Table I.
Of the nine patients with involve­
ment o f the ileum, five were managed 
by segmental ileal resection with pri­
mary anastomosis, two by right hemi-
Table 1— Site of Complications
Requiring Surgical Intervention
Site No. of patients
Ileum alone 9
Rectosigmoid alone 15
Ileum and rectosigmoid 4
Total 28
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colectomy and two underwent bypass 
procedures only.
Nine of the 15 patients who had 
severe proctosigmoid changes under­
went sigmoid colostomy only, 2 had 
transverse colostomies, 2 underwent 
anterior resection with primary an­
astomosis, 1 was treated by abdom­
inoperineal resection and 1 patient 
underwent pelvic exenteration.
Four patients had both ileal and 
proctosigmoid involvement requiring 
extensive surgical intervention. One 
underwent right hemicolectomy for 
the ileal involvement and transverse 
colostomy for the sigmoid lesion. The 
colostomy was closed later without 
resection of the involved site. Two un­
derwent ileal resection and permanent 
sigmoid colostomy. One patient was 
treated by a right hemicolectomy and 
anterior resection of the rectum. All 
of the patients who underwent opera­
tion remained well. The follow-up pe­
riod ranged from 3 to 120 months.
Discussion
In the management of invasive car­
cinoma of the cervix with radiother­
apy, the proximity of the rectum, 
rectosigmoid and colon and, to a 
lesser extent, the terminal ileum, pre­
disposes to radiation colitis or enter­
itis that may require surgical inter­
vention. Of factors such as age, 
obesity, individual susceptibility, the 
presence of diabetes mellitus, diverti- 
culosis, diverticulitis and pelvic in­
flammatory disease, and previously 
performed surgical procedures, the 
two last appear to be the most im­
portant because of tethering of the 
normally mobile small bowel in the 
pelvis.4 Seventeen (32.7%) of our 
patients with complications of radio­
therapy had previously undergone 
abdominal surgery.
The dose and technique of radio­
therapy are important. A risk of 
injury ranging from 1% to 5% is in­
curred when 4500 rad is given to the 
small intestine and 5500 rad to the 
colon and rectum. However, at doses 
of 6500 rad to the small intestine and 
8000 rad to the colon and rectum, 
the risk of injury escalates to 25% 
to 50% .5 The dose of radiation given 
for cure to patients with carcinoma 
of the cervix will, therefore, result in 
a risk of gastrointestinal morbidity 
that increases with the dose delivered. 
This in turn usually increases with the 
stage of the disease.6,7 In spite of our 
treatment policy, which involves the 
use of higher doses of radiation to 
the parametrium in the more ad­
vanced stages of disease, there was 
surprisingly little variation in total
dose and an increased risk of com­
plications in the more advanced stages 
was not demonstrated.3 However, the 
combined use of external beam and 
intracavitary radiation did lead to a 
higher complication rate than the use 
of either modality alone (Table II).
Radiation injury to the gastrointes­
tinal tract can be temporally classified 
into two types. An acute or imme­
diate phase is the result of damage 
to the radiosensitive mucosal cells 
and the characteristic symptoms are 
crampy lower abdominal pain and 
diarrhea. Such symptoms will be 
present in the majority of patients 
with carcinoma of the cervix who re­
ceive radiotherapy. They occur during 
treatment, will usually subside with 
conservative measures and almost al­
ways do so after a few days without 
treatment. Rarely, symptoms are more 
severe and include tenesmus and rec­
tal bleeding. Even then they can usual­
ly be controlled with low residue diet, 
analgesics and antispasmodics, stool 
softeners, steroid enemas and rest. 
Such transient effects on the gastro­
intestinal tract do not correlate with 
later injuries6 and are not the object 
of this communication.
A chronic delayed phase may oc­
cur at any time, but most often, as 
with our patients, occurs between 6 
and 24 months after treatment. The 
pathological changes observed include 
vascular obliteration, mucosal atrophy 
and fibrosis of the intestinal wall.5 
Symptoms arising in the chronic phase 
can be managed initially in the same 
manner as those of the acute phase, 
but intractability to medical manage­
ment with severe rectal bleeding, per­
sistent pain and tenesmus, formation 
of a fistula, progressive constipation 
with bouts of diarrhea gradually lead­
ing to obstruction, and deterioration 
in general health, both physical and 
mental, are indications for surgical in­
tervention. Such symptoms can easily 
be confused with recurrent carci­
noma of the cervix. Pelvic examina­
tion under anesthesia is mandatory 
and thorough investigation, including 
rectosigmoidoscopy with biopsy, intra­
venous pyelography and cystoscopy 
are necessary to rule out this pos­
sibility.
There is still controversy as to the 
best operative procedure for treating 
complications of radiation in this area. 
The main point of contention is 
whether the involved segment of 
ileum, rectosigmoid colon or rectum 
should be bypassed or resected. The 
proponents of bypass only8'9 in radia­
tion enterocolitis think that the ex­
tensive dissection required to free 
multiple adhesions between loops of 
bowel further jeopardizes an already 
tenuous blood supply to some of these 
loops, leading to further necrosis of 
other segments of the intestine. On 
the other hand, those who advocate 
resection10,11 believe that the injury 
due to radiation is progressive and 
when bypass procedures alone are 
done, further complications will al­
most certainly arise from the involved 
segment, especially if it is in the small 
intestine. Others caution that each 
situation must be individualized.11
In our series, the procedures were 
individualized. In the few patients 
with ileal involvement alone, the pri­
mary intent was resection (ileal resec­
tion with anastomosis in five patients, 
right hemicolectomy in two patients) 
and ileal bypass was performed in 
only two patients. Similarly, in the 
four patients with both ileal and rectal 
involvement, ileal resection was per­
formed in all four. Eleven of the 15 
patients with involvement of the rec­
tum initially underwent diverting col­
ostomy alone. Resection of the in­
volved portion followed by closure of 
the colostomy was performed in three 
of these patients later. One patient 
underwent an abdominoperineal re­
section for a low-lying stenosis and 
rectosigmoid fistula. One patient un­
derwent pelvic exenteration for a 
“frozen” pelvis, with a rectovaginal 
and vesicovaginal fistula. In neither 
was there evidence of recurrent tu­
mour in the resected specimen.
The two broad categories of injury 
may be best managed in different 
ways. For radiation enteritis, where
T a b le  II —C o m p lic a tio n s  a n d  M e th o d  o f R a d io th e ra p y
N o . o f
N o . o f p a tie n ts  w ith
M e th o d p a tie n ts c o m p lic a tio n s  ( % )
E x te rn a l beam  a lo n e 51 2 (3 .9 )
In tr a c a v ita r y  a lo n e  
E x te rn a l beam  and
43 4 (9 .3 )
in tr a c a v ita r y 347 46 (1 3 .3 )
441 52 (1 1 .8 )
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stenosis is the main problem, the in­
volved segment should be resected 
with primary anastomosis whenever 
possible. If a fistula is the main prob­
lem, the involved segment of intestine, 
including the fistula and its opening 
into the adjacent viscera, should be 
resected. If the intestine has perfor­
ated and there is peritonitis, the safest 
procedure is to resect the involved 
segment and create a diverting ileos­
tomy and a mucous fistula. These two 
exteriorized ends can then be anas­
tomosed later.
For radiation colitis or proctitis the 
procedures should also be individual­
ized but when ulceration leading to 
bleeding occurs and there is pain and 
spasm with mild or no stenosis, a 
diverting colostomy of the transverse 
or descending colon, followed by 
closure of the colostomy 6 to 8 
months later, may be the operative 
procedure of choice. For a fistula 
or stenosis, however, resection with 
primary closure is preferable, if pos­
sible. If not, Hartmann’s procedure 
with secondary closure should be per­
formed. In the event of perforation, 
Hartmann’s procedure is again the 
treatment of choice. If it is difficult 
or impossible to resect the perforated 
segment, diverting colostomy and 
drainage should be performed. Ab­
dominoperineal resection or pelvic 
exenteration may be required in cer­
tain situations, especially if the low 
rectosigmoid is involved or if recur­
rent carcinoma is suspected. In such 
instances a gracilis myocutaneous 
flap, as recommended by Palmer and 
Bush,13 may help in closing the peri­
neal portion and in decreasing func­
tional disability.
Conclusions
Enterocolitis is the main complica­
tion of radiotherapy for carcinoma 
of the cervix; it occurred in 52 of 
441 patients treated over an 11-year 
period at our institution. Resection, 
whenever possible, is the operation of 
choice. However, when resection 
is not technically possible, bypass may 
provide satisfactory relief of symp­
toms and may be followed later by 
more definitive surgery.
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in most cases of bronchogenic 
carcinoma since 1965. This study was 
carried out to assess the results of 
staging by this method in 75 patients. 
Biopsy sites were marked with 
hemoclips. Three zones were defined: 
zone 3 (inoperable), beyond the midline 
and above the lower border of the 
aortic arch; zone 1 (operable), more 
than 3 cm from the carina, ipsilateral 
to the tumour; and zone 2, between 
zones 1 and 3.
Forty of 75 patients had biopsy 
specimens showing carcinoma. The 
proportion was highest in small celt 
anaplastic carcinoma and lowest in 
squamous cell tumours. Of the 40 
positive biopsies 35 were from zone 
3. All the positive biopsy specimens 
showing small cell anaplastic 
carcinoma were from zone 3. Positive
specimens correlated strongly with 
other evidence of inoperability. 
Mediastinal lymph-node biopsy is a 
definitive staging procedure.
La biopsie des ganglions lymphatiques 
mediastinaux a ete pratiquee comme 
procedure de classification du stade 
clinique dans la plupart des cas de 
cancers broncho-pulmonaires depuis 
1965. Cette etude a ete realisee pour 
evaluer les resultats de classification 
par cette methode chez 75 malades.
Les localisations de biopsie ont ete 
marquees avec des pinces 
hemostatiques. Trois zones ont ete 
definies: la zone 3 (inoperable) situee 
au-dela de la ligne mediane et 
au-dessus de la bordure inferieure 
des arcs aortiques; la zone 1 (operable) 
situee a plus de 3 cm de I'eperon,
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ipsilaterale a la tumeur; la zone 2, 
intermediaire entre les zones 1 et 3.
Quarante des 75 patients ont eu 
une biopsie demontrant la presence 
d'un cancer. La proportion etait la 
plus elevee pour les cancers 
anaplasiques a petites cellules, et 
la plus faible pour les epitheliomas. 
Des 40 biopsies positives, 35 etaient 
de la zone 3. Toutes les biopsies 
positives de cancers anaplasiques a 
petites cellules etaient dans la zone 3. 
Les echantillons positifs ont montre 
une forte correlation avec les autres 
preuves que la tumeur etait inoperable. 
La biopsie des ganglions lymphatiques 
mediastinaux est une procedure 
decisive dans la classification du 
stade clinique des carcinomes 
broncho-pulmonaires.
Since 1965 mediastinal lymph-node 
biopsy has been carried out in most 
cases of bronchogenic carcinoma as a 
staging procedure to assess operability 
and chance of cure. Techniques have 
been devised by Daniels1 (scalene node 
biopsy), Harken and colleagues2 (cerv- 
icomediastinal exploration), Radner3 
(suprasternal biopsy), Carlens4 (media­
stinoscopy through a suprasternal in­
cision), McNeill and Chamberlain5 
(left parasternal mediastinotomy with 
resection of second and third costal 
cartilages) and Jolly and associates6 
(left anterior mediastinotomy without
FIG. 1— Three zones defining resec­
tability of tumour.
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cartilage resection). Each procedure 
has produced better prediction of re­
sectability in patients with lung can­
cer. This study was performed to cor­
relate the site of positive biopsy with 
pathological findings, treatment and 
results.
Method
The Carlens’ technique4 was used 
for mediastinoscopy in 75 patients 
with bronchogenic carcinoma for 
whom resection of the lung was con­
sidered. The mediastinal biopsy sites 
were marked with hemoclips and post­
operative chest roentgenograms were 
obtained.
The sites of the clips were corre­
lated with the cell type of carcinoma 
and with evidence of operability.
To establish some relation between 
the site of biopsy and operability of 
tumours confirmed by biopsy, we 
defined three zones by which to locate 
the positive biopsy (Fig. 1). Zone 1, 
indicating a lesion that was resectable, 
was more than 3 cm from the Carina, 
along the main bronchus on the side 
of the tumour. Zone 3, including 
contralateral and high mediastinal me- 
tastases that indicated an inoperable 
tumour, was beyond the midline or 
cephalad to the lower edge of the 
aortic arch. Zone 2 was intermediate 
between zones 1 and 3.
Results
Biopsy specimens showed malignant
cells in 40 of the 75 patients (Table 
I). Ten of 12 patients with small cell 
anaplastic carcinoma had positive 
nodes, but only 18 of 48 patients with 
squamous cell carcinoma had biopsy 
specimens that were positive for ma­
lignant cells.
The distribution of the positive 
biopsy specimens by zone is shown in 
Table II. All the small cell anaplastic 
carcinomas were in zone 3, indicating 
that the tumour was inoperable. In 
the 18 patients with squamous cell 
carcinoma, 14 of the positive speci­
mens were from zone 3 and 11 of 
these patients had other evidence of 
inoperability. In the three less com­
mon types of carcinoma, 11 of the 12 
metastases were in zone 3.
Eighty-six percent of all patients 
with positive biopsy specimens had 
cancer in zone 3, clearly beyond the 
limits that make surgical cure likely.
A further comparison was carried 
out between patients having positive 
mediastinal lymph-node biopsies and 
other evidence of inoperability, such 
as a widened mediastinum on chest 
roentgenogram, superior vena caval 
obstruction, paralysis of the vocal 
cords or diaphragm, pleural effusion 
and evidence of distant metastases. 
Other evidence of inoperability was 
present in 22 of the 35 patients with 
zone 3 biopsy specimens containing 
malignant cells. In 8 of 10 patients 
with small cell anaplastic cancer the 
tumour had metastasized. It is of par­
ticular interest that four of the five
Tab le  1 -R esu lts o f M e d ia s t in a l L ym ph -N o de  B io p sy  
in  75 Cases o f B ro n ch o ge n ic  C a rc in o m a
Type o f ca rc inom a P o s it iv e  b iopsy N eg a tiv e  b iopsy To ta l
Sm a ll c e l l a n ap la s tic 10 2 12
Squam ous c e ll 18 30 48
A denoca rc inom a 6 1 7
M ixed  ce ll 3 1 4
La rge  ce ll a n ap la s tic 3 1 4
To ta l 40 35 75
T ab le II— Loca tion  o f B io p s ie s  S h ow ing  E v id en ce  o f M a lig n a n t 
T um ou r a cco rd in g  to  C e ll T ype
Zone
Type o f ca rc inom a 1 2 3 T o ta l
Sm a ll c e ll a n ap la s tic 0 0 10 10
Squam ous ce ll 0 4 14 18
A denoca rc inom a 0 0 6 6
M ixed  ce ll 0 0 3 3
Large  c e ll 0 1 2 3
T o ta l 0 5 35 40
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if the patient is subjected to any unusual stress such as 
surgery, trauma, or severe infection. Patients should be 
advised to inform subsequent physicians of the prior 
use of Solu-Medrol.
There have been a few reports of cardiovascular 
collapse associated with the rapid intravenous admini­
stration of large doses of Solu-Medrol (greater than
0.5 grams) in organ transplant recipients. The cause 
and relation to other medications (i.e., diuretics) is not 
known at this time, but physicians should be alert to 
this possibility.
Adverse Reactions:
Adverse reactions are not likely to result from short­
term intravenous administration of Solu-Medrol, but 
may be anticipated if continued therapy with oral or 
intra-muscular corticosteroid preparations is to follow. 
Medrol has less tendency than prednisolone to induce 
retention of sodium and water, and in some cases has 
been observed to produce diuresis and an increased 
excretion of sodium. Likewise, therapy with Medrol 
appears to produce less nervousness and psychic 
stimulation than that produced by prednisolone. While 
epigastric distress has not been totally lacking in 
patients receiving Medrol, the incidence and severity of 
this side reaction to date suggest that although Medrol 
has an enhanced anti-inflammatory potency when com­
pared with prednisolone on a weight basis, the so- 
called ulcerogenic potential of this corticosteroid is no 
greater, and may even be less, than that of 
prednisolone.
With the exception of the differences noted in the 
preceding paragraph, Medrol is similar to hydro­
cortisone and prednisolone in regard to the kinds of 
adverse reactions and metabolic alterations to be 
anticipated when treatment is intensive or prolonged. 
Negative nitrogen balance is usually counteracted by a 
high protein intake. In patients with diabetes mellitus, 
Solu-Medrol may increase insulin requirements during 
the period of administration. Ecchymotic manifesta­
tions, while noted only rarely during the clinical 
evaluation of Medrol, may occur. Excessive loss of 
potassium is not likely to be induced by effective 
maintenance doses of Medrol. If such reactions are 
serious or distressing to the patient, reduction in 
dosage or discontinuance of corticoid therapy may be 
indicated. While a retardant effect on wound healing is 
seldom encountered, except in high doses, it should be 
a matter of consideration when Solu-Medrol is admin­
istered in conjunction with surgery.
Symptoms and Treatment of Overdosage:
Single large doses of Solu-Medrol do not have any 
apparent toxic effect and require no specific therapy. 
Continuous overdosage would require careful gradual 
reduction of dosage in order to prevent the occurrence 
of acute adrenal insufficiency.
Dosage and Administration:
In treating severe shock there is a tendency in current 
medical practice to use massive (pharmacological) 
doses of corticosteroids. The following are Solu-Medrol 
doses suggested by various authors:
Author Dose Repeat
Oaks 100 mg Every 2-6 hours
Weil 200 mg 100 mg. every 4-6 hours
Melby 250 mg Every 4-6 hours
Cavanagh 15 mg/kg Every 24 hours
Dietzman 30 mg/kg In 4 hours if needed
Therapy is initiated by administering Solu-Medrol 
intravenously over a period of at least 10 minutes. In 
general high dose corticosteroid therapy should be 
continued only until the patient’s condition has 
stabilized; usually not beyond 48 to 72 hours.
Although adverse effects associated with high dose 
short term corticoid therapy are uncommon, peptic 
ulceration may occur.
In other indications initial dosage will vary from 10 to 
500 mg depending on the clinical problem being 
treated. The larger doses may be required for short­
term management of severe, acute conditions. The 
initial dose usually should be given intravenously over 
a period of at least 10 minutes. Subsequent doses may 
be given intravenously or intramuscularly at intervals 
dictated by the patient’s response and clinical 
condition.
Availability:
As Solu-Medrol (methylprednisolone sodium succinate) 
in 40 mg and 125 mg Mix-O-Vial; 500 mg and 1 g vials 
with water for injection.
Product monograph is available on request.
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patients with positive biopsies in zone 
2 had other evidence of inoperability.
Discussion
Carcinoma of the lung is an ag­
gressive neoplasm that metastasizes 
to lymph nodes early. This is most 
marked with small cell anaplastic tu­
mours, for which resection is seldom 
recommended because most patients 
already have metastases at the time 
of diagnosis. Tissue diagnosis is there­
fore mandatory to define cell type 
and to stage cancer spread. A number 
of mediastinoscopy procedures have 
been devised over the last 22 years 
to accomplish these ends and the 
present study confirms the value of 
these procedures.
In performing mediastinal lymph- 
node biopsies, the main objective was 
to sample nodes high in the media­
stinum and in the subcarinal region. 
This policy is related to the few posi­
tive biopsy specimens obtained from 
zone 1. Most positive specimens were 
from zone 3, hence were definitive.
Summary
Seventy-five patients considered for 
thoracotomy due to cancer of the 
lung underwent mediastinal lymph- 
node biopsy through a suprasternal 
notch incision. The biopsy sites were 
marked with hemoclips allowing them 
to be easily located on postoperative 
chest roentgenograms. The sites were 
classified and correlated with path­
ological findings. In 40 patients the 
biopsy specimens were positive for 
malignant tumour. Of the entire group, 
86% of tumours had metastasized be­
yond the limits of surgical resectability 
(zone 3). Twenty-two of the 40 pa­
tients with positive biopsy specimens 
had other evidence of inoperability.
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Right Paraduodenal Hernia
N enad  M. G agic , m d , f r c s [c ], FACS*
Right paraduodenal hernias are 
uncommon. Approximately SO cases 
have been reported and 2 more are 
reported in this paper. The diagnosis 
of internal hernia should be considered 
in all patients with abdominal cramps 
and intermittent small bowel 
obstruction. The most valuable 
investigation is roentgenography of the 
small intestine after barium ingestion; 
this usually shows a clumping of the 
intestine, as in a bag, with incomplete 
rotation of the cecum and ascending 
colon. Duodenal hernias should be 
treated surgically even if they are 
asymptomatic, because they may 
cause potentially lethal complications 
such as obstruction, gangrene or 
bowel perforation.
La hernie paraduodenale droite est 
une affection rare. Environ 50 cas 
ont deja ete rapportes et 2 autres 
sont signales dans cette publication. 
Le diagnostic de hernie interne doit 
etre envisage chez tout patient qui 
souffre de crampes et d'obstruction 
intermittente du grele. L'examen le 
plus utile est la radiographie de 
I'intestin grele apres ingestion de 
barium; ceci met habituellement en 
evidence une agregation de I’intestin, 
comme s’il etait dans un sac, avec 
rotation incomplete du caecum et du 
colon ascendant. La hernie duodenale 
doit etre traitee chirurgicalement, 
meme si elle est asymptomatique, car 
elle peut etre la cause de complications 
letales telles que obstruction, 
gangrene ou perforation de I’intestin.
Internal hernias are paraduodenal in 
origin in 30% to 50% of cases. Ap­
proximately 75% occur on the left. 
Right paraduodenal hernia was first 
described by Treitz;1 since then, nu­
merous theories concerning the origin 
of this defect have been proposed.2-9
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We report two patients with right 
paraduodenal hernia, diagnosed pre- 
operatively by roentgenography after 
barium meal and follow-through ex­
amination. We also review the literature 
with respect to incidence, presenting 
symptoms and signs, treatment, and 
morbidity and mortality.
FIG. 1—Case 1. Roentgenogram af­
ter barium meal and follow-through. 
Small bowel appears to be enclosed 
within a sac.
FIG. 2— Case 1. Findings at lapa­
rotomy. Transverse colon has been re­
flected cephalad. Entire small bowel, 
except for terminal ileum, lies inside 
large peritoneal sac.
Case Reports
Case 1
A 14-year-old girl had had cranipy 
abdominal pain with occasional nausea 
for several years. Cramps were most 
often postprandial. The length of the 
attacks varied from a few minutes to 
several hours and on one occasion only, 
the patient brought up fresh blood. Ro­
entgenography after a barium meal and 
follow-through examination showed the 
small bowel as if it were enclosed within 
an oval sac (Fig. 1). The duodenum was 
pulled laterally and superiorly. The ce­
cum and ascending colon were incom­
pletely rotated and were lying in the 
right upper abdominal quadrant.
At laparotomy, the entire small bowel, 
except for 46 cm of the terminal ileum, 
was enclosed within the peritoneal sac 
(Fig. 2). The anterior wall of the sac 
consisted of the mesentery of the ascend­
ing colon.
Ladd’s bands were divided, lateral peri­
toneum was excised, the colon was re­
flected to the right and the intestine was 
replaced. The small bowel was thickened 
and edematous and had enlarged blood 
vessels, indicating long-standing, incom­
plete, small bowel obstruction (Fig. 3). 
The sac was excised and the defect closed 
with interrupted 3-0 sutures of intestinal 
chromic catgut. The postoperative course 
was smooth and the patient was dis­
charged 6 days after the operation.
Case 2
Because of a relapse, this 28-year-old 
man, who had long-standing ulcerative 
colitis, was admitted to hospital. He had 
complained since childhood of crampy 
abdominal pain with occasional nausea 
and vomiting. Most of the discomfort 
was postprandial and attacks lasted oc­
casionally for I hour. There was no 
hematemesis. Since the diagnosis of ul-
F’lG. 3— Case 1. Small bowel is thick­
ened and edematous, with enlarged 
blood vessels.
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cerative colitis had been made, the pa­
tient had related most of his cramps 
and discomfort to that condition.
Roentgenography after barium enema 
confirmed extensive ulcerative colitis in­
volving the entire rectum and colon, 
with malrotation (Fig. 4). Abnormal gas 
distribution in the small bowel was also 
noted; because of this, roentgenography 
after barium meal and follow-through 
examination was carried out and a right 
paraduodenal hernia was demonstrated 
(Fig. 5). Most of the loops of small 
bowel appeared to be enclosed within the 
sac. This was confirmed during a procto­
colectomy. The small bowel was re­
placed, the sac was excised and the de­
fect closed with 3-0 chromic catgut su­
tures. A permanent ileostomy was made. 
Recovery was uncomplicated.
Discussion
More than 50 cases of right para­
duodenal hernia have been reported 
in the English literature since Moyni- 
han’s2 review of autopsy material in 
1906. Most of the patients had a long 
history of gastrointestinal symptoms, 
nausea and bloating after meals, epi­
gastric and abdominal cramps, inflam­
mation or obstruction of the small 
bowel. Most patients were adults, 
with a mean age of 36.6 years. None 
were younger than 8 years.3,8,7,1','l:i 
Why this congenital defect does not 
produce symptoms early in life is un­
clear. The embryology in the region 
of the ligament of Treitz was dis­
cussed by Berardi.18 This is where the 
fixed retroperitoneal duodenum meets 
the mobile intraperitoneal jejunum, 
resulting in an appreciable number of 
variable folds and fossae.
FIG. 4— Case 2. Roentgenogram af­
ter barium enema shows malrotation 
of intestine and long-standing ulcerative 
colitis.
Roentgenography of the small in­
testine after barium meal is the most 
valuable investigation. This will show 
a clumping of the intestine as in a 
bag, lifting of the axis to the right or 
left of the midline, the absence of 
bowel from the pelvis with the ter­
minal ileum outside the sac, a change 
in bowel calibre at the site of exit 
from the sac. the presence of the 
ascending colon behind the mass, in­
complete rotation of the cecum and 
ascending colon, and decreased motil­
ity of the entire small bowel.17,18 An­
giography shows the change in direc­
tion of the mesenteric vessels as 
intestinal loops enter and leave the 
hernial sac.19
Treatment of the condition is sur­
gical. Because the leading edge of 
the hernial sac in the right paraduo­
denal hernia contains the superior 
mesenteric artery, one has to be very 
careful at the time of the operation 
not to damage it. The contents of the 
hernial sac are returned to their nor­
mal position, adhesions are divided, 
the superior mesenteric artery is pre­
served and the defect in the perito­
neum is closed. If the sac is large, it 
should be removed and the defect 
closed.
Summary
Two cases of right paraduodenal 
hernia, diagnosed preoperatively, are 
presented. These hernias may be 
asymptomatic or cause life-threatening 
complications.
All paraduodenal hernias, even if 
asymptomatic, should be considered
FIG. 5—Case 2. Roentgenogram af­
ter barium meal and follow-through 
demonstrates right paraduodenal hernia.
potentially lethal and capable of caus­
ing obstruction, gangrene or perfora­
tion of the bowel.
Diagnosis is confirmed by roent­
genography after barium meal and 
follow-through examination.
At the time of operation, care 
must be taken not to injure the su­
perior mesenteric artery, which is an 
integral part of the wall of the sac and 
its orifice.
The diagnosis of internal hernia 
should be considered in all patients 
with symptoms of crampy abdominal 
pain, intermittent small bowel obstruc­
tion and vomiting, because a delay in 
diagnosis may result in increased mor­
bidity and mortality.
I thank Dr. P. Tam for allowing me 
to include case 2.
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Benign Solid Teratoma of the Ovary 
with Rupture into the Rectum
Edward Farkouh, mb, b ch, facs, frcs[c],*
Michel A llard, md, facs, frcs[c]* and J. Gilles Paquin, md|
The authors present an unusual case 
of benign, solid, complex teratoma 
of the ovary with rupture into the 
rectum. A young woman, investigated 
for bowel problems, was found to 
have a prolapsing tumour in the upper 
rectum. A diagnosis of benign solid 
teratoma of the ovary was made by 
histologic examination of the surgical 
specimen; the tumour had perforated 
the rectal wall and protruded into 
the bowel lumen, a most unusual 
complication for this type of tumour. 
Pararectal teratomas can arise 
from either the ovaries or the soft 
tissues of the sacrococcygeal region. 
The latter do, on rare occasions, 
perforate the rectum. The possible 
mechanisms of rectal perforation by 
these teratomas are briefly discussed.
Les auteurs presentent un cas de 
rupture intrarectale d’un teratome 
benin et solide de I'ovaire. Lors de 
I’investigation d'un probleme digestif, 
une tumeur faisant prolapsus fut 
decouverte dans le rectum d’une 
jeune femme. Le diagnostic ne fut 
etabli que lors de I'examen histologique 
du specimen. La tumeur consistait 
en un teratome solide et benin de 
I’ovaire ayant perfore la paroi rectale. 
II s'agit d'une complication tres 
inhabituelle de ce type de tumeur. 
L'origine des teratomes para-rectaux 
peut etre I’ovaire ou les tissus mous 
de la region sacrococcygienne. Ces 
derniers ont ete decrits comme 
pouvant perforer a I’interieur du 
rectum. Les mecanismes possibles des 
perforations rectales sont brievement 
discutes.
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Rupture of ovarian teratoma into a 
hollow organ is rare.1 Few cases of 
benign cystic teratomas perforating 
the wall of the rectum have been re­
ported.2 This paper describes a unique 
case of a benign, solid, complex tera­
toma that penetrated the wall of the 
rectum and protruded into its lumen 
mimicking rectal tumour.
Case Report
A 26-year-old mother of two children 
was admitted to the Hopital du Sacre- 
Coeur, complaining of pain in the lower 
right side of the abdomen, which had 
begun 12 months earlier. The pain was 
exacerbated by defecation and was asso­
ciated with tenesmus and the sensation 
of something prolapsing into the rectum. 
For a few weeks before admission, the 
patient had had slight difficulty in pass­
ing stools, but she had never noticed 
any rectal bleeding. Menstruation was 
regular and there was no vaginal dis­
charge. Examination of the abdomen 
showed no abnormalities except for slight 
tenderness on deep palpation of the right 
iliac fossa.
Routine laboratory investigations gave 
no abnormal findings. The hemo­
globin value was 12.5 g/dl. Roentgeno­
grams after barium double-contrast en­
ema revealed the presence of a well- 
circumscribed lobulated tumour, about 
8 cm in diameter, protruding into the
FIG. 1—Cut section of ovarian tera­
toma with perforation of rectal wall and 
protrusion into bowel lumen.
lumen of the upper rectum. This polyp­
oid tumour was confirmed by sigmoid­
oscopy; it was located 14 cm from the 
anal margin. Histologic examination of 
the biopsy specimen showed malpighian 
cellular metaplasia, but the true nature 
of the rectal tumour was not recognized.
At laparotomy the right ovary was 
found to be adherent to the rectal wall 
and seemed to be in continuity with the 
intraluminal rectal tumour. The uterus 
and left ovary appeared normal. En bloc 
resection of the tumour-bearing segment 
(12 cm long) of the upper rectum, to­
gether with the adherent right ovary and 
right fallopian tube, was carried out fol­
lowed by end-to-end anastomosis of the 
bowel. The postoperative period was 
uncomplicated and the patient was dis­
charged from hospital 1 week after the 
operation.
Serial sections of the resected speci­
men at the junction of the right ovary 
and the rectal tumour showed that the 
tumour was actually a solid teratoma of 
the ovary that had perforated the rectal 
wall and protruded into the bowel lumen 
(Fig. 1). On the rectal side of the ovary, 
the parenchyma was replaced by tumour 
tissue identical to that of the rectal tu­
mour. It was composed of more or less 
mature well-differentiated tissues de­
rived from all three germ layers, for 
example skin (Fig. 2), muscle, fat. bowel
FIG. 2—Surface of polypoid tumour 
covered by keratinized malpighian epi­
thelial layer with hair follicles (hema­
toxylin and eosin, reduced by 52% 
from X 100).
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epithelium, respiratory epithelium and 
eccrine glands (Fig. 3), apocrine gland­
ular structures and meninges (Fig. 4), 
and nerve fibres. The histologic findings 
thus described are characteristic of a 
benign solid teratoma of the ovary.
Discussion
Teratomas of the ovary are usually 
benign dermoid cysts, but occasionally 
they are solid lesions. The solid, com­
plex teratoma differs from the derm­
oid cyst in that it has a more hete­
rogeneous collection of recognizable 
tissues and organoid structures derived 
from all three germ layers: ectoderm, 
mesoderm and endoderm. Almost all 
cystic ovarian teratomas are benign; 
only 2% have a malignant component. 
In sharp contrast, about 20% of solid 
teratomas show malignant degenera­
tion.3 Malignant changes may occur 
in any of the tissues. Immature, solid 
teratomas may sometimes be accom­
panied by the dissemination of cellular 
implants on the peritoneum. Many 
years ago Peterson,4 studying a group 
of such tumours, found that those 
most likely to show peritoneal disse­
mination and to recur contained glial 
tissue. This observation was later con­
firmed by others.5'7
A histologic grading system for 
solid teratoma of the ovary has been 
proposed by Thurlbeck and Scully.8 
Based upon the maturity of the com­
ponent germ-layer elements, the tu­
mours are graded 0 to 3. Grade 3 
tumours are the most malignant; they 
contain large quantities of embryonal 
immature tissue and the prognosis is 
poor. Grade 0 neoplasms, to which
FIG. 3—Eccrine glands (hematoxylin 
and eosin, reduced by 52% from XlOO).
our case seems to belong, are com­
posed of mature, well-differentiated 
tissue types and have an innocuous 
clinical course.
Our case was unusual since the 
complication in which the solid tera­
toma of the ovary was involved was 
so rare. The nature of the rectal tu­
mour remained obscure until it was 
surgically excised en bloc with the 
adherent right ovary and the specimen 
examined microcospically, revealing 
continuity of the malpighian cell layer 
of the ovarian tumour on one side 
with the intrarectal extension of the 
tumour on the other. This finding 
confirmed that the rectal teratoma had 
its origin in the adjacent right ovary.
Teratomas in close proximity to 
the rectal wall may originate not only 
from the ovaries but also from the 
soft tissues of the sacrococcygeal re­
gion. Gonadal teratomas are most 
often found in children or young 
adults, while those of sacrococcygeal 
origin tend to be detected in the first 
few months of life, except for a few 
that have been recorded in adults.9 
The majority of the sacrococcygeal 
teratomas present externally, but may 
have a large internal component. 
However, a small percentage of these 
tumours are totally presacral and their 
presence can only be detected by 
rectal examination. A few of the sac­
rococcygeal teratomas, if not resected 
early in life, may perforate into the 
rectum;10 the commonest complica­
tions related to these tumours are in­
fection and malignant degeneration.9
The possible mechanisms enabling 
these pararectal teratomas to perforate
FIG. 4— Meningeal tissue with psam­
moma bodies (hematoxylin and eosin, 
reduced by 52% from X250).
the bowel wall are thought to be: (a) 
ischemic pressure necrosis, (b) secon­
dary infection with adhesion to the 
bowel wall and eventual rupture into 
the lumen of the rectum and (c) 
malignant degeneration with direct ex­
tension into, and infiltration of, the 
rectum. Since the tumour in our case 
was of the mature well-differentiated 
type with no evidence of malignant 
change and the histologic sections did 
not reveal signs of inflammation, the 
probable reason for rupture of this 
benign, solid, ovarian teratoma into 
the rectum was pressure necrosis and 
devascularization of the bowel wall.
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Home Study Course 
in Immunology
The University of Wisconsin is pleased 
to offer a home study course in immu­
nology. Physicians can enrol at any 
time and study at their own pace.
The course covers basic concepts 
about B cells, T cells, neutrophils, 
macrophages and complement. The 
concepts are utilized to define a 
useful clinical approach to patients.
For further information please con­
tact: Home Study-CME, University 
of Wisconsin, 481 WARF Building, 
610 Walnut St., Madison, Wisconsin 
53706, or call (608) 263-2853.
continued on page 107
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Retroperitoneal Leiomyoma with Periorbital 
and Peripheral Edema
D.C. D rinkwater , J r., md , J.O . L ough, md , f r c p [c] and R .A . B row n , md, frcs[c]
Removal of a large retroperitoneal 
leiomyoma from a 51-year-old woman 
resulted in complete resolution of 
periorbital edema and pitting edema 
of the hands and feet from which 
she had suffered for 8 months. 
Cardiac, renal and dietary studies 
gave normal results. The diagnosis 
of leiomyoma, which is uncommon in 
the retroperitoneal region, was 
supported by the findings on light 
and electron microscopy. The patient 
remains asymptomatic after 3 years. 
The association of such widespread 
edema with a retroperitoneal tumour 
is rare; the cause is unknown.
L'ablation d’un gros leiomyome 
retroperitoneal chez une femme de 
51 ans a entraine la resolution 
complete d’un oedeme periorbitaire 
et d'un oedeme en godet des mains 
et des pieds, dont elle souffrait depuis 
8 mois. Les etudes cardiaque, renale 
et dietetique ont donne des resultats 
normaux. Le diagnostic de 
leiomyome, dont la localisation 
retroperitoneale est rare, a repose 
sur les observations de microscopie 
optique et electronique. La patiente 
demeure asymptomatique apres 3 ans. 
L’association d'un oedeme aussi etendu 
avec une tumeur retroperitoneale 
est rare; la cause en est inconnue.
Periorbital edema and edema of the 
hands and feet is an unusual mani­
festation of retroperitoneal leiomyo­
ma. In no recent review has it been 
reported. The purpose of this paper 
is to record this rare finding and to 
note that there was complete resolu­
tion of the condition after surgical ex­
tirpation of the mass and for a follow­
up period of 3 years.
Case Report
A 51-year-old woman was admitted to
From the departments of surgery and pathology, the Montreal General Hospital, Montreal, PQ
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hospital for evaluation and treatment of an abdominal mass. Six months earlier she had noticed swelling of her hands and feet and around her eyes on rising each morning. At the end of the day the swelling was limited to her lower extremities. A salt-restricted diet, eleva­tion of the legs and use of support stock­ings had no appreciable effect. She de­nied any weight loss, fatigue, polydypsia or polyphagia. The cardiovascular system was normal and there was no history
FIG. 1—Computerized tomogram de­monstrating right retroperitoneal mass (arrow), immediately adjacent to and contiguous with vertebral bodies.
of hypertension, or cardiac or renal dis­ease. The vital signs were normal. She was moderately obese. Symmetrical peri­orbital edema, severe pitting edema of the ankles and feet and mild pitting edema of the hands were noted. A 6 x 8-cm, nontender, firm, nonpulsatile mass was palpated in the midabdomen on the right side. The rest of the ab­dominal findings were unremarkable. The findings on neurologic examination were normal. There was no lymphadenopathy.
FIG. 2—Circumscribed leiomyomaafter removal from right psoas muscle.
FIG. 3—Electron-microscopic section showing ovoid nuclei with cytoplasmic myofilaments, pinocytic vesicles (V), attachment zones (arrow) and basement mem­brane (BM), all characteristic of smooth muscle (uranyl acetate and lead citrate stain, reduced by 7% from X3700).
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The results of routine laboratory in­
vestigations were within normal limits. 
Endocrine tests, however, showed a urine 
free cortisol value of 115 mg/d (normal 
10 to 12 mg/d), 17-hydroxysteroids 2.3 
mg/d (normal 2 to 6 mg/d), 17-keto- 
genic steroids 5.6 mg/d (normal 7 to 12 
mg/d), 17-ketosteroids 7.5 mg/d (nor­
mal 6 to 15 mg/d) and vanillylmandelic 
acid 2.2 mg/d (normal 1 to 5 mg/d) on 
proper diet. Her morning and evening 
blood cortisol levels were 233 and 83 
p.g/1 respectively (normal 50 to 250 
pg/1).
Intravenous pyelography demonstrated 
that the mass was situated lateral and 
inferior to the right kidney but did not 
involve it or the ureter. Ultrasonography 
confirmed that the 8 x  6-cm mass was 
noncystic and separate from the kidney. 
Computerized tomography (Fig, 1) 
showed a large, fusiform, low-density 
mass in the right psoas muscle, displacing 
the caudal portion of the vena cava 
medially. This was compatible with a 
leiomyosarcoma or a rhabdomyosarcoma. 
There was no bone destruction.
At operation a 9 X 7-cm mass was 
found in the right psoas muscle. Grossly 
it was well encapsulated, with attach­
ment to the adjacent vertebral bodies of 
L4 and L5. There was no obstruction 
of the inferior vena cava and no other 
organs were involved. Removal of the 
mass from the psoas muscle was facil­
itated by previous retrograde catheter­
ization of the right ureter.
Grossly, the mass (Fig. 2), weighing 
239 g, was contained within a smooth 
shiny capsule. The sectioned surface was 
firm and yellow. There was no necrosis 
or hemorrhage. Microscopically, the mass 
was well circumscribed but no definite 
capsule was noted. There were uniform, 
interlacing bundles of cells with sausage­
shaped nuclei and scanty cytoplasm in a 
fibrillar stroma. The cells were rarely 
pleomorphic with only occasional mi­
toses. Electron microscopy confirmed the 
diagnosis of leiomyoma by showing myo­
filament attachment zones, pinocytic ve­
sicles and a basement membrane (Fig. 3).
The perioperative course was uncom­
plicated and 8 days postoperatively the 
patient was discharged from hospital. She 
was on a regular diet and was not taking 
diuretics. She had no evidence of swell­
ing. Three years later she was asymptom­
atic and the edema had not recurred.
Discussion
Benign smooth muscle tumour (lei­
omyoma) of the retroperitoneal region 
is relatively rare and is less common 
than its malignant counterpart leiomy­
osarcoma. In a review by Braasch 
and Mon1 of retroperitoneal tumours 
treated at the Lahey Clinic from 1930 
to 1960, only 2 of 101 tumours were 
leiomyomas. This infrequency was 
confirmed in a recent study of 100 
patients with smooth muscle tumours 
by Ranchod and Kempson,2 in which
no retroperitoneal leiomyomas were 
noted.
Peripheral extremity (hands and 
feet) and periorbital swelling in the 
absence of renal, cardiovascular or 
dietary deficiencies has not to our 
knowledge been described in associa­
tion with retroperitoneal tumours. 
Common presenting signs and symp­
toms of retroperitoneal tumours are 
abdominal pain, abdominal mass, 
weight loss, anorexia, nausea and 
vomiting. Hypoglycemia has been re­
ported in association with fibrosarco­
mas.3 An infrequent finding is swelling 
confined to the lower extremity due 
to inferior vena caval obstruction; this 
was reported in 17% of cases in a 
recent series of primary retroperito­
neal tumours by Bose.4 Perry and as­
sociates5 reported a case of total oc­
clusion of the abdominal aorta by a 
malignant fibrous histiocytoma, and 
Rossi and Libertino6 reported a case 
of neurocutaneous syndrome associ­
ated with a retroperitoneal lymphan­
gioma.
Because of the diffuse nature of our 
patient’s edema, it is unlikely that the 
cause was obstructive or mechanical. 
There was also no evidence of a hor­
monal, renal or dietary deficiency or 
of origin in nervous tissue. Perhaps 
future observations will help to clarify 
the precise mechanism of this unusual 
association of a retroperitoneal lei­
omyoma and diffuse edema.
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Correction
In the November 1981 issue, the sec­
tion in the List of Contents and the 
flag on page 591 headed “Canadian 
Association of General Surgeons” 
should have read “Canadian Associa­
tion of Clinical Surgeons”. The Jour­
nal apologizes for this proofreading 
error to the authors of all papers in­
cluded in that section and to members 
of the two associations.
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Early Gastric Cancer
C. H eughan, b chir, frcs, frcs[c], FACS, D. Kepkay, md, frcp[c], 
A.M. Cruz, md and H. Idikio, mb, bs, frcp[c]
Early gastric cancer confined to the 
mucosa or submucosa, similar to 
that described in the Japanese 
literature, exists in Newfoundland, 
an area of North America in which 
gastric cancer is four times more 
prevalent than on the rest of the 
continent. If untreated, this early 
gastric cancer will progress to 
advanced disease.
The clinical presentation of 10 
patients suffering from cancer confined 
to the mucosa and submucosa of 
the stomach is described.
The disease presents with acute 
or chronic bleeding or unexplained 
dyspepsia; no abnormality of the 
stomach can be seen on 
roentgenograms. The diagnosis may 
be suspected at endoscopic 
examination. Cytologic studies using 
touch preparations may be 
suggestive but the diagnosis should 
be confirmed by biopsy before 
operation is performed.
Le cancer precoce de I'estomac confine 
a la muqueuse ou a la sous-muqueuse, 
semblable a ce qui est decrit dans 
la litterature japonaise, existe a 
Terre-Neuve, une region d’Amerique 
du Nord ou le cancer gastrique est 
quatre fois plus frequent que sur le 
reste du continent. Non traite, ce 
cancer precoce de I'estomac evolue 
vers une maladie de stade avance.
On decrit le tableau clinique de 
10 malades souffrant d'un cancer 
confine a la muqueuse ou a la 
sous-muqueuse gastrique.
La maladie apparait sous la forme 
d’un saignement aigu ou chronique 
ou d’une dyspepsie inexpliquee; 
aucune anomalie de I’estomac n'est 
revelee a la radiographie. Le diagnostic 
peut etre soupconne a I'examen 
endoscopique. Les etudes cytologiques 
peuvent etre evocatrices mais le 
diagnostic doit etre confirme par une 
biopsie avant de proceder a I'operation.
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The prognosis for gastric cancer in 
North America is dismal. Only about 
50% of patients who have gastric 
cancer undergo and survive resection 
and only about 15% are alive after 
5 years.
In Japan, by contrast, Yamagata 
and associates1 and Kidokoro2 have 
reported a 5-year survival rate of over 
90% in patients treated surgically for 
cancer limited to the mucosa or sub­
mucosa. Furthermore, in over one 
third of Japanese patients with carci­
noma of the stomach, the disease is 
diagnosed when it is still confined to 
the superficial layers. If the biology 
of gastric cancer in North America 
is the same as in Japan, the high 
proportion of early tumours diag­
nosed in Japanese series must be due 
to better diagnostic techniques, includ­
ing the use of mass screening by gas- 
trocamera, double-contrast upper gas­
trointestinal roentgenography and the 
liberal use of endoscopy and biopsy. 
The differences in prognosis and in­
cidence have raised some doubt as to 
whether cancer of the stomach is the 
same disease in North America as in 
Japan.
The chances of North Americans 
accepting mass screening by gastro- 
camera are remote, particularly since 
the incidence of gastric cancer is low 
compared with that in Japan and is 
falling. North American practice must, 
therefore, be directed towards diag­
nosing mucosal cancer in patients who 
present with upper gastrointestinal 
symptoms.
Gastric Cancer in Newfoundland
The majority of the 550 000 in­
habitants of Newfoundland are of 
British or Irish descent.
Pfeiffer and colleagues3 documented 
a mortality from gastric cancer in 
men of 30 per 100 000 in Newfound­
land, a figure approximately four 
times higher than those reported in 
the United States and mainland Can­
ada, but somewhat lower than com­
parable figures for Japan, Chile and 
Iceland. The mortality in Newfound­
land shows a notable regional varia­
tion and Newfoundlanders who take 
up residence in mainland Canada are 
subject to the low mainland rates.
The provincial cancer registry re­
ports approximately 100 new patients 
per year with gastric carcinoma.
This paper reviews our experience 
with 10 mucosal cancers seen in one 
hospital over an 8-year period. In 
eight patients, the diagnosis of cancer 
was made before gastrectomy. Path­
ological examination confirmed the 
diagnosis of cancer limited to the mu­
cosa and submucosa in all 10 patients.
Patients and Methods
Patient records from the General 
Hospital in St. John's were reviewed 
for the period July 1, 1972 to Mar. 
31, 1980. The pathologic features of 
10 patients having mucosal disease 
were reviewed. Ages ranged from 43 
to 76 years; five patients were in their 
seventh decade. Six of the 10 were 
men. Eight patients were diagnosed 
as having gastric cancer before oper­
ation.
Four of the 10 patients presented 
with bleeding; 3 noted hematemesis 
or melena and 1 patient had iron def­
iciency anemia. Four other patients 
complained of dyspepsia, one other 
had anorexia and weight loss and one 
an acute exacerbation of ulcer pain.
All patients but one underwent con­
ventional roentgenography after a 
barium meal. Eight patients under­
went endoscopic examination with 
conventional equipment. Four to six 
biopsy specimens were taken from any 
suspicious lesions and touch prepara­
tions were made on ground glass 
slides, which were immediately sprayed 
with fixative. We routinely use touch 
preparation of individual specimens 
for cytologic examination. This prep­
aration contains fewer red cells than 
brushings, and abnormal mucosal cells 
print more readily onto the ground 
glass than do normal mucosal cells. 
Both of these features make the study 
of individual cells easier. Standard 
criteria for malignancy applied. The 
mucosal biopsy specimens were then 
fixed in formalin solution and em­
bedded in paraffin. Serial sections 
were cut and stained with hematox­
ylin and eosin for light microscopy.
All patients underwent a conven­
tional gastrectomy with no attempt 
at aggressive removal of the lymph 
nodes draining the stomach.
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Findings and D iscussion
Conventional contrast roentgen­
ography after barium meal did not 
suggest a diagnosis of cancer in any 
of the nine patients who had this ex­
amination. In four of the nine, gastric 
ulceration was demonstrated. The 
other five patients had roentgenograms 
that either appeared normal or demon­
strated a duodenal lesion that was not 
confirmed by endoscopic examination.
The endoscopic appearance of the 
lesions was suspicious of cancer in 
five of nine patients. In nine patients 
the cytologic examination and biopsy 
specimens (Figs. 1 to 3) were judged 
to show malignant tumours and this 
was confirmed on examination of the 
resected specimens. The notable fea­
tures of these lesions were irregular 
shape and dirty, grey slough in the 
ulcer base. They were only 4 or 5 mm 
in size and sometimes contiguous with 
the edge of a benign gastric ulcer. 
Distortion of the folds approaching 
the ulcer has been of little diagnostic 
value in the acute phase due to sur­
rounding edema. Healing of an ulcer 
is no guarantee of benignity in these 
mucosal lesions.
Although no aggressive attempt was 
made to remove the lymph nodes 
from the stomach, in one later patient 
(not included in our group of 10 pa­
tients) a single node close to a cancer 
confined to the submucosa contained 
metastatic tumour. In none of the 10 
patients reported in this series were 
any lymph nodes affected.
All the tumours were in the distal 
part of the stomach so total gastrec­
tomy was not necessary either on 
technical grounds or for reasons of 
cancer cure. So far no patient has 
shown evidence of recurrence; the 
longest follow-up is 6 years.
In 1 of our 10 patients the proximal 
margin of resection passed through a 
mucosal cancer. Seven years later he 
returned with a massive tumour. This 
clearly illustrates how important it is
FIG. 1— Gastric ulcer with inflam­
matory cells at base. At left hand edge 
is area of cancer (arrow) superficial to 
muscularis mucosae (hematoxylin and 
eosin, reduced by 50% from X50).
for the operating surgeon to know the 
location of the tumour since there is 
nothing to see or to feel from the se­
rosal surface.
The two growths that were protu­
berant were sessile, both were less 
than 1 cm in diameter and appeared 
to be covered by mucosa. When biop­
sy was performed both were friable 
and bled easily.
Eight of the 10 lesions were de­
pressed or ulcerated. This proportion 
is similar to that reported by Sakita4 
in a series of 421 superficial cancers.
It should be noted that a number 
of patients not included in this series 
have shown suspicious or frankly ma­
lignant cells on cytologic examination 
of gastric ulcers. In most, this ab­
normality has reverted to normal as 
the lesions healed. Two patients, how­
ever, underwent gastrectomy because 
the malignant appearance of cells on 
cytologic examination persisted; in 
neither patient did the resected speci­
men show any evidence of cancer.
Three of the 10 patients are worthy 
of special mention. One had a gastrec­
tomy for gastric cancer in 1963. The 
growth infiltrated the muscle coat; no 
nodes were involved. Postoperatively, 
he complained of bloating and 
pain. Numerous endoscopic exam­
inations and roentgenograms made 
after barium meal showed bile gas­
tritis and on one occasion a food 
bezoar was broken up during endo­
scopy. Another endoscopic examina­
tion in 1973 showed an area of slough 
on the gastric side of the stomach. 
Cytologic examination and biopsy 
specimens showed malignant cells, so 
a revision gastrectomy was performed.
FIG. 2—Higher power view of edge 
of ulcer shown in Fig. 1 (reduced by 
32% from X200).
The resected specimen confirmed mu­
cosal disease. The patient’s symptoms 
were unchanged when he died in 1976 
of a presumed myocardial infarction; 
no autopsy was performed.
A second patient presented with a 
3-week history of anorexia and weight 
loss. Roentgenography after barium 
meal suggested linitis plastica, which 
was confirmed at endoscopic examina­
tion. In addition to a deformed aperi- 
staltic antrum, a raised area in the 
antrum was demonstrated; a biopsy 
specimen of the raised area showed 
carcinoma. At laparotomy, the stom­
ach appeared normal and a blind 
50% gastrectomy was performed. The 
resected specimen contained an area 
of carcinoma confined to the mucosa 
and submucosa.
The third patient underwent a gas­
trectomy for cancer. The tumour was 
confined to the mucosa but the re­
sected margin was not clear of tu­
mour. He was lost to follow-up for 
7 years when he was referred again 
with episodes of dyspepsia and hema- 
temesis associated with alcoholic binge 
drinking. An extensive adenocarcino­
ma was found at the suture line and 
was judged to be unresectable.
We had no problems with post­
gastrectomy syndromes except for one 
patient who required revision of his 
Bilroth II gastrectomy to a Roux- 
en-Y stoma because of bilious vom­
iting.
Four patients have been followed 
up for 3 years or more.
Conclusions
There are very few references to
FIG. 3— High power view showing 
cluster of malignant “signet-ring" cells 
(hematoxylin and eosin, reduced bv 
32% from X500).
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the clinical syndrome of early gastric 
cancer in the North American litera­
ture. Hence, we believe it is important 
to report this small series and to draw 
some tentative conclusions.
Early cancer should be suspected in 
any patient over 40 years of age who 
presents with acute or chronic upper 
gastrointestinal blood loss or dyspep­
sia with no radiologically demon­
strable cause or with any gastric le­
sions shown on a roentgenogram re­
gardless of the appearance. The opti­
mal time for endoscopic examination 
is during a healing phase when the 
surrounding edema has subsided and 
interpretation of the touch prepara­
tions is more reliable because the
changes due to inflammation and re­
generation are less marked.
Before operation is carried out the 
diagnosis should be confirmed by 
biopsy and in equivocal cases repeated 
examinations should be performed 
and specimens taken until a definite 
answer is obtained. It is likely that 
the urgency with which suspected 
cancer is traditionally treated may be 
inappropriate.
The gastric remnant that is left fol­
lowing partial gastrectomy is subject 
to the same genetic and environmental 
influences that induced the original 
tumour. Therefore, long-term follow­
up by regular endoscopic examination 
is desirable. In our series, geographic,
economic and logistic difficulties pre­
vented this.
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Cesarean Section: Recent Trends
M arkus C. M artin , m d , c m , frcs[c ], facog, Stan  M oyyen, md 
AND MORRIE G e LFAND, MD, FRCSfc], FACOG
There has been a rapid increase in 
the number of cesarean sections 
performed. At the Sir Mortimer B. 
Davis-Jewish General Hospital in 
Montreal, the authors reviewed the 
records of all cesarean sections 
performed between Jan. 1, 1973 and 
Dec. 31, 1979. The rate increased 
from 10.8% in 1973 to 19% in 
1977, due primarily to an increasing 
trend to diagnose, and perform 
cesarean section for, dystocia.
All breech presentations are also 
delivered by cesarean section but 
fewer cesarean sections are being 
performed for fetal distress. Cesarean 
section is still a major operation and 
the procedure is associated with 
substantial maternal morbidity.
II y a eu une augmentation rapide 
du nombre des cesariennes. A I'Hopital 
Juif-Sir Mortimer B. Davis de 
Montreal, les auteurs ont etudie les 
dossiers des cesariennes pratiquees 
entre le 1er janvier 1973 et le 31 
decembre 1979. Le taux a augmente 
de 10.8% en 1973 a 19% en 1977, 
et ceci est principalement du a la 
tendance grandissante de diagnostiquer
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les dystocies et a pratiquer dans ces 
cas une cesarienne. Toutes les 
presentations par le siege sont aussi 
accouchees par cesarienne mais moins 
de cesariennes sont effectuees dans 
les cas de souffrance foetale. La 
cesarienne demeure une operation 
majeure et cette intervention est 
rattachee a une morbidite maternelle 
importante.
The European12 and American3-5 lit­
erature has indicated a rapid increase 
in the number of cesarean sections 
being performed during the past few 
years. This has received much scru­
tiny5,7 because any deviation from the 
status quo in patient management re­
quires, at least, a decrease in the risk- 
to-benefit ratio. With any surgical pro­
cedure there is an inherent risk, but 
with the advent of safer anesthetic 
procedures this risk has been dimin­
ishing. The benefit derived from the 
increasing rate of cesarean sections as 
measured by improved perinatal out­
come is more difficult to document.8 
In this paper we study the trend in 
cesarean section rates at the Sir Mor­
timer B. Davis-Jewish General Hospi­
tal in Montreal, compare our rates 
and indications with other major cen­
tres and evaluate the rate of maternal 
complications associated with cesarean 
section.
Methods
The records of deliveries from Jan.
1, 1973 to Dec. 31, 1979 at the Jewish 
General Hospital were reviewed. Two 
of us (M.C.M. and S.M.) studied all 
the available charts of patients who 
underwent cesarean section and col­
lated the appropriate data for the cal­
endar years 1973, 1976 and 1978. 
The perinatal mortality was assessed 
for each year from 1973 until 1979. 
For our definitions, we adopted the 
commonly accepted terms used by the 
American College of Obstetricians 
and Gynecologists.
Findings
During the 7-year period of the 
study, there were 15 929 deliveries 
of which 2406 were by cesarean sec­
tion (Table I). The percentage of ce­
sarean sections performed increased 
from 10.8% in 1973 to a high of 
19% in 1977 (Fig. 1).
T a b le 1— N u m b e r o f  D e l iv e r ie s  a n d
C e s a r e a n  S e c t io n s  b y  Y e a r
N o . o f N o . o f  c e s a r e a n
Y e a r d e l iv e r ie s s e c t io n s  ( % )
1973 1 7 1 9 1 8 6  ( 1 0 .8 )
1974 2 361 2 4 8  ( 1 0 .5 )
1975 2 342 3 0 8  ( 1 3 .2 )
1976 2 4 0 9 3 5 8  ( 1 4 .9 )
1977 2 394 4 5 5  ( 1 9 .0 )
1978 2 334 4 2 4  ( 1 8 .2 )
1979 2 370 4 2 7  ( 1 8 .0 )
15 9 2 9 2 4 0 6  ( 1 5 .1 )
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It is not only at our institution, 
but also across N orth America, 
that notable changes are occurring 
in the rate of cesarean sections per­
formed. In 1975, the Mayo Clinic 
paper9 showed a minimal rise with an 
absolute rate of 3.7%. But thereafter 
numerous papers, all showing much 
more marked increases in the rate, 
rapidly changed the accepted norms.
What is most striking about our 
data is the lack of correlation between 
our rising cesarean section rate after 
1974 and our stable perinatal mortal­
ity (Fig. 1). Minkoff and Schwarz10 
noted a similar absence of correla­
tion at their institution after 1972. 
This has been further confirmed by 
the upper New York state group” 
who noted that the number of ce­
sarean sections performed correlated 
with the perinatal mortality in 1968/9, 
but not in 1977/8.
Public versus Private
The number and percentages of 
deliveries and cesarean sections 
among private and public patients in 
1978 are shown in Table II. The over­
all rate was 18%; 64% were primary 
and 36% repeat cesarean sections. 
Among public patients the cesarean 
section rate was 23.3%, 85% of 
which consisted of primary proce­
dures. Among the private sector the 
total rate was 18% but the primary 
cesarean sections accounted for only 
63%.
Anesthesia
In 1978, the majority of cesarean 
sections were done under general 
anesthesia. However, epidural anal­
gesia was used in more than 25%. 
This was a substantial increase over 
our 1973 figures, in which less than 
5% of patients had epidural anes­
thesia (Table III).
FIG . 1— Percentage of all deliveries 
perform ed by cesarean section (white 
circles) and perinatal mortality per 1000 
infants weighing over 1000 g (black 
circles), from 1973 to 1979.
Age
Fig. 2 illustrates the changing pat­
terns from 1973 to 1978 in the ages 
of women who had a primary cesarean 
section. The most striking feature 
was the increase in cesarean sections
among multiparous patients, shatter­
ing the misconception that such wom­
en are immune to the need for cesa­
rean section. Furthermore, among the 
multiparous women, the average age 
was increased. In 1978 the largest 
group of women who underwent cesa-
T a b le  I I — N u m b e r a n d  P e rc e n t a g e  o f D e l iv e r ie s  a n d  C e s a re a n
S e c t io n s  a m o n g  P u b lic  a n d  P r iv a t e  P a t ie n t s  in  1978
N o. of
d e liv e r ie s  ( % )
N o. o f
c e s a r e a n  s e c t io n s  ( % )
T y p e  o f p a t ie n t T o ta l P r im a ry R e p e a t
P u b lic 86 (3 .7 ) 20 (2 3 .3 * ) 17 (8 5 ) 3 (1 5 )
P r iv a te 2 248 (9 6 .3 ) 404 (1 8 .0 * ) 254 (6 3 ) 150 (3 7 )
2 334 (1 0 0 .0 ) 424 (1 8 .2 * ) 271 (6 4 ) 153 (3 6 )
* %  o f a l l  d e l iv e r ie s  p e rfo rm e d  by c e s a re a n  s e c t io n .
60
40
20  -
_ E S _
< 2 0  2 0 -2 4  25 -29  3 0 -3 4  3 5 -3 9  40+
AGE
Fig. 2a
<20 20-24 25-29 30-34  35-39 40+
AGE, YR
Fig. 2b
FIG. 2— Number of primary cesarean sections performed by patient age. 
(a) in 1973, (b) in 1978. Hatched bars =  primiparous, solid bars — multiparous.
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rean section was in the age range 30 
to 34 years.
In d ic a t io n s
The indications for primary cesare­
an section in 1973, 1976 and 1978 
are shown respectively in Tables IV, 
V and VI.
Our commonest indication was dys­
tocia, which was responsible for over 
30% of all cesarean sections. Among 
primiparous patients it was responsible 
for over 50% of all sections.
►
Y°
y
T a b le  IV — In d ic a tio n s  f o r  C e s a re a n  S ec tio n  
in  173 P a t ie n ts , 1973*
> P r im ip a ro u s , M u ltip a ro u s , %  of a ll
In d ic a tio n no . ( % ) no. (%) T o ta l ,  no . (%) d e liv e r ie s
y R e p e a t 0  (0 ) 76 (1 0 0 ) 76 (4 3 .9 ) 4.4
P r im a ry 72 (7 4 .2 ) 25 (2 5 .8 ) 97 (5 6 .1 ) 5.6
> D ystoc ia 44 (6 1 .1 ) 9 (3 6 ) 53 (3 0 .6 ) 3.1
B reech 5 (6 .9 ) 3 (1 2 ) 8 (4 .6 ) 0.5
C ord  p ro lap se 1 (1 .4 ) 0 (0 ) 1 (0 .6 ) 0.1
F e ta l d is tre ss 9 (1 2 .5 ) 5 (2 0 ) 14 (8 .1 ) 0.8
P la c e n ta  p re v ia 3 (4 .2 ) 4 (1 6 ) 7 (4 .0 ) 0.4
► A b ru p tio  p la c e n ta e 5 (6 .9 ) 1 (4 ) 6 (3 .5 ) 0.3
P re v io u s  s u rg e ry 3 (4 .2 ) 0 (0 ) 3 (1 .7 ) 0.2
y M isc e lla n e o u s 2 (2 .8 ) 3 (1 2 ) 5 (2 .9 ) 0.3
r *13 c h a rts  cou ld  n o t be tra c e d .
S
V- T a b le  I I I T yp es  o f  A n e s th e s ia  U s e d  in 
1973 a n d  1978
V
T y p e  of 
a n e s th e s ia
N o. o f c e s a re a n  s e c tio n s  ( % )
y 197 3* 1978
>
A
G e n e ra l
E p id u ra l
Local
163 (9 4 .2 )  
8 (4 .6 )  
2 (1 .2 )
304 (7 1 .7 )  
120 (2 8 .3 )
T o ta l 173 (1 0 0 .0 ) 424 (1 0 0 .0 )
*13 c h a rts  cou ld  n o t be fo u n d .
1
y T a b le  V — In d ic a tio n s  fo r  C e s a re a n  S e c tio n , 1976
N o . of c e s a re a n %  o f  a l l
In d ic a tio n sections  ( % ) d e liv e r ie s
♦ R e p e a t 104 (2 9 ) 4 .3
P r im a ry 254 (7 1 ) 10.5
>■ D ystoc ia 120 (3 3 .5 ) 5.0
C e p h a lo p e lv ic
* d is p ro p o rtio n 72 (2 0 .1 ) 3 .0
Lack  o f p ro g ress 48 (1 3 .4 ) 2 .0
B reech 41 ( l l . 5 ) 1 .7
C ord p ro lap se 3 (0 .8 ) O .l
F e ta l d is tre ss 54 ( I 5 . l ) 2 .2
T P la c e n ta  p re v ia 2 (0 .6 ) O .l
A b ru p tio  p la c e n ta e 2 (0 .6 ) O .l
T o x e m ia 8 (2 .2 ) 0 .3
P re v io u s  s u rg e ry 2 (0 .6 ) O .l
r M isc e lla n e o u s 22 (6 .1 ) 0 .9
r
v T a b le  V I— In d ic a tio n s  fo r  C e s are a n  S e c tio n , 1978
>* P rim ip a ro u s , M u lt ip a ro u s , %  o f a ll
In d ic a tio n no . (%) n o . ( % ) T o ta l ,  n o . ( % ) d e liv e r ie s
A R e p e a t 0 (0 ) 153 (1 0 0 ) 153 (3 6 ) 6 .6
P rim a ry 189 (6 9 .7 ) 82 (3 0 .3 ) 271 (6 4 ) l l . 6
r D ystoc ia 106 (5 6 .1 ) 24 (2 9 .3 ) 130 (3 0 .7 ) 5.6
B reech 35 (1 8 .5 ) 25 (3 0 .5 ) 60 (1 4 .2 ) 2.6
C ord  p ro lapse 0 (0 ) 2 (2 .4 ) 2 (0 .5 ) O .l
F e ta l d is tre ss 26 (1 3 .8 ) 9 ( l l . O ) 35 (8 .3 ) 1.5
P la c e n ta  p re v ia 4 (2 .1 ) 7 (8 .5 ) l l  (2 .6 ) 0.5Y A b ru p tio  p la c e n ta e l  (0 .5 ) l  (1 .2 ) 2 (0 .5 ) O .l
P re v io u s  s u rg e ry 3 (1 .6 ) l  (1 .2 ) 4 (0 .9 ) 0.2
r M isc e lla n e o u s 14 (7 .4 ) 13 (1 5 .9 ) 27 (6 .4 ) 1.2
Our repeat cesarean section rate 
was phenomenally high in 1973 —  al­
most 44% . However, more recently 
it has been in the 30% to 35% range, 
which is much closer to the acceptable 
rate in the obstetrical literature.11
In 1973, breech presentation was 
a minor indication, being responsible 
for less than 5% . In 1976 it was 
responsible for 11 % of cesarean sec­
tions and by 1978 it accounted for 
almost 15% of cases. Again these fig­
ures compare well with those in the 
literature.12
Fetal distress traced an interesting 
pattern during the 1970s. In 1973 it 
was responsible for 8.1% of all sec­
tions, but in 1976 coinciding with the 
increase in electronic fetal monitoring 
there was a dramatic doubling of the 
percentage, to 15.1. In 1978, as a re­
sult of increasing expertise in fetal 
monitoring, we are back to a rate of 
8.3%.
The Canadian PAS study of 197613 
reported that one third of cesarean 
sections were due to dystocia, 28% 
were repeat and only 5.6% were due 
to fetal distress.
There has been no change with 
respect to the minor indications such 
as placenta previa, previous surgery 
and abruptio placentae. They ac­
counted for approximately 10% of the 
cases in 1973 and in 1978.
The most remarkable finding has 
been the rise in the percentage of 
infants delivered by primary section; 
in 1973 the percentage was only 5.6, 
in 1976 it was 10.5 and in 1978 it 
was 11.6. This correlates with the 
three main indications for cesarean 
section, which also rose rapidly during 
this period.
M a t e r n a l  C o m p l i c a t io n s
Overall, maternal death is extremely 
uncommon. At our institution no 
death was reported in 1973 or in 
1978.
Maternal morbidity, however, was 
common, with infections constituting 
the largest portion. Endometritis and 
urinary tract infections were predom­
inant among women who had pri­
mary cesarean section, compared with 
those who underwent elective repeat 
cesarean section (Table VII). In 1973, 
urinary tract infection developed in 
over 25% of women who had cesare­
an section, but in 1978 it occurred in 
only 5% (Table VIII). The frequency 
of endometritis also decreased, from 
16% to 7% . Thus, a definite trend in 
reduced febrile morbidity has made 
this major operative procedure much 
more palatable to the professional and 
general population.
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Discussion
Analysis of the short- and long­
term trends for cesarean section at 
our institution showed us that after 
an initial increase in the mid 1970s. 
we have stabilized the frequency of 
cesarean sections performed at just 
under 20%. There was an unexplained 
increase in dystocia as an indication 
for cesarean section and all our breech 
presentations are now managed by 
cesarean section.
Because the increased number of 
cesarean sections performed at our
institution has not resulted in de­
creased perinatal mortality, we must 
reassess the value of the procedure, 
as others are doing.'0 One of the many 
factors has been the substantial de­
cline in forceps application thereby 
increasing the already broad category 
of dystocia. The recent National In­
stitutes of Health study'3 reflected 
this concern, particularly with respect 
to the group of infants weighing over 
2500 g for which cesarean section does 
not appear to increase the survival 
rates. This report also recommended 
that the outcome of breech presenta­
tion after cesarean section be reas­
sessed and that vaginal delivery of a 
term infant in the breech position is 
still an acceptable obstetrical choice 
under certain conditions.
We must deal with the factors that 
influence the health of the mother as 
well as that of the fetus. The com­
plications that we found confirm that 
the increase in cesarean sections per­
formed has resulted in a proportional 
increase in morbidity and potential 
mortality.
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T a b le  V I I M a te r n a l  C o m p lic a t io n s  in  173  P a t ie n t s ,  1 9 7 3 *
—
C o m p lic a t io n
N o . o f  c e s a r e a n  s e c tio n s
P r im a r y R e p e a t T o t a l  ( % )
F e v e r  ( ^ 3 8 ° C ) 0 4 4 (2 .3 )
E n d o m e tr i t is 19 9 28  (1 6 .2 )
U r in a r y  t r a c t  in fe c t io n 33 15 4 8  (2 7 .7 )
A n e m ia 8 1 9 (5 .2 )
W o u n d  in fe c t io n 2 0 2 (1 .2 )
T h ro m b o e m b o lic  d is e a s e 1 0 1 (0 .6 )
B o w e l i le u s 1 0 1 (0 .6 )
P y e lo n e p h r i t is 1 0 1 (0 .6 )
N o n e 32 47 7 9  (4 5 .7 )
*13  c h a r ts  m is s in g .
T a b le  V I I I — M a te r n a l  C o m p lic a t io n s ,  1978
C o m p lic a t io n
N o . o f  c e s a r e a n  s e c tio n s
P r im a r y R e p e a t T o t a l  ( % )
F e v e r  ( ^ 3 8 ° C ) 8 14 2 2  (5 .2 )
E n d o m e tr it is 19 11 3 0  (7 .1 )
U r in a r y  t r a c t  in fe c t io n 12 9 21 (5 .0 )
A n e m ia 0 5 5 (1 .2 )
W o u n d  in fe c t io n 5 1 6 (1 .4 )
T h r o m b o e m b o lic  d is e a s e 1 2 3 (0 .7 )
B o w e l o b s tr u c t io n 1 0 1 (0 .2 )
P n e u m o n ia 3 1 4 (0 .9 ) ,
P o s to p . h e m o r r h a g e 1 0 1 ( 0 .2 ) '
N o n e 221 110 331  (7 8 .1 )
SESAP III Question
628. At the time of abdominal operation, a suspected intraoperative vesical injury is best detected by
(A) diminished return of urine from a urethral catheter
(B) presence of bloody urine during surgical procedure
(C) distention of the bladder with a solution of indigo carmine dye during operation
(D) inspection of the bladder
(E) intraoperative intravenous pyelogram (IVP)
For the incomplete statement above select the one answer that is best of the five given.
For the critique of Item 628 see page 101 of this issue.
(Reproduced by permission from SESAP III Syllabus: Surgical Education and Self-assessment Program 
No. 3. For enrolment in the Surgical Education and Self-assessment Program No. 3, please apply to the 
American College of Surgeons, 55 East Erie St., Chicago, IL 60611.)
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Mania Operativa: an Uncommon, Unrecognized 
Cause of Limb Amputation
G.A. H u n t e r , mb , f r c s , frcs[c] and A.B. Kennard , m b , bs
Mania operativa is an obsession with 
pain and disability and the seeking 
of relief from this pain by repeated 
surgical procedures. The authors 
report eight patients in whom a minor 
injury was followed by multiple 
operations, culminating in amputation 
of the upper or lower limb, at 
increasingly higher levels, in an 
unsuccessful attempt to relieve the 
patient's pain. They believe these 
patients had mania operativa.
There are many varieties of 
psychogenic pain, which present the 
surgeon with a problem in both 
diagnosis and management. The 
authors discuss identifiable factors 
in the patient, the surgeon and society. 
By calling attention to this condition, 
they hope to avoid unnecessary 
multiple surgical procedures on such 
patients.
La “mania operativa” est une obsession 
de la douleur et de I’invalidite, et la 
recherche du soulagement de cette 
douleur par le recours a des 
interventions chirurgicales repetees. 
Les auteurs decrivent huit malades 
chez qui une blessure banale a ete 
suivie d’operations multiples se 
terminant par I'amputation d’une 
membre superieur ou inferieur, a un 
niveau de plus en plus eleve, dans 
une tentative infructueuse pour 
soulager la douleur du patient. Ils 
croient que ces malades souffraient 
de “mania operativa”.
II existe plusieurs types de douleurs 
psychogenes qui posent au chirurgien 
un probleme de diagnostic aussi bien 
que le traitement. Les auteurs 
discutent les facteurs identifiables 
chez le malade, le chirurgien et dans 
la societe. En attirant I'attention sur 
cette affection, ils esperent eviter 
pour ces patients des interventions 
chirurgicales inutiles multiples.
From the amputee clinic, Workmen’s 
Compensation Board Hospital and 
Rehabilitation Centre, Downsview,
Ont.
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You will readily understand that when 
these patients, attacked with a “mania 
operativa passiva” find themselves un­
fortunately in the presence of surgeons 
affected with an analagous, though this 
time active, madness “mania operativa 
activa”, the most fantastic operations 
may result from this unlucky collision. 
Amputations have been done.
J.M. C harcot1
Although Charcot1 in 1889 was refer­
ring to cases of hysterical hip disease, 
which had often led to amputation, it 
was the German surgeon Stromeyer,2 
according to Chertok,3 who introduced 
the term “mania operativa activa” in 
1873. Stromeyer recorded a series of 
operations performed on patients suf­
fering from psychogenic pain: painful 
symptoms in the knee led to amputa­
tion at the level of the thigh or to 
disarticulation of the hip joint. In­
volvement of the hand led to amputa­
tion of the forearm or the upper arm 
and even to disarticulation of the 
shoulder joint hut without relieving 
the pain.
In this paper, we report eight pa­
tients, seen at an amputee clinic, in 
whom a minor injury was followed by 
multiple surgical procedures, culmin­
ating in amputation, at increasingly 
higher levels, in an unsuccessful at­
tempt to relieve the patient’s pain. We 
believe that the condition in these pa­
tients merits a positive diagnosis of 
mania operativa, that is, an obsession 
with pain and disability and the seek­
ing of relief from this pain by re­
peated surgical procedures —  in these 
cases amputation of the upper or 
lower limb.
Case Reports
Case l
A 33-year-old woman struck her right 
hand on a table. Roentgenograms re­
vealed no fracture or dislocation. Be­
cause of pain in the hand, carpal tunnel 
release was followed by tenolysis of the 
extensor tendons within a year of the 
accident. Skin necrosis developed after 
the second operation, necessitating a 
split-thickness skin graft and an unsuc­
cessful skin pedicle flap to the dorsum 
of the hand. Two years after her acci­
dent, she requested a below-elbow am­
putation, which was carried out in an 
attempt to relieve unremitting pain in 
the hand. Thirteen years later, she still 
has stump pain and is unable to wear 
a prosthesis. She also had a history of
multiple abdominal operations, finally 
resulting in removal of her right kidney.
Case 2
A 19-year-old man with a weak left 
leg due to poliomyelitis suffered a minor 
crush injury to the left foot. Roentgeno­
grams of the injured foot showed no 
fracture or dislocation. To relieve the 
patient’s persistent pain, the left big toe 
was fused. This was followed by fusion 
of the first metatarsal and medial cu­
neiform bones. One year later a Syme 
amputation was carried out but, at the 
patient’s request, this was revised, ini­
tially to a below-knee and 6 years later 
to an above-knee amputation. This man 
was noted to be a chronic alcoholic with 
a poor work record.
Case 3
A 26-year-old man, immature and un­
employable, twisted his right ankle. 
Roentgenograms revealed no fracture. 
Because of continuing pain, the Achilles 
tendon was first injected and later ex­
plored, but no abnormality was found.
Lumbar sympathectomy failed to re­
lieve the patient’s foot pain, and. at the 
patient’s request, a below-knee amputa­
tion was carried out. The patient still 
complains of pain in the stump and is 
unable to wear a prosthesis.
Case 4
A fracture of the terminal phalanx 
of the left little finger was sustained by 
this 30-year-old woman. Six months later 
she requested amputation of the finger to 
relieve her pain. Subsequent revision was 
performed at a transmetacarpal level and 
during the course of these procedures 
multiple sinuses were explored. At that 
time it was suggested that these wounds 
had been self-inflicted. Finally, at the 
patient’s request, a below-elbow amputa­
tion was carried out. Further operation 
was necessary to heal multiple sinuses 
and skin fistulas. The wound has healed 
but she cannot tolerate a prosthesis. Re­
view of her history indicated that she 
had suffered from depression, anorexia 
nervosa and drug addiction.
Case 5
A 33-year-old man sustained a minor 
laceration to his right fifth finger. The 
wound failed to heal and 9 months later 
amputation of the finger was carried out 
at the patient’s request. This procedure 
was followed over the next 9 years by 
transmetacarpal amputation, ray resec­
tion, fusion of the wrist and eventually 
a below-elbow amputation because of
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pain and recurrent failure of the wound 
to heal. This patient was a drug addict 
and had attempted suicide on three oc­
casions. A number of references were 
made on the patient’s chart to the pos­
sibility of self-inflicted wounds.
Case 6
Although there was no radiologic evi­
dence of a fracture, this 30-year-old man 
who had twisted his right ankle con­
tinued to complain of pain in his foot. 
Two attempts at fusion of the ankle and 
subtalar joints failed to relieve the pain. 
A lumbar sympathectomy was followed 
by a below-knee amputation at the pa­
tient’s request 10 years after the injury, 
and two further revisions of his stump 
have been carried out in an attempt to 
relieve persistent pain. He was noted to 
be a drug addict, anxious and insecure.
Case 7
This 28-year-old chronic alcoholic 
sprained his right ankle. After conserva­
tive treatment for 6 years failed to re­
lieve the pain, a tenodesis was carried 
out. Over the next 15 years 14 bone and 
soft-tissue operations around the foot 
were carried out, culminating in a Syme 
amputation which was subsequently re­
vised to a below-knee amputation. The 
patient still complains of stump and 
phantom pain and is still requesting 
further surgery.
Case 8
A 29-year-old man fell 12 feet, suf­
fering a dorsal dislocation of the first 
right tarsometatarsal joint. Closed reduc­
tion was carried out, but 6 years later 
the joint was fused because of continuing 
pain.
A Syme amputation followed by supra­
condylar and above-knee amputations 
failed to alleviate the patient’s pain or 
obtain satisfactory prosthetic fitting. He 
was noted to have a sociopathic per­
sonality and he has not worked since his 
accident.
Discussion
Although this type of patient is for­
tunately uncommon in medical prac­
tice, it should be remembered that 
there are many varieties of psycho­
genic pain which present a problem 
in both diagnosis and management.
Mania operativa is a pattern of be­
haviour, the underlying psychopath­
ology of which is diverse and which 
includes the following conditions: (a) 
Munchausen syndrome, (b) SHAFT 
syndrome, (c) polysurgery and poly- 
surgical addiction, (d) phantom limb 
sensation and painful phantom and 
(e) reflex sympathetic dystrophy.4
•  Munchausen syndrome. Since 
Asher’s original description5 there 
have been several reports of this syn­
drome,6 but none have included limb 
amputation as a complication of sur­
gical treatment.
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•  SHAFT syndrome (the chronic 
pain syndrome).7’8 In this syndrome 
the patient submits to and demands 
surgery to meet needs, whether finan­
cial or psychological, hence the acro­
nym representing sad, Jiostile, anxious 
frustrating patients who tenaciously 
cling to the health care system. Wallace 
and Fitzmorris7 reported on two such 
patients whose pain in the upper ex­
tremity culminated in digital and 
above-elbow amputations.
•  Polysurgery and polysurgical 
addiction. Menninger9 considered that 
the neurotic patient is unconsciously 
transferring dependence to the sur­
geon, who is seen as a strong, incisive 
and ruthless father figure.
In addition to these syndromes, the 
picture can be clouded, as it was in 
our patients, with associated factors 
such as alcoholism, drug addiction, 
self-mutilation, hypochondriasis and 
sociopathic personality.
There must be identifiable factors 
to account for this rare but serious 
problem, which may be more common 
than is recognized. We will discuss 
some factors with regard to the pa­
tient, the surgeon and society.
The Patient
The patient may suffer from pre­
existing or post-traumatic mental dis­
ease and often holds a grudge against 
society, hospitals and doctors. Drug 
addiction may contribute to a maso­
chistic desire for self-mutilation, in 
itself a partial suicide attempt.
Repeated hospital visits fulfil a de­
sire to become the centre of interest 
and attention in the dramatic role of 
a patient. Since all these patients were 
seen in the Workmen’s Compensation 
Board Hospital and Rehabilitation 
Centre, this syndrome may be due to 
a simple desire not to work, coupled 
with secondary financial gain. It 
should be noted, however, that finan­
cial compensation to Board patients 
never equals the patient’s former in­
come and permanent disability pay­
ments are relatively small, by today’s 
standards, even for limb amputation.
The Surgeon
If one accepts an excessive number 
of surgical procedures performed on 
one patient as one of the categories 
for defining “unnecessary surgery”, it 
should be noted that orthopedic sur­
geons have been cited as those who 
perform the highest percentage of 
unnecessary surgery.10
Most surgeons are poorly trained in 
psychiatric medicine and naively be­
lieve that amputation will cure pain 
in these patients.11 When faced with
failure, the situation arouses bewilder­
ment, contempt and anger. Anger may 
incite latent sadistic tendencies,9 and 
the entire cycle is repeated as the 
patient and surgeon regard each other 
as being either incompetent or psy­
chologically disturbed.
If one is to blame the patient for 
hoping to gain financially from am­
putation, it should be remembered 
that in a fee-for-service system the 
surgeon may have secondary motives 
for involving himself in repeated sur­
gical procedures.
Society
Deceiving the medical profession is 
not a criminal offence or grounds for 
commitment. Universal health care, 
which in the minds of the public is 
“free”, encourages many diverse 
opinions and consultations; often the 
surgeon has insufficient information 
on the patient to realize the problem 
before making a decision about fur­
ther surgical procedures.
Conclusion
When a patient presents in a de­
pressed, even hostile, state, with long­
standing bizarre pain after a trivial 
injury and has a turbulent social his­
tory, possibly including drug addiction, 
we recommend that the surgeon ob­
tain the old records and arrange a 
psychiatric consultation before pro­
ceeding with primary or secondary 
amputation of a limb, often at the 
patient’s request. Such procedures are 
harmful to the patient and costly to 
society.
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Management of Ulnar Artery Aneurysm in the Hand:
a Case Report
R.D. Martin, md, frcs[c] and R.T. Manktelow , md, frcs[c]
Despite the common occurrence of 
trauma to the hand, arterial aneurysms 
in this area are rare. The authors 
describe the symptoms, signs and 
microvascular treatment of a true 
aneurysm of the ulnar artery in the 
palm of an 18-year-old youth. Although 
there is no clear evidence that 
vascular restoration is needed after 
resection of the aneurysm, the authors 
believe that reconstruction of the 
ulnar artery using microvascular 
techniques will ensure that blood 
supply to the digits is adequate.
En depit de la frequence des 
traumatismes de la main, les 
anevrysmes arteriels dans cette region 
sont rares. Les auteurs decrivent 
les symptomes, les signes et le 
traitement d'un anevrysme vrai de 
I’artere cubitale dans la paume d’une 
jeune homme de 18 ans. Bien qu’il 
n’y ait pas de preuve evidente 
qu’une restauration vasculaire soit 
necessaire apres la resection de 
I’anevrysme, les auteurs croient que 
la reconstruction de I'artere cubitale 
par microchirurgie permettra d'assurer 
un apport sanguin adequat aux 
doigts.
The first report of an arterial aneu­
rysm in the hand was made by Guat- 
tani in 1772.1 Although the hand is 
highly vascular and is frequently sub­
jected to trauma, only 52 cases of true 
aneurysms have been described; 30 
of those were aneurysms of the ulnar 
artery.2-6 In this report we describe 
the clinical and pathologic features, 
and treatment of another case. Be­
cause of new developments in micro­
vascular surgery, the treatment of this 
condition must be re-examined.
Case Report
An 18-year-old left-handed boy had 
for 3 months had episodes of lancinating 
pain in his right hand over the volar
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aspect of the base of the little and ring 
fingers. On several occasions he had ex­
perienced coolness, pallor and numbness 
in either his index or long fingers for 
periods ranging from 5 to 10 minutes. 
These episodes seemed unrelated to posi­
tion, activity or temperature change and 
involved only his right hand. He was 
an accomplished musician who usually 
played the guitar for 3 hours each day 
but the symptoms of coolness and numb­
ness prevented this. Several weeks before 
admission he noticed a small, painless 
lump in the proximal hypothenar area. 
He gave no history of trauma to his 
hands.
The right upper extremity appeared 
normal except for a pulsating mass, 2 
cm in diameter, in the hypothenar emin­
ence. The mass was firm, not tender 
and fairly mobile, with no associated 
thrill or bruit. The distal circulation was 
normal at the time of examination, as 
were motor and sensory functions.
Occluding the radial artery at the 
wrist slightly diminished the pulsation in 
the mass but did not adversely affect 
circulation distally. When the ulnar ar­
tery was occluded, there was still good 
circulation to all fingertips but much 
less pulsation in the hypothenar mass. 
Other findings on physical examination 
and results of routine laboratory tests 
were normal.
Arteriography was done to outline the
FIG. 1— Arteriogram of right hand 
showing smooth-walled circular dilata­
tion at junction between ulnar artery and 
superficial palmar arch.
aneurysm and associated vessels (Fig. 1). 
This study supported the diagnosis of 
an aneurysm of the distal portion of the 
ulnar artery at its junction with the su­
perficial palmar arch.
At operation, with a pneumatic tourni­
quet in place, the aneurysm with-^Sroxi- 
mal and distal vessels was easily dis­
sected free from surrounding tissues. 
There was no fibrosis around the aneu­
rysm. Proximal and distal vessels ap­
peared to be normal (Fig. 2).
The aneurysm was resected leaving a 
gap of 2 cm in the ulnar artery, which 
was reconstructed using a reverse vein 
graft. Superficial vein, 2 mm in diameter, 
was taken from the dorsum of the hand 
and end-to-end microvascular anastomo­
sis done with 10-0 nylon sutures (Fig. 
3). Following release of the clamps, there 
was good flow through the anastomoses. 
Digital occlusion of the radial artery 
was continued for 15 minutes to en­
courage flow through the reconstructed 
vessel.
The resected aneurysm was in fact 
larger than it appeared on the arterio­
gram because the lumen was partially 
occluded by thrombus. The sac had a 
fairly thick wall and microscopic exam­
ination proved that it was a true aneu­
rysm (Fig. 4). There were no postoper­
ative complications and the patient was 
discharged from hospital 5 days after 
the operation. The Allen test performed 
2 weeks later gave a negative result and 
the patient was free of symptoms.
FIG. 2— Aneurysm at operation.
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Discussion
Peripheral artery aneurysms most 
commonly result from direct trauma 
due to a penetrating injury that dis­
rupts all three layers of the vascular 
wall. Arterial flow is usually main­
tained past the obstruction and the 
blood lost through the vessel wall is 
contained by surrounding tissues and 
becomes a pulsating hematoma. In a 
few weeks there is central liquefaction 
of the hematoma and a fibrous cap­
sule develops. This is a false aneu­
rysm. True aneurysms have a sac, 
formed by dilation of the whole ar­
terial wall. Thus, the true aneurysm 
contains elements of internal elastic 
lamina and smooth muscle, which can 
be demonstrated under the micro­
scope. True aneurysms may be trau­
matic, mycotic, arteriosclerotic, idio­
pathic or congenital.
In 1976, Chapuis and associates7 
reviewed the world literature and 
found only 47 cases of unilateral true 
aneurysms in the palm. There have 
been two reports of bilateral palmar 
ulnar artery aneurysms.8,9 However, 
the incidence of damaged ulnar ar­
teries in the palm is much higher.10 
In 1970, Conn and colleagues" sug­
gested the term hypothenar hammer 
syndrome to describe patients with 
vascular changes in the palm resulting 
in pathologic changes in the ulnar ar­
tery. Minor repetitive trauma causes 
vasospasm and intimal damage that 
may lead to vessel thrombosis or an­
eurysm formation.
There are three stages in the patho­
physiology of the hypothenar hammer 
syndrome. First, minor repetitive 
trauma causes distal vasospasm, which
FIG. 3— Vein graft in place.
remains reversible for a time. Second, 
greater or more prolonged injury oc­
curs in which damage to the vessel 
intima may result, followed by throm­
bosis and vascular occlusion, with dis­
tal spasm. Third, more severe trauma 
occurs in which the tunica media is 
injured with resultant weakness and 
aneurysm formation with distal vaso­
spasm and distal embolization. Hypo­
thenar hammer syndrome is best un­
derstood through an appreciation of 
the anatomical relations of the ulnar 
artery and superficial palmar arch and 
the hamate bone (Fig. 5). Here, just 
distal to Guyon’s canal, the vessel lies 
unprotected as it courses over the 
transverse carpal ligament and carpal 
bones. A force applied to the artery 
on its palmar and ulnar aspect will 
crush it against the unyielding hook 
of the hamate. Most true palmar an­
eurysms have been located in this 
segment of the artery.12
Symptoms are caused by local ir­
ritation of the hypothenar eminence 
by the aneurysm and by distal is­
chemic change in the fingers, includ­
ing coolness, pallor, ulcers and gan­
grene. The ischemic changes may be 
caused by vasospasm, emboli or vascu­
lar insufficiency. Neurologic changes 
may be related to direct pressure of 
the aneurysm on the ulnar nerve. The 
intermittent numbness and coolness of 
the fingers in our patient was likely 
due to vasospasm of the distal digital 
arteries or embolization from the an­
eurysm, which was partially occluded 
by thrombus.
Surgical resection is indicated for 
symptomatic arterial aneurysms of the 
palm. Surgical resection produces a 
local sympathectomy and removes the
source of embolization. Opinions dif­
fer on the need for restoring vessel 
continuity after resection. Most of the 
literature deals with hypothenar ham­
mer syndrome in which the condition 
was more often thrombosis than an­
eurysm.10"14 Millender and associates1, 
mentioned reanastomosis as a possibil­
ity but thought it unnecessary. Smith12 
stated that “collateral circulation is al­
ways sufficient” and that “no attempt 
need be made to restore continuity of 
the divided ends of the artery”. Conn 
and associates,11 concerned about plac­
ing incisions in the palm, preferred 
sympathectomy.
Given and associates14 reported 
their experience with two groups of 
47 patients having ulnar artery throm­
bosis. One group was treated mainly 
by resection and ligation. Of these, 
60% had excellent or good results 
while 40% remained unimproved. An-
FIG. S— Normal anatomic relations 
between ulnar artery and hook of ham­
ate bone.
FIG. 4—Section through aneurysm showing smooth muscle and elastic fibres 
identifying true aneurysm. Arrow points to internal elastic lamina. T =  thrombus 
in lumen, S =  smooth muscle (reduced by 19% from X40).
98 VOLUME 25, NO. 1, JAN U A R Y  1982 / THE CANADIAN JOURNAL OF SURGERY
other group underwent resection and 
vein graft reconstruction. In this 
group 89% had excellent or good 
results with only 11 % being unim­
proved. On the basis of these results 
they advised that an attempt should 
be made to re-establish normal flow.
There is no clear evidence to sup­
port the need for vascular restoration. 
Following resection, the presence of 
good back flow from the distal end 
may indicate that reconstitution of 
vessel continuity is unnecessary. Pa­
tients who do not have good back 
flow should have the vessel recon­
structed. Even when the circulation 
appears satisfactory through other 
routes, an interposition vein graft gives 
greater assurance that the supply is 
adequate and that a vascular reserve 
is available.
Conclusion
True aneurysms in the hand are un­
common. They are usually the result 
of closed trauma over the hypothenar 
area and have an understandable ana­
tomical basis. When they are symp­
tomatic, surgical resection is indicated 
and microsurgical reconstruction 
should he considered.
We thank Dr. M. Silver, department 
of pathology, University of Toronto, 
for the histologic interpretation.
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Nouvelle methode simplifiee d’implantation 
d’electrodes epicardiques temporaires
Y.F. Glock, md,* J.M. Herreros, md-t et F.J. T eijeira, md !
Les auteurs presentent une nouvelle 
methode simplifee d’implantation 
d’electrodes epicardiques temporaires 
realisable extemporanement, en 
per-operatoire, a partir d’une electrode 
standard. L'etude comparative avec 
I’electrode standard montre a I’etage 
auriculaire comme a I'etage 
ventriculaire, une amelioration des 
seuils myocardiques, tant au niveau 
du milliamperage que du voltage 
(P <  0.05 a I’etage auriculaire et 
P <  0.005 a I’etage ventriculaire).
Du departement de chirurgie 
cardio-vasculaire et thoracique,
Centre Hospitalier Universitaire de 
Sherbrooke, Sherbrooke, PQ
*Professeur adjoint, president IV  et 
Xprojesseur agrege et directeur du 
departement de chirurgie cardio- 
vasculaire et thoracique, Universite 
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Accepte pour publication le 28 
septembre, 1981
Les demandes de tires-a-part doivent 
etre adressees au D r FJ . Teijeira, 
Departement de chirurgie cardio- 
vasculaire et thoracique, Universite de 
Sherbrooke, Sherbrooke, PQ J1H 5N4
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Au 7e jour, cette mise en place 
d’electrode apparait plus fiable que 
I'electrode standard et montre une 
degradation moindre de ses 
caracteristiques (P <  0.05).
The authors present a new simplified 
method for implanting temporary 
epicardial electrodes, which can be 
carried out extemporaneously during 
operation from a standard electrode. 
The modified electrode showed an 
improvement over the standard 
electrode in the myocardial thresholds 
with respect to milliamperage as 
well as voltage at both atrial and 
ventricular levels (P <  0.05 for atrial 
and P <  0.005 for ventricular). On 
the 7th day after placement the 
modified electrode appears to be 
more reliable than the standard 
electrode and demonstrates less 
degeneration of its threshold and 
current characteristics (P <  0.05).
L’implantation d’electrodes epicardi­
ques temporaires est systematique 
pour la plupart des equipes chirurgi- 
cales. A I’etage ventriculaire, elle
permet de controler les troubles de 
conduction auriculo-ventriculaire et 
les bradyarythmies avec fibrillation 
auriculaire; a I’etage auriculaire, elle 
rend possible le diagnostic de certains 
troubles rythmiques supra-ventricu- 
laires par enregistrement d’un electro­
gramme auriculaire, et elle autorise le 
traitement des arythmies auriculaires 
en l’absence de fibrillation auricu­
laire.1'8
La stimulation auriculaire, conser- 
vant une systole auriculaire, ameliore 
les index et debit cardiaques.9
Le seuil de I’electrode epicardique 
temporaire augmente significativement 
en periode postoperatoire quand une 
electrode standard est utilisee.10,11 
Cette augmentation du seuil peut etre 
reduite si la partie denudee de l’elec- 
trode est exclusivement intra-myocar- 
dique.11-13 Nous proposons une nou­
velle technique d’implantation d'elec­
trodes epicardiques temporaires a par­
tir d’une electrode standard qui, a cet 
avantage, associe la simplicity tech­
nique. Nous avons etudie dans les 
jours postoperatoires, les caracteris­
tiques de cette electrode comparees a 
celles d’une electrode standard.
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P atien ts e t m ethode
Chez 14 patients ay ant subi une chi- 
rurgie cardiaque (12 pontages aorto- 
coronariens et 2 remplacements valvu- 
laires mitraux) nous avons implante 
des couples d’electrodes (O-Flexon 
2597.63; Davis & Geek, Willowdale, 
Ont.) a la face diaphragmatique du 
ventricule droit, une electrode placee 
selon la technique standard et la se- 
conde modifiee selon notre technique 
(figs. 1 a 3).
FIG . 1— Confection du harpon: l’e- 
lectrode standard est denudee de fayon 
a confectionner un “harpon” de Teflon 
sur une longueur (d) inferieure ou egale 
au trajet intra-myocardique.
FIG . 2— Mise en place de I’electrode 
par traction douce: la zone denudee est 
exclusivement intra-myocardique.
FIG . 3— Artifice de fixation de 1’e- 
lectrode par elle-meme a la peau.
L’implantation d’un couple d’elec­
trodes standard et modifie a ete pra- 
tiquee a l’etage auriculaire chez 11 
patients (10 pontages aorto-coronaires,
1 remplacement valvulaire mitral). 
Pour permettre une comparaison
des caracteristiques de l’electrode 
(seuil [volt], courant note [mA]); a) 
les caracteristiques de chaque elec­
trode d'un couple ont ete mesurees 
par rapport a une electrode souscuta- 
nee commune de reference, et b) 
chaque couple d’electrodes a ete im­
plante dans une aire myocardique de
2 cm2 afin d’eviter le biais lie aux 
variations de seuil inherent aux dif- 
ferentes zones de tissu myocardique. 
Ces mesures ont ete recueillies a l’aide 
d’un analyseur (Medtronic 5300, Med­
tronic Inc., Minneapolis, Minn.) a la
6' heure, et les 4e et 7e jours post- 
operatoires.
Nous avons compare les moyennes 
des differences observees entre I’elec- 
trode standard et l’electrode modifiee 
par le test de Student (significatif, P 
<  0.05).
Les mesures comparatives faites le 
1" jour sur 14 couples d’electrodes 
ventriculaires fonctionnelles et 11 
couples d’electrodes auriculaires fonc­
tionnelles, ont ete repetees au 7e jour 
sur 11 couples d’electrodes ventricu­
laires et 9 couples d’electrodes auricu­
laires fonctionnelles, ceci en raison de 
la dysfonction de l’electrode standard 
au T ' jour dans les autres cas.
R esultats
A l’etage ventriculaire, l’etude de
FIG. 4— Evolution de la moyenne (A) des differences d’amperage et de voltage 
entre I’electrode standard et I’electrode modifiee a l’etage ventriculaire au 1", 4* 
et 7e jour (P <  0.005). N  =  nom bre ,°s =  erreur type de la moyenne, t =  valeur 
absolue du t de Student.
FIG. 5— Evolution de la moyenne (A) des differences d’amperage et de 
voltage entre l’electrode standard et I’electrode modifiee a I’etage auriculaire au 
1", 4 et T  jour (P <  0.05).
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la moyenne des differences de courant 
recurrent observees est significative 
a la 6' heure, au 4e et au 7e jour (P < 
0.005) ou elle est respectivement de 
3.26 ±  0.70 mA, 3.39 ±  0.95 mA et 
5.14 ±  0.79 mA. Elle se fait toujours 
dans le sens d’un milliamperage mini­
mum pour notre electrode modifiee. 
On constate qu’elle augmente avec le 
temps du l er au 36 jour de fagon signi­
ficative (P < 0.05) (fig. 4).
En ce qui a trait au voltage requis, 
les constatations sont identiques (fig. 
4). La moyenne des differences au 1" 
jour (1.03 ±  0.21 V) au 4' jour 
(0.96 ±  0.46 V) et au T  jour (1.84 
±  0.21 V) est significative (P < 
0.05) en faveur de l’electrode modifiee 
qui montre le voltage le plus bas. 
Cette difference est accusee entre le 
1" et le 7* jour de fagon significative 
(P <  0.05).
A l’etage auriculaire, les constata­
tions sont superposables (fig. 5). La 
moyenne des differences de milliam­
perage entre l’electrode standard et 
l'electrode modifiee est significative 
(P <  0.05), ceci a la 6' heure (6.2 ±  
1.1 mA), au 4e jour (4.9 =t 1.4 mA) 
et au T  jour (5.3 ±  1.8 mA). II en 
est de meme des voltages requis dont 
les valeurs sont successivement de 2.44 
±  0.49 V au 1" jour, de 2.84 ±  0.5 
V au 4e jour et de 3.36 ±  0.66 V au 
T  jour. L’ablation des electrodes au 
T  jour s’est toujours faite sans aucun 
probleme.
Discussion
De nombreux auteurs insistent sur 
la necessite de l’implantation postope-
ratoire des electrodes epicardiques 
temporaires a l’etage auriculaire1,2'6'9 
et a l’etage ventriculaire.3'5,10-13
Nos resultats comme ceux des au- 
tres auteurs10"13 objectivent une aug­
mentation du milliamperage myocar- 
dique dans la phase postoperatoire 
dans l’electrode standard, ce qui re­
presente un danger letal en cas de 
dysfonctionnement, ou un inconfort 
du fait de la stimulation diaphragma- 
tique liee a la necessite d’un voltage 
plus fort. Cette majoration du seuil 
est liee a la fuite electrique due a la 
partie denudee extra-myocardique 
baignee par les fluides sero-sanguins 
pericardiques.10,11 Elle peut etre dimi- 
nuee par l’enfouissement intra-myo- 
cardique de la partie denudee de l’elec- 
trode. L’electrode epicardique tempo- 
raire de Yokoyama et Wada13 repre­
sente un modele different d’electrode 
alors que celle d’Aris et collabora- 
teurs,11 celle de Katsumoto12 et la 
notre sont realisables extemporane- 
ment a partir de l’electrode standard. 
Les resultats electriques sont super­
posables a ceux observes par ces 
auteurs.11'13 La fiabilite de notre elec­
trode par rapport a l’electrode stan­
dard est superieure. Au T  jour, 100% 
des electrodes modifiees sont fonction- 
nelles contre 81% des electrodes stan­
dards ventriculaires et 76% des elec­
trodes standards auriculaires. Notre 
simplification technique reside dans 
l’absence de points de fixation a ad- 
joindre tant au niveau du myocarde 
que de la peau. Notre electrode est 
arrimee a la peau et au coeur par 
elle-meme et son ablation se fait 
toujours sans probleme.
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ITEM 628
The instillation of any dye helps to detect a bladder injury. Indigo carmine is preferred because tissue- 
staining is reduced. Decreased urine flow from the urethral catheter, or the presence of bloody urine, 
is suggestive of some trauma, but is not diagnostic.’ Identifying the bladder and searching for a hole is 
not always reliable. An intraoperative intravenous pyelogram may be helpful in suspected ureteral 
injuries, but intravesical indigo carmine is a simpler procedure in this instance.
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Surgical Management of Pulmonary Metastases
G.A. Patterson, md, frcs[c], T.R.J. Todd, md, frcs[c], 
R. Ilves, md, frcs[c], F.G. Pearson, md, facs, frcs[c] 
and J.D. Cooper, md, frcs[c]
Between 1969 and 1979 at the Toronto 
General Hospital, 78 patients were 
assessed for possible resection of 
pulmonary metastases, assuming that 
the primary tumour was controlled 
and no other known metastatic foci 
were present. Primary tumours were 
renal in 16 patients, colorectal in 
15 and breast in 10; 11 had sarcoma,
5 melanoma and 21 had miscellaneous 
primary cancers. Metastases were 
resected in 64 patients. Thirteen 
patients did not undergo resection 
since additional information indicating 
inoperability was provided by whole 
lung tomography in 6, mediastinoscopy 
in 4 and thoracotomy in 3. One patient 
was considered medically to have 
inoperable disease.
There was one death postoperatively 
and major complications were 
encountered in six patients. Follow-up 
was possible in 62 of the 64 patients 
who underwent resection. Actuarial 
survival at 2 and 5 years was 63% 
and 42% respectively. Of 12 patients 
who had a disease-free interval of 
less than 12 months, only 3 are alive 
(mean survival 37.6 months). Of 48 
patients with a disease-free interval 
longer than 12 months, 24 are alive 
(mean survival 55.1 months). Six 
of 14 patients with primary tumour of 
the colorectum are alive a mean of 
40 months (range from 6 to 80 
months) after resection; the other 8 
survived a mean of 22 months (range 
from 5 to 61 months). Of 14 patients 
with renal tumours, only 3 are alive;
11 patients died, having survived
a mean of 22.5 months (range from 
3 to 59 months).
This review supports resection of 
pulmonary metastases in selected 
patients, particularly those with a 
disease-free interval of longer than
12 months.
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1969 et 1979, 78 malades ont ete 
evalues sur la possibilite de resequer 
des metastases pulmonaires, en 
supposant que la tumeur primaire etait 
jugulee et qu'aucun autre foyer 
metastatique connu n'etait present.
La tumeur primaire etait d’origine 
renale chez 16 patients, colorectale 
chez 15 et mammaire chez 10; 11 
avaient un sarcome, 5 un melanome 
et 21 avaient divers cancers primaires. 
Des metastases ont ete reseques 
chez 64 malades. Treize patients n'ont 
pas subi de resection a cause de 
■ 'information additionnelle obtenue par 
tomographie pulmonaire chez 6, par 
mediastinoscopie chez 4 et par 
thoracotomie chez 3 indiquant que 
la tumeur etait inoperable. Chez un 
malade, la maladie a ete consideree 
medicalement comme etant inoperable.
II y a eu un deces postoperatoire 
et des complications majeures ont ete 
rencontrees chez 6 patients. Les 
suites therapeutiques sont disponibles 
pour 62 des 64 patients qui ont subi 
la resection. Les taux de survie, a 
2 et 5 ans calcules par la methode 
actuarielle ont ete respectivement 
de 63% et 42%. Des 12 patients qui 
avaient eu un intervalle exempt de 
maladie de moins de 12 mois, 
seulement 3 sont vivants (survie 
moyenne de 37.6 mois). Des 48 malades 
qui avaient eu une periode exempte 
de maladie de plus de 12 mois, 24 
sont vivants (survie moyenne de 55.1 
mois). Six des 14 patients porteurs 
d'une tumeur du colon ou du rectum 
sont vivants, 40 mois en moyenne 
(ecart de 6 a 80 mois) apres la 
resection; les 8 autres ont survecu 
22 mois en moyenne (ecart de 5 a 
61 mois). Des 14. malades qui avaient 
une tumeur renale, seulement 3 sont 
vivants; 11 sont decedes apres avoir 
survecu durant une moyenne de 22.5 
mois (ecart de 3 a 59 mois).
Cette etude soutient la resection 
des metastases pulmonaires chez des 
patients choisis, particulierement 
chez ceux qui ont ete exempts de 
maladie pendant plus de 12 mois.
Traditionally patients with pulmonary 
metastases were thought to have wide­
spread unresectable disease. However, 
in 1935, Farrell1 demonstrated that
many patients who died o f pulmonary 
metastases had no other metastatic 
foci. Subsequently, in 1939, Barney 
and Churchill2 reported the first exci­
sion o f a metastatic pulmonary nodule 
resulting in long-term survival. Several 
reports followed advocating resection 
o f pulmonary metastatic lesions.3'6 
This approach is not universally ac­
cepted. Therefore, we have analysed 
our experience at the Toronto General 
Hospital between Jan. 1, 1969 and 
Dec. 31, 1978 in managing patients 
with pulmonary metastatic nodules.
Patients and Methods
Study Population
Seventy-eight patients (37 men, 41 
women; mean age 53.3 years) were 
considered for resection o f their pul­
monary metastatic lesions. Criteria for 
consideration included: (a) no evi­
dence o f residual primary tumour and 
(b) no initial evidence o f other meta­
static foci. The type o f primary tu­
mour is shown in Table I. O f the 78 
patients, 47 were asymptomatic but 
had an abnormal chest film. In the 
other 31 patients the commonest 
symptom was cough (24 cases). A  
solitary pulmonary metastasis was 
present in 47 patients while 31 had 
multiple metastatic tumours.
Diagnostic Investigations
The 10-year period o f this review
Table I—Type of Primary Tumour
No. of
Tumour type patients
Renal 16
Colorectal 15
Sarcoma 11
Breast 10
Melanoma 5
Cervical 5
Adenoid cystic 4
Endometrial 2
Bladder 2
Testicular 2
Ovarian 2
Pancreatic 1
Thyroid 1
Adamantinoma 1
Hemangiopericytoma 1
Total 78
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accounts for a certain variability in 
the investigations employed. Fifty-four 
patients had whole lung tomography; 
11 were found to have additional le­
sions not apparent on routine roent­
genography.
Percutaneous aspiration needle biop­
sy was attempted in 34 patients. A 
malignant neoplasm was diagnosed in 
26 (76%) and the tumour type specif­
ically identified in 20 of them (77%). 
In the other eight patients the results 
were negative mainly because of tech­
nical failure producing an inadequate 
sample for cytologic examination.
Forty-two patients underwent me­
diastinoscopy; in 37 patients no me- 
tastases were found. Mediastinoscopy 
gave a positive result in five patients: 
in three of seven patients with meta­
static breast carcinoma who under­
went this procedure, in one patient 
with metastatic adrenal carcinoma and 
in one with metastatic leiomyosar­
coma.
Patients with Inoperable Metastases
Fourteen patients did not undergo 
resection since additional information 
was gained during their investigation 
that precluded resection. In six of 
them multiple additional metastases 
were discovered by whole lung tomo­
graphy. Positive findings on media­
stinoscopy eliminated four others 
from consideration for resection (three 
with breast carcinoma and one with 
adrenocortical carcinoma). Three pa­
tients were found to have extensive or 
inoperable disease at thoracotomy and 
the chest was closed without resection. 
One elderly patient had refractory 
congestive heart failure.
Resection Group
Sixty-four patients underwent re­
section of 110 tumours (Table II). In 
three patients sternotomy was per­
formed for excision of bilateral tu­
mours and the remainder underwent 
thoracotomy. Fifty-three had a single 
thoracotomy and 8 had bilateral 
thoracotomies. Of the latter, three 
patients had synchronous bilateral 
thoracotomies and five had staged
procedures. There were 53 wedge re­
sections (including enucleation), 52 
lobectomies and 2 pneumonectomies.
R esults
Six patients had major complica­
tions. Four had respiratory failure and 
one of them required re-exploration 
for postoperative bleeding. Empyema 
with subsequent bronchopleural fis­
tula developed in one patient. A ster­
nal osteomyelitis and dehiscence oc­
curred in another. There was one 
death postoperatively.
Twenty-nine of the 62 patients fol­
lowed up are alive, 3 to 156 months 
after resection; only 6 of them have 
recurrent metastatic disease. Thirty- 
three patients died; 29 had definite
metastatic disease at the time of death. 
In 23 of the 29 death was thought 
to be due to the metastatic disease. 
The 2- and 5-year actuarial survival 
rates for the entire group were 63% 
and 42% respectively (Fig. 1). For 
patients with a disease-free interval 
longer than 12 months the comparable 
figures were 69% and 42% but for 
those with a disease-free interval of 
less than 12 months the rates were only 
40% and 20% respectively. Disease- 
free interval was defined as the in­
terval between effective control of 
the primary disease and presentation 
with pulmonary metastases. In 24 pa­
tients with multiple tumours, an ac­
tuarial survival of 67% and 40% at 
2 and 5 years, respectively, did not 
differ from the actuarial survival of
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FIG . 1— Actuarial survival following resection of pulmonary metastases for 
entire group (squares), including those with disease-free interval (DFI) of less than 
12 months (black circles) and those with D FI longer than 12 m onths (white 
circles). Numbers on curves represent num bers of patients alive and available 
for analysis in succeeding period.
FIG . 2— Actuarial survival of patients with single (squares) and multiple 
(circles) pulm onary metastases. N um bers on curves represent numbers of patients 
alive and available for analysis in succeeding period.
/
Table 11—Number of Tumours Resected per 
Patient
No. of patients No. of tumours resected
38 1
15 2
5 3
3 4
3 5
64 n o
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40 patients with single tumours (62% 
and 43%) (Fig. 2). When individual 
primary tumour types are considered, 
10 patients with sarcoma had a better 
survival than 14 patients with primary 
colorectal or 14 patients with renal 
tumours, although patients with colo­
rectal tumours fared better than those 
with renal carcinoma (Fig. 3).
D iscussion
Since the successful excision of a 
renal secondary tumour more than 40 
years ago by Barney and Churchill,2 
the removal of pulmonary metastatic 
tumours has been considered accept­
able under certain circumstances. The 
availability of more effective adjuvant 
therapy has also altered the philos­
ophy towards this group of patients.7 
Several series3-6,8 have reported favour­
able results in patients whose pul­
monary metastatic tumours were re­
sected. The majority of patients in 
our series were asymptomatic, abnor­
malities having been noted at routine 
radiologic assessment. This has been 
the finding of others.3 In many of 
our patients routine posteroanterior 
chest films were the only form of 
radiologic examination before the tu­
mour was resected. However, when 
whole lung tomography was used, it 
was found to be quite helpful; 20% 
of the time additional lesions were 
discovered. Significant management 
decisions were made as a result of 
the new information provided by to­
mography. This is especially true in 
recent years since sternotomy and ex­
cision of bilateral lesions have become 
more popular.
We could not assess the role of 
computerized axial tomography since
the equipment was available only in 
the later years of the study. However, 
this procedure has been shown in 
several reports9,10 to be more accurate 
than whole lung tomography in ident­
ifying additional pulmonary meta- 
stases. In one study, computerized 
axial tomography defined additional 
lesions in 35% of patients who had 
undergone routine tomographic assess­
ment.10 Unfortunately neither stand­
ard nor axial tomography can differ­
entiate benign from malignant pro­
cesses. In the study of Schaner and 
associates,9 60% of the additional le­
sions discovered by axial tomography 
were ultimately found to be benign. In 
our view computerized axial tomo­
graphy is a sensitive but not specific 
study, which should be carried out in 
any patient before a presumed meta­
static pulmonary nodule is removed.
Percutaneous aspiration needle biop­
sy has been used increasingly in re­
cent years as a diagnostic tool. In our 
hospital it provided an accurate and 
specific means of determining histol­
ogy. The morbidity associated with 
the procedure is restricted for the 
most part to easily managed pneu­
mothoraces.11 When expert cytologic 
interpretation of samples is available, 
it is a most worthwhile aid in the in­
vestigation of patients with pulmonary 
metastatic disease.
The value of mediastinoscopy is 
unclear. Of 42 patients who under­
went mediastinoscopy, 5 were found 
to have positive mediastinal nodes. As 
a result four were eliminated from 
consideration for resection. In the ma­
jority of patients with small peri­
pheral tumours mediastinoscopy gave 
negative results. Moreover, in all pa­
tients with colorectal, renal and sarco­
matous tumours who underwent me­
diastinoscopy the findings were nega­
tive. The only tumour type for which 
mediastinoscopy appeared to be val­
uable was primary breast cancer. 
Therefore, mediastinoscopy appears to 
be an appropriate procedure in situa­
tions where there are central or large 
multiple tumours or where metastatic 
nodules from primary breast cancer 
are suspected.
Median sternotomy was used in 
only three patients in this series, al­
though several patients who under­
went bilateral thoracotomy might have 
been better served by median ster­
notomy. In recent years we have 
found that sternotomy for bilateral 
disease is a favourable approach. The 
relative number of wedge resections 
and enucleations has also increased. 
In the early years of this review lo­
bectomy was performed for lesions 
that would now be managed by wedge 
resection. Thus, the ratio of wedge 
resections to lobectomy reported in 
this series is not representative of our 
current practice.
Some authors4’6 have advocated 
using the tumour doubling time to 
define more accurately the biologic 
nature of the specific metastases. 
They have reported increased survival 
in patients whose tumour doubling 
times exceeded 40 days. Tumour 
doubling time was available in only 
a few of the patients reported here 
and usually we did not use doubling 
time to select patients for resection. 
Although McCormack and Martini6 
found no correlation between disease- 
free interval and survival, we found 
a direct relation (Fig. 1).
The actuarial survival figures from 
our series compared favourably with 
those in the literature.3,6,8 We were 
surprised to find that patients with 
primary renal tumours had a shorter 
survival than those with colorectal 
tumours. Our findings support those 
of Joseph and colleagues5 who thought 
that multiplicity of tumours was less 
important than their biologic nature. 
We found no difference in actuarial 
survival between patients with single 
as opposed to multiple tumours.
C onclusions
The results reported here are no 
doubt influenced by additional forms 
of treatment (chemotherapy or radio­
therapy) received by many of the pa­
tients. Although the relative merit of 
these additional therapeutic measures 
cannot be assessed, the role of sur­
gery can be examined by this retro­
spective analysis. There is a clear
FIG. 3— Actuarial survival by tum our type. Black circles =  sarcomas, white 
circles -  colorectal tumours and squares =  renal tumours. Numbers on curves 
represent number of patients alive and available for analysis for succeeding period.
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Instructions to Contributorsplace for resection in those patients 
who have pulmonary metastatic dis­
ease in the presence of a controlled 
primary, and no evidence of active 
metastatic disease elsewhere. This is 
particularly true when the disease-free 
interval is at least 12 months. Such 
resections can be carried out with 
acceptable morbidity and mortality 
and provide a reasonable prognosis 
in the majority of cases. It is parti­
cularly difficult to assess whether the 
reasonable survival provided reflects 
the surgical intervention or the biol­
ogy of the tumour. It is strictly im­
possible to conduct appropriate ran­
domized trials as the individual tu­
mour-host relation is a completely 
controlled variable. However, we have 
demonstrated that resection carries a 
low risk, extirpates the tumour and is 
associated with a reasonable survival.
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en frangais ou en anglais, et accompagnes d ’une lettre demandant leur publica­
tion dans le Journal. Veuillez les dactylographier sur une seule face d ’une feuille 
non reglee avec double interligne et grandes marges.
Les principales unites de mesure doivent etre exprimees selon le Systeme inter­
national d’unites si c ’est possible.
Les illustrations telles que des photographies d ’appareils cliniques, des radio- 
graphies, des photomicrographies, des graphiques et des diagrammes, en 
triplicata, doivent etre fournies sous la forme d'epreuves sur papier glace sans 
montage, les bordures intactes, d ’un format ne depassant pas 20 X 25 cm. Cha- 
que illustration doit etre munie d ’une legende dactylographiee sur une page 
separee du texte de Particle. S'il s'agit de radiographie, envoyez une copie et non 
/ ’original. S ’i l s ’agit d ’une photomicrographie, indiquez le contraste et I ’echelle de 
I'agrandissement. Les lettres qui servent a identifier les elements d ’une illustra­
tion doivent etre d'une dimension suffisante afin de demeurer visibles lorsque les 
necessites de Pimpression imposent une reduction de Pimage fournie.
II ne faut pas qu’on puisse identifier un patient grace a une illustration a moins 
qu’il n'y ait expressement consenti par ecrit; faute de permission les traits de sa 
physionomie doivent etre obliteres.
Les illustrations en couleur ne seront publiees qu'aux frais de Pauteur. Si Pil­lustration provient d ’une autre source, il convient d ’obtenir tant de I ’auteur que 
de I ’editeur de I ’ouvrage dont elle est tiree, Pautorisation de s ’en servir aux fins de la publication.
II faut que les tableaux soient conformes au format rectangulaire du Journal et 
rediges sur des feuilles separees du texte, un tableau par feuille.
Les references doivent etre citees dans le texte au moyen d ’un chiffre et 
groupees dans I ’ordre a la fin de Particle selon la maniere de faire adoptee par ce 
Journal. Les references a des periodiques doivent etre conformes a celles dans cette revue.
11. T odd TRJ, W eisbrod G, T ao LC, Sanders 
DE, D elarue NC, C hamberlain DW, 
Ilves R, Pearson FG , Cass W , Cooper 
JD : Aspiration needle biopsy of thoracic 
lesions. A nn Thorac Surg  1981; 32: 154-61
Un resume, en franqais et aussi en anglais, qui ne doit pas depasser 125 mots 
doit accompagner chaque article sur une feuille separee.
A titre d ’approbation, un exemplaire du manuscrit redige sera envoye a I ’auteur 
mais non les epreuves.
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BOOK REVIEWS
ACUTE DISORDERS OF THE AB­
DOMEN. Diagnosis and Treatment. 
V.I. Sreenivas. 200 pp. Illust. Springer- 
Verlag New York Inc., New York, 
1980. $13.95, paperbound. ISBN 0- 
387-90483-2.
The author discusses conditions causing 
the acute abdomen in a concise, clear 
and concentrated fashion. The first part 
of the book outlines the steps of clinical 
investigation; the majority of the book 
discusses specific conditions that may re­
quire surgical intervention and the book 
concludes with a discussion of urologic 
and medical conditions that may simulate 
conditions for which surgical treatment 
is imperative. Each discussion follows 
the classical format of etiology, path­
ogenesis, signs and symptoms, laboratory 
investigations and radiologic or other 
investigations. Where appropriate, illus­
trative roentgenograms have been in­
cluded. These are of high quality and
clearly show all the pertinent findings.
This has been accomplished in 195 
pages and the book has the advantage of 
“one author” evenness of presentation. If 
there is any criticism, it would be that in­
formation is so concise that it is not easy 
to read about a number of conditions 
and sort out all the pertinent details.
This book is particularly suited to the 
needs of clinical clerks, junior residents 
and family practitioners who are faced 
early in their career, or infrequently, 
with patients suffering from abdominal 
pain of perplexing origin. At $13.95 it 
is an excellent buy and should be in 
every emergency department and in the 
library of medical students and junior 
residents. It is a good book.
N.T. McPhedran, md, frcs[c], facs
Professor of surgery,
University of Calgary,
Calgary, Alta.
MANUEL I)U TRAITEMENT ORTHO- 
PEDIQUE DES FRACTURES. Des 
membres et des ceintures. R. Borgi, 
J. Butel, R. Seringe, F. Fassier et G. 
Frere. 171 pp. Illust. Masson, Paris, 
1981. Prix non mentionne. ISBN 2- 
225-67420-5.
The small size of this book is deceiving 
in the sense that the amount of informa­
tion contained in it is valuable, even 
excessive; many methods described 
have never been used on this continent 
and others are rarely used at present, 
even in Europe. This makes the book 
in some parts little more than a list of 
methods available for a particular frac­
ture. The authors state clearly for each 
fracture which method they prefer, but 
in some the technique could have been 
elaborated. The book will give the 
uninitiated a complete listing of all the 
methods for the closed treatment of frac­
tures. It may be useful for the exper­
ienced orthopedist who occasionally 
wishes to resort to infrequently used tech­
niques and for whom few instructions 
plus his own experience would allow the 
use of the methods without further con­
sultation. The intermediate resident or 
orthopedist will have to use the biblio­
graphy for detail on the techniques be­
fore attempting some of them. This 
bibliography, at the end of each chapter, 
is quite complete and pertinent.
I enjoyed reading this book and agree 
entirely with the prologue by Professor 
Merle d’Aubigne that the authors have 
made a good effort to provide an in­
ventory of the closed methods for treat­
ing fractures, and that it is important 
to remind orthopedists that fractures 
should be treated by the simplest method 
that gives the best result with the fewest 
complications.
Jorge Basora, md. frcs[c]
Director, department of orthopedics. 
Centre Hospitalier Universitaire, 
Universite de Sherbrooke,
Sherbrooke, PQ
OPERATIVE TECHNIQUES IN VAS­
CULAR SURGERY. Edited by John 
J. Bergan and James S.T. Yao. 310 
pp. Illust. Grune & Stratton, Inc., New 
York, 1980. $54. ISBN 0-8089-1334-4.
Devoted to the technical aspects of vas­
cular surgery, “Operative Techniques in 
Vascular Surgery” is based on a sympo­
sium organized by Drs. Bergan and Yao. 
The book is comprehensive and includes
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sections on surgery of the aorta and its 
branches, cerebral revascularization, sur­
gery of the upper extremity, femoral and 
infrageniculate arterial bypass, reopera­
tion for graft complications, extra-ana­
tomical bypass, portal hypertension and 
direct venous reconstructive surgery. The 
numerous contributors are all eminent 
surgeons, well known for the contribu­
tions they have made in the specific area 
they present. For example, who is more 
qualified to write about thoracoabdomin­
al aortic aneurysms than E. Stanley 
Crawford, or carotid surgery than Jesse 
E. Thompson or the LeVeen shunt than 
Harry H. LeVeen? Moreover, this book 
has an international flavour including 
chapters by H.H.G. Eastcott and R.M. 
Greenhalgh from London, and by Henner 
Miiller-Wiefel from Dusseldorf.
This book is basically a technical atlas 
and as such consists of a series of illus­
trations with a complementary text. 
Since each contributor was obviously 
responsible for his own illustrations, there 
is a wide discrepancy in type and qual­
ity, but in general they are clear and 
well annotated. The accompanying text 
is concise and appropriate.
Almost all techniques currently used 
in vascular surgery are described. Al­
though the experienced vascular surgeon 
may find relatively little that is new, 
it does afford him the opportunity to 
reinforce his experience and compare his 
techniques with those of recognized au­
thorities. Furthermore, even the very 
experienced surgeon will pick up a trick 
or two that may allow him to simplify 
a procedure. This book will prove in­
valuable to the resident in training and 
to the novice vascular surgeon and in­
NOT1CES
continued from page 78
Neurosurgery Postgraduate Course
The 12th Annual Neurosurgery Post­
graduate Course and the 6th Annual 
Neurosurgical Nurses’ Conference will 
be held on June 3 and 4, 1982 in San 
Francisco, California. The course will 
provide an update on selected, often 
controversial, topics in clinical neuro­
surgery. The lectures will be presented 
by a distinguished visiting faculty: 
Fred Epstein, Irvin Kricheff, Leonard 
Malis and Robert Spetzler. Selected 
faculty from the University of Califor­
nia at San Francisco will also parti­
cipate.
Cerebral and spinal neoplasms, ce­
rebrovascular disease and recent clin­
ically relevant advances in the neuro­
logic sciences will be covered in depth. 
In addition to the didactic sessions, 
there will be luncheon discussions be­
tween small groups of registrants and 
individulal members of the faculty on 
a variety of neurosurgical problems.
This program is presented by the
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deed should be considered a must for 
every vascular trainee. It represents a 
1980 state of the art collection of vas­
cular surgical techniques.
N athan M. Sheiner, md, frcs[c]
Chief, cardiovascular and thoracic 
surgery,
The Sir Mortimer B. Davis- 
Jewish General Hospital,
Montreal, PQ
STATUS OF THE CURABILITY OF 
CHILDHOOD CANCERS. The Uni­
versity of Texas System Cancer Center 
M.D. Anderson Hospital and Tumor 
Institute 24th Annual Clinical Con­
ference on Cancer. Edited by Jan van 
Eys and Margaret P. Sullivan. 329 pp. 
Illust. Raven Press, New York, 1980. 
$31.50. ISBN 0-89004-478-3.
Among pediatric diseases, cancer is the 
leading cause of death. This book is a 
compilation of papers presented on the 
subject at a recent symposium held at 
the M.D. Anderson Hospital and Tumor 
Institute in Houston, Texas. The authors 
are recognized leaders in their respective 
fields; half of them are from the M.D. 
Anderson Hospital.
The working papers are divided into 
four sections. The first deals with defini­
tion of biologic and functional “cures”, 
the role of supportive therapy in attain­
ing current cure rates and a discussion 
of statistical methods. The second sec­
tion addresses the contributions of sur­
gery, chemotherapy and radiotherapy to 
improved survival rates in patients with 
solid tumours. The lack of appreciable
improvement in the treatment of brain 
tumours and metastatic neuroblastoma 
in children over 1 year of age is no­
table. The third part deals with the leu­
kemias and lymphomas. Salient features 
include an overview of Hodgkin’s dis­
ease and the influence of front-end prog­
nostic factors (those present in children 
with acute lymphoblastic leukemia at 
diagnosis that help categorize them as 
being at low or high risk for relapse). 
These factors include leukocyte count, 
the presence or absence of central-nerv­
ous-system leukemia, of a thymic mass 
on the chest film and of thymus-derived 
(T cell) or bursa-derived (B cell) sur­
face markers on bone-marrow lympho­
blasts. The final section deals with the 
physical and neuropsychologic sequelae 
in long-term survivors, including the 
spectre of a second malignant lesion. The 
risks of genetic aberrations in the off­
spring of survivors and methods of pre­
venting cancer are discussed. While there 
is some overlap and repetition of subject 
matter, this book highlights the advances 
in survival made with standardized pro­
tocol studies, the value of a multidis­
ciplinary approach to treatment and the 
need for minimizing therapy in selected 
cases to preserve the physical and psy­
chologic integrity of long-term survivors.
This book will be useful to any health 
professional interested in the manage­
ment of cancer in children. It summar­
izes the current state of the art with 
regard to childhood cancers.
S.K. Ali, md, bs. frcp[c]
Pediatric hematology/oncology,
Janeway Child Health Centre,
St. John's, Nfld.
department of neurological surgery of 
the University of California School of 
Medicine at San Francisco. It is spon­
sored by Extended Programs in Med­
ical Education and will meet the 
criteria for 16 hours of ACCM E/ 
AM A/CM A Category 1 (formal) con­
tinuing education credit for physi­
cians. The program is also approved 
for nursing credit.
For further information, please 
write: Extended Programs in Medical 
Education, University of California 
School of Medicine, Room 569-U, 
Third and Parnassus, San Francisco, 
CA 94143, or call (415) 666-4251.
Conference on Total Hip Joint 
Replacement
Sponsored by the National Institute 
of Arthritis, Diabetes, and Digestive 
and Kidney Diseases with assistance 
from the National Institutes of Health 
Office for Medical Applications of 
Research, a consensus development 
conference on total hip joint replace­
ment will be held Mar. 1 to 3, 1982
at the Masur Auditorium, Building 10, 
National Institutes of Health in Beth- 
esda, Maryland.
The conference is designed to con­
duct a scientific evaluation of the safe­
ty and effectiveness of total hip joint 
replacement procedures. Key ques­
tions to be addressed are: W hat are 
the indications and contraindications 
for total hip joint replacement? W hat 
are the current scientific principles 
guiding selection of materials, devices, 
and procedures? What is the short- 
and long-term prognosis, with respect 
to medical status and functional ac­
tivity after total hip joint replacement? 
What are the problems related to re­
vision surgery for total hip joint re­
placements? What advances in science 
and technical skill lie in the future for 
total hip joint replacement?
On the first two days of the con­
ference, experts in the procedures for 
total hip joint replacement will present 
data on safety and efficacy. A consen­
sus panel, comprising specialists and 
generalists, will consider the evidence 
presented and issue a draft statement
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responding to the key conference 
questions. On the third day, this draft 
statement will be read to the con­
ference audience and comments and 
questions invited.
For program information write to: 
Stephen L. Gordon, Ph.D.. Director, 
musculoskeletal diseases program, Na­
tional Institute of Arthritis, Diabetes.
PETER EASTHOPE E.I.T.
B.A.Sc. Mechanical Engineering 
M.Sc. Pathology
Consultant in biomechanics and 
design of clinical devices.
3760-72nd St.
RR #1
Delta, BC V4K 3N2 
(604) 382-9315, 946-4952
— S82-005
GENERAL SURGEON —  FRCS(C), wide experi- 
ence in trauma, vascular and Gl endoscopy 
seeks position in solo or group practice. Reply: 
Box S101, CJS. — S82-001
ACADEMIC APPOINTMENT: ONT. —  Applica­
tions are invited for a full-time position in the 
Department of Urology at Queen’s University. 
The successful applicant w ill have responsibility 
for teaching in an established postgraduate pro­
gram involving clinical practice and administra­
tion. There are excellent opportunities for basic 
and clinical research. Please send curriculum 
vitae with names of three referees to: Dr. A. 
Morales, Acting Head, Department of Urology, 
Queen's University, Kingston, Ontario, Canada 
K7L 2V7. — S82-004
OTOLARYNGOLOGIST: ONT. —  required for 
peripheral general hospital —  Metropolitan Tor­
onto. Full-time staff appointment. Please send 
particulars to: Dr. M. Charendoff, Head, Depart­
ment of Surgery, c/o Medical Staff Office, North 
York Branson Hospital, 555 Finch Ave. W., Wil- 
lowdale, Ont. M2R 1N5. — S82-003
CRITICAL CARE FELLOWSHIP —  Surgical In­
tensive Care Unit, University Hospital, Univer­
sity of Saskatchewan, Saskatoon, Saskatchewan. 
One year, renewable once, for physicians who 
are eligible for the Royal College Certification 
Examination in General Surgery or Anesthesia. 
Experience offered in: Surgical critical care mul­
tidisciplinary unit in multiple trauma, open-heart 
surgery, major complications following general 
surgical procedures, neurosurgical post-op care 
and infections in critically ill patients. Competi­
tive salary. Opportunities for clinical research 
available. Positions open from January 2, 1982, 
Send curriculum vitae to: Jaime C. Pinilla, MD, 
FRCS(C), Director, Surgical Intensive Care Unit, 
Department of Surgery, University Hospital, Sas­
katoon, Sask. S7N 0W0. — S82-002
and Digestive and Kidney Diseases, 
Westwood Building, Rm. 405. Beth- 
esda, MD 20205. or call (301) 496- 
7326.
For administrative information 
write to: Mr. Peter Murphy, Prospect 
Associates, 11325 Seven Locks Rd., 
Ste. 220, Potomac, MD 20854, or 
call (301) 983-0535.
Ewart Angus Surgical Intensive Care Unit, 
Wellesley Hospital, Toronto. Available July 1, 
1S82 for a period of one year in a multi­
disciplinary acute surgical unit with 600 
admissions per year. Duties will include 
patient care and clinical research in a strong 
academic and teaching unit with all types of 
patient population excepting cardiac surgery. 
Reply to: Dr. D.P. Jones, Director, Surgical 
ICU, Suite 219, E.K. Jones Building, 160 
Wellesley St. E., Toronto, Ont. M4Y 1J3. (416) 
966-6656 —  S81-019
Sofra-H ille
Framycetin Sulphate
ROUSSEL
ANTIBIOTIC
Indications: Treatment of infected or potentially 
infected burns, crush injuries, lacerations. Also vari­
cose ulcers, bedsores and ulcerated wounds.
Contraindications: Known allergy to lanolin or fra­
mycetin. Cross-sensitization may occur among the 
group of streptomyces-derived antibiotics (neomycin, 
paromomycin, kanamycin) of which framycetin is a 
member, but this is not invariable.
Precautions: In most cases absorption of the anti­
biotic is so slight that it can be discounted. Where 
very large body areas are involved (e.g. 30% or more 
body burn), the possibility of ototoxicity being even­
tually produced should be considered. Prolonged use 
of antibiotics may result in the overgrowth of non- 
susceptible organisms, including fungi. Appropriate 
measures should be taken if this occurs.
Dosage: A single layer to be applied directly to the 
wound and covered with an appropriate dressing. If 
exudative,dressings should be changed at least daily. 
In case of leg ulcers cut dressing accurately to size 
of ulcer.
Supplied: A  lightweight, paraffin gauze dressing 
impregnated with 1%  framycetin sulphate B.P. 
Sofra-Tulle also contains anhydrous lanolin 9.95%. 
Available in 2 sizes: 10 cm by 10 cm sterile single 
units, cartons of 10 and 50; 10 cm by 30 cm sterile 
single units, cartons of 10. Store at controlled room 
temperature.
CLASSIFIED ADVERTISING
As a further service to its readers the Canadian Journal of Surgery is pleased 
to accept suitable classified advertisements. The deadline is I month before 
issue date. Regular classified rates (for each insertion): $31.00 for the first 
40 words or less, additional words 30« each, to maximum of 150 words 
(additional $12.00 for frame). Special Display under 75 words, 244" X2", 
$75.00. $5.00 charge (first insertion only) for CJS box numbers. Display 
rates available on request.
Copy should be mailed to the Canadian Journal of Surgery, PO Box 
8650, Ottawa, Ontario K1G 0G8.
CLINICAL FELLOWSHIP
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